<full-text-retrieval-response xmlns="http://www.elsevier.com/xml/svapi/article/dtd" xmlns:bk="http://www.elsevier.com/xml/bk/dtd" xmlns:cals="http://www.elsevier.com/xml/common/cals/dtd" xmlns:ce="http://www.elsevier.com/xml/common/dtd" xmlns:ja="http://www.elsevier.com/xml/ja/dtd" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:sa="http://www.elsevier.com/xml/common/struct-aff/dtd" xmlns:sb="http://www.elsevier.com/xml/common/struct-bib/dtd" xmlns:tb="http://www.elsevier.com/xml/common/table/dtd" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xocs="http://www.elsevier.com/xml/xocs/dtd" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"><coredata><prism:url>https://api.elsevier.com/content/article/pii/S0223523418309449</prism:url><dc:identifier>doi:10.1016/j.ejmech.2018.10.067</dc:identifier><eid>1-s2.0-S0223523418309449</eid><prism:doi>10.1016/j.ejmech.2018.10.067</prism:doi><pii>S0223-5234(18)30944-9</pii><dc:title>A novel series of napabucasin derivatives as orally active inhibitors of signal transducer and activator of transcription 3 (STAT3) </dc:title><prism:publicationName>European Journal of Medicinal Chemistry</prism:publicationname><prism:aggregationType>Journal</prism:aggregationtype><pubType>fla</pubtype><prism:issn>02235234</prism:issn><prism:volume>162</prism:volume><prism:startingPage>543</prism:startingpage><prism:endingPage>554</prism:endingpage><prism:pageRange>543-554</prism:pagerange><dc:format>text/xml</dc:format><prism:coverDate>2019-01-15</prism:coverdate><prism:coverDisplayDate>15 January 2019</prism:coverdisplaydate><prism:copyright>© 2018 Elsevier Masson SAS. All rights reserved.</prism:copyright><prism:publisher>Elsevier Masson SAS.</prism:publisher><dc:creator>Li, Chungen</dc:creator><dc:creator>Chen, Caili</dc:creator><dc:creator>An, Qi</dc:creator><dc:creator>Yang, Tao</dc:creator><dc:creator>Sang, Zitai</dc:creator><dc:creator>Yang, Yang</dc:creator><dc:creator>Ju, Yuan</dc:creator><dc:creator>Tong, Aiping</dc:creator><dc:creator>Luo, Youfu</dc:creator><dc:description>
                  The transcription factor STAT3 is an attractive target for a variety of cancers therapy. Napabucasin, applied in phase III clinical trials for the treatment of a variety of cancers, was regarded as one of the most promising anticancer drug by targeting STAT3. Herein, a novel series of napabucasin derivatives were designed and synthesized, which presented a potent inhibitory activity on a variety of cancers cells. Among the derivatives compound 8q exhibited potent inhibitory activity on U251, HepG2, HT29 and CT26 cells with the IC50 values of 0.22, 0.49, 0.07 and 0.14 μM, respectively, which was over 10-fold more potent than napabucasin. Treatment with compound 8q decreased protein expression level of total STAT3 and p-STAT3Y705 
                     in vitro. The binding of compound 8q with STAT3 were further validated by electrophoretic mobility shift assay and surface plasmon resonance analysis. Compound 8q has a KD of 110.2 nM for full-length STAT3 recombinant protein. Moreover, the aqueous solubility of 8q was over 4.5-fold than that of napabucasin. In addition, compound 8q 
                     in vivo significantly reduced tumor growth compared to untreated mice, and exhibited good safety profile, indicating its great potential as an efficacious drug candidate for oncotherapy.
               </dc:description><openaccess>0</openaccess><openaccessArticle>false</openaccessarticle><openaccessType/></openaccesstype><openArchiveArticle>false</openarchivearticle><openaccessSponsorName/></openaccesssponsorname><openaccessSponsorType/></openaccesssponsortype><openaccessUserLicense/></openaccessuserlicense><dcterms:subject>Antitumor activity</dcterms:subject><dcterms:subject>STAT3 inhibitors</dcterms:subject><dcterms:subject>Napabucasin derivatives</dcterms:subject><link href="https://api.elsevier.com/content/article/pii/S0223523418309449" rel="self"/></link><link href="https://www.sciencedirect.com/science/article/pii/S0223523418309449" rel="scidir"/></link></coredata><objects><object ref="figs1" category="standard" type="IMAGE-DOWNSAMPLED" multimediatype="JPEG image file" mimetype="image/jpeg" width="176" height="88" size="5979">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523418309449-figs1.jpg?httpAccept=%2A%2F%2A</object><object ref="fx1" category="standard" type="IMAGE-DOWNSAMPLED" multimediatype="JPEG image file" mimetype="image/jpeg" width="500" height="129" size="17547">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523418309449-fx1.jpg?httpAccept=%2A%2F%2A</object><object ref="fx10" category="standard" type="IMAGE-DOWNSAMPLED" multimediatype="JPEG image file" mimetype="image/jpeg" width="30" height="37" size="939">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523418309449-fx10.jpg?httpAccept=%2A%2F%2A</object><object ref="fx11" category="standard" type="IMAGE-DOWNSAMPLED" multimediatype="JPEG image file" mimetype="image/jpeg" width="29" height="45" size="995">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523418309449-fx11.jpg?httpAccept=%2A%2F%2A</object><object ref="fx12" category="standard" type="IMAGE-DOWNSAMPLED" multimediatype="JPEG image file" mimetype="image/jpeg" width="38" height="40" size="891">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523418309449-fx12.jpg?httpAccept=%2A%2F%2A</object><object ref="fx13" category="standard" type="IMAGE-DOWNSAMPLED" multimediatype="JPEG image file" mimetype="image/jpeg" width="30" height="44" size="947">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523418309449-fx13.jpg?httpAccept=%2A%2F%2A</object><object ref="fx14" category="standard" type="IMAGE-DOWNSAMPLED" multimediatype="JPEG image file" mimetype="image/jpeg" width="48" height="46" size="970">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523418309449-fx14.jpg?httpAccept=%2A%2F%2A</object><object ref="fx15" category="standard" type="IMAGE-DOWNSAMPLED" multimediatype="JPEG image file" mimetype="image/jpeg" width="65" height="44" size="1301">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523418309449-fx15.jpg?httpAccept=%2A%2F%2A</object><object ref="fx16" category="standard" type="IMAGE-DOWNSAMPLED" multimediatype="JPEG image file" mimetype="image/jpeg" width="62" height="47" size="1289">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523418309449-fx16.jpg?httpAccept=%2A%2F%2A</object><object ref="fx17" category="standard" type="IMAGE-DOWNSAMPLED" multimediatype="JPEG image file" mimetype="image/jpeg" width="66" height="45" size="1322">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523418309449-fx17.jpg?httpAccept=%2A%2F%2A</object><object ref="fx18" category="standard" type="IMAGE-DOWNSAMPLED" multimediatype="JPEG image file" mimetype="image/jpeg" width="72" height="42" size="1376">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523418309449-fx18.jpg?httpAccept=%2A%2F%2A</object><object ref="fx19" category="standard" type="IMAGE-DOWNSAMPLED" multimediatype="JPEG image file" mimetype="image/jpeg" width="64" height="26" size="1121">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523418309449-fx19.jpg?httpAccept=%2A%2F%2A</object><object ref="fx2" category="standard" type="IMAGE-DOWNSAMPLED" multimediatype="JPEG image file" mimetype="image/jpeg" width="195" height="71" size="3789">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523418309449-fx2.jpg?httpAccept=%2A%2F%2A</object><object ref="fx20" category="standard" type="IMAGE-DOWNSAMPLED" multimediatype="JPEG image file" mimetype="image/jpeg" width="54" height="34" size="1226">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523418309449-fx20.jpg?httpAccept=%2A%2F%2A</object><object ref="fx21" category="standard" type="IMAGE-DOWNSAMPLED" multimediatype="JPEG image file" mimetype="image/jpeg" width="54" height="28" size="1125">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523418309449-fx21.jpg?httpAccept=%2A%2F%2A</object><object ref="fx22" category="standard" type="IMAGE-DOWNSAMPLED" multimediatype="JPEG image file" mimetype="image/jpeg" width="61" height="35" size="1159">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523418309449-fx22.jpg?httpAccept=%2A%2F%2A</object><object ref="fx23" category="standard" type="IMAGE-DOWNSAMPLED" multimediatype="JPEG image file" mimetype="image/jpeg" width="65" height="35" size="1140">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523418309449-fx23.jpg?httpAccept=%2A%2F%2A</object><object ref="fx24" category="standard" type="IMAGE-DOWNSAMPLED" multimediatype="JPEG image file" mimetype="image/jpeg" width="66" height="34" size="1137">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523418309449-fx24.jpg?httpAccept=%2A%2F%2A</object><object ref="fx25" category="standard" type="IMAGE-DOWNSAMPLED" multimediatype="JPEG image file" mimetype="image/jpeg" width="65" height="37" size="1097">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523418309449-fx25.jpg?httpAccept=%2A%2F%2A</object><object ref="fx26" category="standard" type="IMAGE-DOWNSAMPLED" multimediatype="JPEG image file" mimetype="image/jpeg" width="79" height="35" size="1311">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523418309449-fx26.jpg?httpAccept=%2A%2F%2A</object><object ref="fx27" category="standard" type="IMAGE-DOWNSAMPLED" multimediatype="JPEG image file" mimetype="image/jpeg" width="78" height="34" size="1359">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523418309449-fx27.jpg?httpAccept=%2A%2F%2A</object><object ref="fx28" category="standard" type="IMAGE-DOWNSAMPLED" multimediatype="JPEG image file" mimetype="image/jpeg" width="65" height="43" size="1335">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523418309449-fx28.jpg?httpAccept=%2A%2F%2A</object><object ref="fx29" category="standard" type="IMAGE-DOWNSAMPLED" multimediatype="JPEG image file" mimetype="image/jpeg" width="64" height="42" size="1378">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523418309449-fx29.jpg?httpAccept=%2A%2F%2A</object><object ref="fx3" category="standard" type="IMAGE-DOWNSAMPLED" multimediatype="JPEG image file" mimetype="image/jpeg" width="34" height="29" size="898">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523418309449-fx3.jpg?httpAccept=%2A%2F%2A</object><object ref="fx30" category="standard" type="IMAGE-DOWNSAMPLED" multimediatype="JPEG image file" mimetype="image/jpeg" width="66" height="48" size="1412">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523418309449-fx30.jpg?httpAccept=%2A%2F%2A</object><object ref="fx31" category="standard" type="IMAGE-DOWNSAMPLED" multimediatype="JPEG image file" mimetype="image/jpeg" width="70" height="47" size="1435">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523418309449-fx31.jpg?httpAccept=%2A%2F%2A</object><object ref="fx32" category="standard" type="IMAGE-DOWNSAMPLED" multimediatype="JPEG image file" mimetype="image/jpeg" width="68" height="49" size="1436">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523418309449-fx32.jpg?httpAccept=%2A%2F%2A</object><object ref="fx33" category="standard" type="IMAGE-DOWNSAMPLED" multimediatype="JPEG image file" mimetype="image/jpeg" width="88" height="39" size="1479">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523418309449-fx33.jpg?httpAccept=%2A%2F%2A</object><object ref="fx34" category="standard" type="IMAGE-DOWNSAMPLED" multimediatype="JPEG image file" mimetype="image/jpeg" width="88" height="40" size="1530">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523418309449-fx34.jpg?httpAccept=%2A%2F%2A</object><object ref="fx35" category="standard" type="IMAGE-DOWNSAMPLED" multimediatype="JPEG image file" mimetype="image/jpeg" width="56" height="36" size="1128">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523418309449-fx35.jpg?httpAccept=%2A%2F%2A</object><object ref="fx4" category="standard" type="IMAGE-DOWNSAMPLED" multimediatype="JPEG image file" mimetype="image/jpeg" width="33" height="35" size="916">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523418309449-fx4.jpg?httpAccept=%2A%2F%2A</object><object ref="fx5" category="standard" type="IMAGE-DOWNSAMPLED" multimediatype="JPEG image file" mimetype="image/jpeg" width="36" height="34" size="884">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523418309449-fx5.jpg?httpAccept=%2A%2F%2A</object><object ref="fx6" category="standard" type="IMAGE-DOWNSAMPLED" multimediatype="JPEG image file" mimetype="image/jpeg" width="56" height="40" size="1090">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523418309449-fx6.jpg?httpAccept=%2A%2F%2A</object><object ref="fx7" category="standard" type="IMAGE-DOWNSAMPLED" multimediatype="JPEG image file" mimetype="image/jpeg" width="29" height="35" size="887">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523418309449-fx7.jpg?httpAccept=%2A%2F%2A</object><object ref="fx8" category="standard" type="IMAGE-DOWNSAMPLED" multimediatype="JPEG image file" mimetype="image/jpeg" width="30" height="33" size="834">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523418309449-fx8.jpg?httpAccept=%2A%2F%2A</object><object ref="fx9" category="standard" type="IMAGE-DOWNSAMPLED" multimediatype="JPEG image file" mimetype="image/jpeg" width="29" height="35" size="842">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523418309449-fx9.jpg?httpAccept=%2A%2F%2A</object><object ref="gr1" category="standard" type="IMAGE-DOWNSAMPLED" multimediatype="JPEG image file" mimetype="image/jpeg" width="649" height="253" size="30993">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523418309449-gr1.jpg?httpAccept=%2A%2F%2A</object><object ref="gr2" category="standard" type="IMAGE-DOWNSAMPLED" multimediatype="JPEG image file" mimetype="image/jpeg" width="650" height="130" size="13929">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523418309449-gr2.jpg?httpAccept=%2A%2F%2A</object><object ref="gr3" category="standard" type="IMAGE-DOWNSAMPLED" multimediatype="JPEG image file" mimetype="image/jpeg" width="377" height="260" size="14994">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523418309449-gr3.jpg?httpAccept=%2A%2F%2A</object><object ref="gr4" category="standard" type="IMAGE-DOWNSAMPLED" multimediatype="JPEG image file" mimetype="image/jpeg" width="657" height="400" size="69578">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523418309449-gr4.jpg?httpAccept=%2A%2F%2A</object><object ref="gr5" category="standard" type="IMAGE-DOWNSAMPLED" multimediatype="JPEG image file" mimetype="image/jpeg" width="521" height="153" size="21752">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523418309449-gr5.jpg?httpAccept=%2A%2F%2A</object><object ref="gr6" category="standard" type="IMAGE-DOWNSAMPLED" multimediatype="JPEG image file" mimetype="image/jpeg" width="795" height="257" size="111642">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523418309449-gr6.jpg?httpAccept=%2A%2F%2A</object><object ref="gr7" category="standard" type="IMAGE-DOWNSAMPLED" multimediatype="JPEG image file" mimetype="image/jpeg" width="528" height="363" size="45615">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523418309449-gr7.jpg?httpAccept=%2A%2F%2A</object><object ref="gr8" category="standard" type="IMAGE-DOWNSAMPLED" multimediatype="JPEG image file" mimetype="image/jpeg" width="532" height="239" size="26092">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523418309449-gr8.jpg?httpAccept=%2A%2F%2A</object><object ref="sc1" category="standard" type="IMAGE-DOWNSAMPLED" multimediatype="JPEG image file" mimetype="image/jpeg" width="522" height="198" size="14616">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523418309449-sc1.jpg?httpAccept=%2A%2F%2A</object><object ref="sc2" category="standard" type="IMAGE-DOWNSAMPLED" multimediatype="JPEG image file" mimetype="image/jpeg" width="661" height="227" size="19268">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523418309449-sc2.jpg?httpAccept=%2A%2F%2A</object><object ref="figs1" category="thumbnail" type="IMAGE-THUMBNAIL" multimediatype="GIF image file" mimetype="image/gif" width="219" height="109" size="5100">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523418309449-figs1.sml?httpAccept=%2A%2F%2A</object><object ref="fx1" category="thumbnail" type="IMAGE-THUMBNAIL" multimediatype="GIF image file" mimetype="image/gif" width="219" height="57" size="4215">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523418309449-fx1.sml?httpAccept=%2A%2F%2A</object><object ref="fx10" category="thumbnail" type="IMAGE-THUMBNAIL" multimediatype="GIF image file" mimetype="image/gif" width="137" height="167" size="2537">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523418309449-fx10.sml?httpAccept=%2A%2F%2A</object><object ref="fx11" category="thumbnail" type="IMAGE-THUMBNAIL" multimediatype="GIF image file" mimetype="image/gif" width="131" height="202" size="2831">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523418309449-fx11.sml?httpAccept=%2A%2F%2A</object><object ref="fx12" category="thumbnail" type="IMAGE-THUMBNAIL" multimediatype="GIF image file" mimetype="image/gif" width="169" height="178" size="2565">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523418309449-fx12.sml?httpAccept=%2A%2F%2A</object><object ref="fx13" category="thumbnail" type="IMAGE-THUMBNAIL" multimediatype="GIF image file" mimetype="image/gif" width="137" height="202" size="2791">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523418309449-fx13.sml?httpAccept=%2A%2F%2A</object><object ref="fx14" category="thumbnail" type="IMAGE-THUMBNAIL" multimediatype="GIF image file" mimetype="image/gif" width="216" height="208" size="3125">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523418309449-fx14.sml?httpAccept=%2A%2F%2A</object><object ref="fx15" category="thumbnail" type="IMAGE-THUMBNAIL" multimediatype="GIF image file" mimetype="image/gif" width="219" height="147" size="4151">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523418309449-fx15.sml?httpAccept=%2A%2F%2A</object><object ref="fx16" category="thumbnail" type="IMAGE-THUMBNAIL" multimediatype="GIF image file" mimetype="image/gif" width="218" height="164" size="4350">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523418309449-fx16.sml?httpAccept=%2A%2F%2A</object><object ref="fx17" category="thumbnail" type="IMAGE-THUMBNAIL" multimediatype="GIF image file" mimetype="image/gif" width="219" height="150" size="4188">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523418309449-fx17.sml?httpAccept=%2A%2F%2A</object><object ref="fx18" category="thumbnail" type="IMAGE-THUMBNAIL" multimediatype="GIF image file" mimetype="image/gif" width="219" height="128" size="4208">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523418309449-fx18.sml?httpAccept=%2A%2F%2A</object><object ref="fx19" category="thumbnail" type="IMAGE-THUMBNAIL" multimediatype="GIF image file" mimetype="image/gif" width="219" height="90" size="3310">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523418309449-fx19.sml?httpAccept=%2A%2F%2A</object><object ref="fx2" category="thumbnail" type="IMAGE-THUMBNAIL" multimediatype="GIF image file" mimetype="image/gif" width="219" height="80" size="3314">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523418309449-fx2.sml?httpAccept=%2A%2F%2A</object><object ref="fx20" category="thumbnail" type="IMAGE-THUMBNAIL" multimediatype="GIF image file" mimetype="image/gif" width="219" height="136" size="5263">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523418309449-fx20.sml?httpAccept=%2A%2F%2A</object><object ref="fx21" category="thumbnail" type="IMAGE-THUMBNAIL" multimediatype="GIF image file" mimetype="image/gif" width="219" height="115" size="3819">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523418309449-fx21.sml?httpAccept=%2A%2F%2A</object><object ref="fx22" category="thumbnail" type="IMAGE-THUMBNAIL" multimediatype="GIF image file" mimetype="image/gif" width="219" height="127" size="3533">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523418309449-fx22.sml?httpAccept=%2A%2F%2A</object><object ref="fx23" category="thumbnail" type="IMAGE-THUMBNAIL" multimediatype="GIF image file" mimetype="image/gif" width="219" height="117" size="3239">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523418309449-fx23.sml?httpAccept=%2A%2F%2A</object><object ref="fx24" category="thumbnail" type="IMAGE-THUMBNAIL" multimediatype="GIF image file" mimetype="image/gif" width="219" height="113" size="3203">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523418309449-fx24.sml?httpAccept=%2A%2F%2A</object><object ref="fx25" category="thumbnail" type="IMAGE-THUMBNAIL" multimediatype="GIF image file" mimetype="image/gif" width="219" height="123" size="3316">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523418309449-fx25.sml?httpAccept=%2A%2F%2A</object><object ref="fx26" category="thumbnail" type="IMAGE-THUMBNAIL" multimediatype="GIF image file" mimetype="image/gif" width="219" height="97" size="3134">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523418309449-fx26.sml?httpAccept=%2A%2F%2A</object><object ref="fx27" category="thumbnail" type="IMAGE-THUMBNAIL" multimediatype="GIF image file" mimetype="image/gif" width="219" height="96" size="3209">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523418309449-fx27.sml?httpAccept=%2A%2F%2A</object><object ref="fx28" category="thumbnail" type="IMAGE-THUMBNAIL" multimediatype="GIF image file" mimetype="image/gif" width="219" height="144" size="4967">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523418309449-fx28.sml?httpAccept=%2A%2F%2A</object><object ref="fx29" category="thumbnail" type="IMAGE-THUMBNAIL" multimediatype="GIF image file" mimetype="image/gif" width="219" height="143" size="4932">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523418309449-fx29.sml?httpAccept=%2A%2F%2A</object><object ref="fx3" category="thumbnail" type="IMAGE-THUMBNAIL" multimediatype="GIF image file" mimetype="image/gif" width="152" height="131" size="2576">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523418309449-fx3.sml?httpAccept=%2A%2F%2A</object><object ref="fx30" category="thumbnail" type="IMAGE-THUMBNAIL" multimediatype="GIF image file" mimetype="image/gif" width="219" height="160" size="5027">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523418309449-fx30.sml?httpAccept=%2A%2F%2A</object><object ref="fx31" category="thumbnail" type="IMAGE-THUMBNAIL" multimediatype="GIF image file" mimetype="image/gif" width="219" height="146" size="4522">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523418309449-fx31.sml?httpAccept=%2A%2F%2A</object><object ref="fx32" category="thumbnail" type="IMAGE-THUMBNAIL" multimediatype="GIF image file" mimetype="image/gif" width="219" height="158" size="4943">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523418309449-fx32.sml?httpAccept=%2A%2F%2A</object><object ref="fx33" category="thumbnail" type="IMAGE-THUMBNAIL" multimediatype="GIF image file" mimetype="image/gif" width="219" height="98" size="3614">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523418309449-fx33.sml?httpAccept=%2A%2F%2A</object><object ref="fx34" category="thumbnail" type="IMAGE-THUMBNAIL" multimediatype="GIF image file" mimetype="image/gif" width="219" height="99" size="3543">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523418309449-fx34.sml?httpAccept=%2A%2F%2A</object><object ref="fx35" category="thumbnail" type="IMAGE-THUMBNAIL" multimediatype="GIF image file" mimetype="image/gif" width="219" height="142" size="4819">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523418309449-fx35.sml?httpAccept=%2A%2F%2A</object><object ref="fx4" category="thumbnail" type="IMAGE-THUMBNAIL" multimediatype="GIF image file" mimetype="image/gif" width="149" height="158" size="2852">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523418309449-fx4.sml?httpAccept=%2A%2F%2A</object><object ref="fx5" category="thumbnail" type="IMAGE-THUMBNAIL" multimediatype="GIF image file" mimetype="image/gif" width="161" height="152" size="2815">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523418309449-fx5.sml?httpAccept=%2A%2F%2A</object><object ref="fx6" category="thumbnail" type="IMAGE-THUMBNAIL" multimediatype="GIF image file" mimetype="image/gif" width="219" height="158" size="4672">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523418309449-fx6.sml?httpAccept=%2A%2F%2A</object><object ref="fx7" category="thumbnail" type="IMAGE-THUMBNAIL" multimediatype="GIF image file" mimetype="image/gif" width="131" height="158" size="2525">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523418309449-fx7.sml?httpAccept=%2A%2F%2A</object><object ref="fx8" category="thumbnail" type="IMAGE-THUMBNAIL" multimediatype="GIF image file" mimetype="image/gif" width="137" height="152" size="2326">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523418309449-fx8.sml?httpAccept=%2A%2F%2A</object><object ref="fx9" category="thumbnail" type="IMAGE-THUMBNAIL" multimediatype="GIF image file" mimetype="image/gif" width="131" height="158" size="2450">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523418309449-fx9.sml?httpAccept=%2A%2F%2A</object><object ref="gr1" category="thumbnail" type="IMAGE-THUMBNAIL" multimediatype="GIF image file" mimetype="image/gif" width="219" height="85" size="4437">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523418309449-gr1.sml?httpAccept=%2A%2F%2A</object><object ref="gr2" category="thumbnail" type="IMAGE-THUMBNAIL" multimediatype="GIF image file" mimetype="image/gif" width="219" height="44" size="2537">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523418309449-gr2.sml?httpAccept=%2A%2F%2A</object><object ref="gr3" category="thumbnail" type="IMAGE-THUMBNAIL" multimediatype="GIF image file" mimetype="image/gif" width="219" height="151" size="4533">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523418309449-gr3.sml?httpAccept=%2A%2F%2A</object><object ref="gr4" category="thumbnail" type="IMAGE-THUMBNAIL" multimediatype="GIF image file" mimetype="image/gif" width="219" height="133" size="13645">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523418309449-gr4.sml?httpAccept=%2A%2F%2A</object><object ref="gr5" category="thumbnail" type="IMAGE-THUMBNAIL" multimediatype="GIF image file" mimetype="image/gif" width="219" height="64" size="7169">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523418309449-gr5.sml?httpAccept=%2A%2F%2A</object><object ref="gr6" category="thumbnail" type="IMAGE-THUMBNAIL" multimediatype="GIF image file" mimetype="image/gif" width="219" height="71" size="16643">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523418309449-gr6.sml?httpAccept=%2A%2F%2A</object><object ref="gr7" category="thumbnail" type="IMAGE-THUMBNAIL" multimediatype="GIF image file" mimetype="image/gif" width="219" height="150" size="12669">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523418309449-gr7.sml?httpAccept=%2A%2F%2A</object><object ref="gr8" category="thumbnail" type="IMAGE-THUMBNAIL" multimediatype="GIF image file" mimetype="image/gif" width="219" height="99" size="6631">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523418309449-gr8.sml?httpAccept=%2A%2F%2A</object><object ref="sc1" category="thumbnail" type="IMAGE-THUMBNAIL" multimediatype="GIF image file" mimetype="image/gif" width="219" height="83" size="3245">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523418309449-sc1.sml?httpAccept=%2A%2F%2A</object><object ref="sc2" category="thumbnail" type="IMAGE-THUMBNAIL" multimediatype="GIF image file" mimetype="image/gif" width="219" height="75" size="3050">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523418309449-sc2.sml?httpAccept=%2A%2F%2A</object><object ref="figs1" category="high" type="IMAGE-HIGH-RES" multimediatype="JPEG image file" mimetype="image/jpeg" width="781" height="389" size="51206">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523418309449-figs1_lrg.jpg?httpAccept=%2A%2F%2A</object><object ref="fx1" category="high" type="IMAGE-HIGH-RES" multimediatype="JPEG image file" mimetype="image/jpeg" width="2213" height="573" size="113666">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523418309449-fx1_lrg.jpg?httpAccept=%2A%2F%2A</object><object ref="fx10" category="high" type="IMAGE-HIGH-RES" multimediatype="JPEG image file" mimetype="image/jpeg" width="137" height="167" size="4513">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523418309449-fx10_lrg.jpg?httpAccept=%2A%2F%2A</object><object ref="fx11" category="high" type="IMAGE-HIGH-RES" multimediatype="JPEG image file" mimetype="image/jpeg" width="131" height="202" size="4632">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523418309449-fx11_lrg.jpg?httpAccept=%2A%2F%2A</object><object ref="fx12" category="high" type="IMAGE-HIGH-RES" multimediatype="JPEG image file" mimetype="image/jpeg" width="169" height="178" size="4205">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523418309449-fx12_lrg.jpg?httpAccept=%2A%2F%2A</object><object ref="fx13" category="high" type="IMAGE-HIGH-RES" multimediatype="JPEG image file" mimetype="image/jpeg" width="137" height="202" size="4729">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523418309449-fx13_lrg.jpg?httpAccept=%2A%2F%2A</object><object ref="fx14" category="high" type="IMAGE-HIGH-RES" multimediatype="JPEG image file" mimetype="image/jpeg" width="216" height="208" size="5792">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523418309449-fx14_lrg.jpg?httpAccept=%2A%2F%2A</object><object ref="fx15" category="high" type="IMAGE-HIGH-RES" multimediatype="JPEG image file" mimetype="image/jpeg" width="292" height="196" size="7337">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523418309449-fx15_lrg.jpg?httpAccept=%2A%2F%2A</object><object ref="fx16" category="high" type="IMAGE-HIGH-RES" multimediatype="JPEG image file" mimetype="image/jpeg" width="277" height="208" size="7299">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523418309449-fx16_lrg.jpg?httpAccept=%2A%2F%2A</object><object ref="fx17" category="high" type="IMAGE-HIGH-RES" multimediatype="JPEG image file" mimetype="image/jpeg" width="295" height="202" size="7543">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523418309449-fx17_lrg.jpg?httpAccept=%2A%2F%2A</object><object ref="fx18" category="high" type="IMAGE-HIGH-RES" multimediatype="JPEG image file" mimetype="image/jpeg" width="319" height="187" size="8368">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523418309449-fx18_lrg.jpg?httpAccept=%2A%2F%2A</object><object ref="fx19" category="high" type="IMAGE-HIGH-RES" multimediatype="JPEG image file" mimetype="image/jpeg" width="286" height="117" size="5565">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523418309449-fx19_lrg.jpg?httpAccept=%2A%2F%2A</object><object ref="fx2" category="high" type="IMAGE-HIGH-RES" multimediatype="JPEG image file" mimetype="image/jpeg" width="865" height="316" size="28802">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523418309449-fx2_lrg.jpg?httpAccept=%2A%2F%2A</object><object ref="fx20" category="high" type="IMAGE-HIGH-RES" multimediatype="JPEG image file" mimetype="image/jpeg" width="240" height="149" size="6710">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523418309449-fx20_lrg.jpg?httpAccept=%2A%2F%2A</object><object ref="fx21" category="high" type="IMAGE-HIGH-RES" multimediatype="JPEG image file" mimetype="image/jpeg" width="240" height="126" size="5011">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523418309449-fx21_lrg.jpg?httpAccept=%2A%2F%2A</object><object ref="fx22" category="high" type="IMAGE-HIGH-RES" multimediatype="JPEG image file" mimetype="image/jpeg" width="271" height="157" size="5387">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523418309449-fx22_lrg.jpg?httpAccept=%2A%2F%2A</object><object ref="fx23" category="high" type="IMAGE-HIGH-RES" multimediatype="JPEG image file" mimetype="image/jpeg" width="289" height="155" size="5485">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523418309449-fx23_lrg.jpg?httpAccept=%2A%2F%2A</object><object ref="fx24" category="high" type="IMAGE-HIGH-RES" multimediatype="JPEG image file" mimetype="image/jpeg" width="295" height="152" size="5581">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523418309449-fx24_lrg.jpg?httpAccept=%2A%2F%2A</object><object ref="fx25" category="high" type="IMAGE-HIGH-RES" multimediatype="JPEG image file" mimetype="image/jpeg" width="292" height="164" size="6256">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523418309449-fx25_lrg.jpg?httpAccept=%2A%2F%2A</object><object ref="fx26" category="high" type="IMAGE-HIGH-RES" multimediatype="JPEG image file" mimetype="image/jpeg" width="350" height="155" size="6876">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523418309449-fx26_lrg.jpg?httpAccept=%2A%2F%2A</object><object ref="fx27" category="high" type="IMAGE-HIGH-RES" multimediatype="JPEG image file" mimetype="image/jpeg" width="348" height="152" size="7154">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523418309449-fx27_lrg.jpg?httpAccept=%2A%2F%2A</object><object ref="fx28" category="high" type="IMAGE-HIGH-RES" multimediatype="JPEG image file" mimetype="image/jpeg" width="289" height="190" size="8792">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523418309449-fx28_lrg.jpg?httpAccept=%2A%2F%2A</object><object ref="fx29" category="high" type="IMAGE-HIGH-RES" multimediatype="JPEG image file" mimetype="image/jpeg" width="286" height="187" size="8552">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523418309449-fx29_lrg.jpg?httpAccept=%2A%2F%2A</object><object ref="fx3" category="high" type="IMAGE-HIGH-RES" multimediatype="JPEG image file" mimetype="image/jpeg" width="152" height="131" size="4422">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523418309449-fx3_lrg.jpg?httpAccept=%2A%2F%2A</object><object ref="fx30" category="high" type="IMAGE-HIGH-RES" multimediatype="JPEG image file" mimetype="image/jpeg" width="295" height="216" size="9250">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523418309449-fx30_lrg.jpg?httpAccept=%2A%2F%2A</object><object ref="fx31" category="high" type="IMAGE-HIGH-RES" multimediatype="JPEG image file" mimetype="image/jpeg" width="310" height="207" size="8761">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523418309449-fx31_lrg.jpg?httpAccept=%2A%2F%2A</object><object ref="fx32" category="high" type="IMAGE-HIGH-RES" multimediatype="JPEG image file" mimetype="image/jpeg" width="304" height="219" size="9310">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523418309449-fx32_lrg.jpg?httpAccept=%2A%2F%2A</object><object ref="fx33" category="high" type="IMAGE-HIGH-RES" multimediatype="JPEG image file" mimetype="image/jpeg" width="391" height="175" size="9467">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523418309449-fx33_lrg.jpg?httpAccept=%2A%2F%2A</object><object ref="fx34" category="high" type="IMAGE-HIGH-RES" multimediatype="JPEG image file" mimetype="image/jpeg" width="392" height="178" size="9592">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523418309449-fx34_lrg.jpg?httpAccept=%2A%2F%2A</object><object ref="fx35" category="high" type="IMAGE-HIGH-RES" multimediatype="JPEG image file" mimetype="image/jpeg" width="248" height="161" size="6808">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523418309449-fx35_lrg.jpg?httpAccept=%2A%2F%2A</object><object ref="fx4" category="high" type="IMAGE-HIGH-RES" multimediatype="JPEG image file" mimetype="image/jpeg" width="149" height="158" size="4691">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523418309449-fx4_lrg.jpg?httpAccept=%2A%2F%2A</object><object ref="fx5" category="high" type="IMAGE-HIGH-RES" multimediatype="JPEG image file" mimetype="image/jpeg" width="161" height="152" size="4886">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523418309449-fx5_lrg.jpg?httpAccept=%2A%2F%2A</object><object ref="fx6" category="high" type="IMAGE-HIGH-RES" multimediatype="JPEG image file" mimetype="image/jpeg" width="251" height="181" size="6559">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523418309449-fx6_lrg.jpg?httpAccept=%2A%2F%2A</object><object ref="fx7" category="high" type="IMAGE-HIGH-RES" multimediatype="JPEG image file" mimetype="image/jpeg" width="131" height="158" size="3973">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523418309449-fx7_lrg.jpg?httpAccept=%2A%2F%2A</object><object ref="fx8" category="high" type="IMAGE-HIGH-RES" multimediatype="JPEG image file" mimetype="image/jpeg" width="137" height="152" size="3934">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523418309449-fx8_lrg.jpg?httpAccept=%2A%2F%2A</object><object ref="fx9" category="high" type="IMAGE-HIGH-RES" multimediatype="JPEG image file" mimetype="image/jpeg" width="131" height="158" size="4090">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523418309449-fx9_lrg.jpg?httpAccept=%2A%2F%2A</object><object ref="gr1" category="high" type="IMAGE-HIGH-RES" multimediatype="JPEG image file" mimetype="image/jpeg" width="2873" height="1121" size="275210">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523418309449-gr1_lrg.jpg?httpAccept=%2A%2F%2A</object><object ref="gr2" category="high" type="IMAGE-HIGH-RES" multimediatype="JPEG image file" mimetype="image/jpeg" width="2877" height="575" size="117409">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523418309449-gr2_lrg.jpg?httpAccept=%2A%2F%2A</object><object ref="gr3" category="high" type="IMAGE-HIGH-RES" multimediatype="JPEG image file" mimetype="image/jpeg" width="1671" height="1153" size="124554">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523418309449-gr3_lrg.jpg?httpAccept=%2A%2F%2A</object><object ref="gr4" category="high" type="IMAGE-HIGH-RES" multimediatype="JPEG image file" mimetype="image/jpeg" width="2910" height="1771" size="604381">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523418309449-gr4_lrg.jpg?httpAccept=%2A%2F%2A</object><object ref="gr5" category="high" type="IMAGE-HIGH-RES" multimediatype="JPEG image file" mimetype="image/jpeg" width="2306" height="675" size="186378">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523418309449-gr5_lrg.jpg?httpAccept=%2A%2F%2A</object><object ref="gr6" category="high" type="IMAGE-HIGH-RES" multimediatype="JPEG image file" mimetype="image/jpeg" width="3520" height="1136" size="1116493">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523418309449-gr6_lrg.jpg?httpAccept=%2A%2F%2A</object><object ref="gr7" category="high" type="IMAGE-HIGH-RES" multimediatype="JPEG image file" mimetype="image/jpeg" width="2340" height="1607" size="367091">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523418309449-gr7_lrg.jpg?httpAccept=%2A%2F%2A</object><object ref="gr8" category="high" type="IMAGE-HIGH-RES" multimediatype="JPEG image file" mimetype="image/jpeg" width="2358" height="1061" size="228357">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523418309449-gr8_lrg.jpg?httpAccept=%2A%2F%2A</object><object ref="sc1" category="high" type="IMAGE-HIGH-RES" multimediatype="JPEG image file" mimetype="image/jpeg" width="2311" height="875" size="129104">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523418309449-sc1_lrg.jpg?httpAccept=%2A%2F%2A</object><object ref="sc2" category="high" type="IMAGE-HIGH-RES" multimediatype="JPEG image file" mimetype="image/jpeg" width="2926" height="1004" size="170816">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523418309449-sc2_lrg.jpg?httpAccept=%2A%2F%2A</object><object ref="am" category="standard" type="AAM-PDF" multimediatype="Acrobat PDF file" mimetype="application/pdf" size="9053041">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523418309449-am.pdf?httpAccept=%2A%2F%2A</object></objects><scopus-id>85056896268</scopus-id><scopus-eid>2-s2.0-85056896268</scopus-eid><pubmed-id>30472602</pubmed-id><link href="https://api.elsevier.com/content/abstract/scopus_id/85056896268" rel="abstract"/></link><originalText><xocs:doc xsi:schemaLocation="http://www.elsevier.com/xml/xocs/dtd http://null/schema/dtds/document/fulltext/xcr/xocs-article.xsd"><xocs:meta xmlns:xoe="http://www.elsevier.com/xml/xoe/dtd">
      <xocs:content-family>serial</xocs:content-family>
      <xocs:content-type>JL</xocs:content-type>
      <xocs:cid>271932</xocs:cid>
      <xocs:ssids>
         <xocs:ssid type="alllist">291210</xocs:ssid>
         <xocs:ssid type="subj">291732</xocs:ssid>
         <xocs:ssid type="subj">291789</xocs:ssid>
         <xocs:ssid type="subj">291858</xocs:ssid>
         <xocs:ssid type="subj">291928</xocs:ssid>
         <xocs:ssid type="content">31</xocs:ssid>
      </xocs:ssids>
      <xocs:srctitle>European Journal of Medicinal Chemistry</xocs:srctitle>
      <xocs:normalized-srctitle>EUROPEANJOURNALMEDICINALCHEMISTRY</xocs:normalized-srctitle>
      <xocs:orig-load-date yyyymmdd="20181101">2018-11-01</xocs:orig-load-date>
      <xocs:available-online-date yyyymmdd="20181101">2018-11-01</xocs:available-online-date>
      <xocs:vor-load-date yyyymmdd="20181123">2018-11-23</xocs:vor-load-date>
      <xocs:vor-available-online-date yyyymmdd="20181123">2018-11-23</xocs:vor-available-online-date>
      <xocs:ew-transaction-id>2020-12-23T20:42:47</xocs:ew-transaction-id>
      <xocs:eid>1-s2.0-S0223523418309449</xocs:eid>
      <xocs:pii-formatted>S0223-5234(18)30944-9</xocs:pii-formatted>
      <xocs:pii-unformatted>S0223523418309449</xocs:pii-unformatted>
      <xocs:doi>10.1016/j.ejmech.2018.10.067</xocs:doi>
      <xocs:item-stage>S300</xocs:item-stage>
      <xocs:item-version-number>S300.3</xocs:item-version-number>
      <xocs:item-weight>FULL-TEXT</xocs:item-weight>
      <xocs:hub-eid>1-s2.0-S0223523418X00191</xocs:hub-eid>
      <xocs:timestamp yyyymmdd="20201225">2020-12-25T02:14:46.288903Z</xocs:timestamp>
      <xocs:dco>0</xocs:dco>
      <xocs:tomb>0</xocs:tomb>
      <xocs:date-search-begin>20190115</xocs:date-search-begin>
      <xocs:year-nav>2019</xocs:year-nav>
      <xocs:indexeddate epoch="1541091830">2018-11-01T17:03:50.9565Z</xocs:indexeddate>
      <xocs:articleinfo>absattachment articleinfo articletitlenorm authfirstinitialnorm authfirstsurnamenorm cid cids contenttype copyright crossmark dateloaded dateloadedtxt datesearch datesort dateupdated dco docsubtype doctype doi eid ewtransactionid hubeid indexeddate issn issnnorm itemstage itemtransactionid itemweight openaccess openarchive pg pgfirst pglast pii piinorm pubdatestart pubdatetxt pubyr sectiontitle sortorder srctitle srctitlenorm srctype ssids alllist content subj subheadings suppl tomb volfirst volissue volumelist webpdf webpdfpagecount yearnav figure table body acknowledge affil appendices articletitle auth authfirstini authfull authkeywords authlast footnotes grantnumber grantsponsor grantsponsorid highlightsabst primabst pubtype ref specialabst</xocs:articleinfo>
      <xocs:issns>
         <xocs:issn-primary-formatted>0223-5234</xocs:issn-primary-formatted>
         <xocs:issn-primary-unformatted>02235234</xocs:issn-primary-unformatted>
      </xocs:issns>
      <xocs:crossmark is-crossmark="1">true</xocs:crossmark>
      <xocs:vol-first>162</xocs:vol-first>
      <xocs:volume-list>
         <xocs:volume>162</xocs:volume>
      </xocs:volume-list>
      <xocs:suppl>C</xocs:suppl>
      <xocs:vol-iss-suppl-text>Volume 162</xocs:vol-iss-suppl-text>
      <xocs:sort-order>41</xocs:sort-order>
      <xocs:first-fp>543</xocs:first-fp>
      <xocs:last-lp>554</xocs:last-lp>
      <xocs:pages>
         <xocs:first-page>543</xocs:first-page>
         <xocs:last-page>554</xocs:last-page>
      </xocs:pages>
      <xocs:cover-date-orig>
         <xocs:start-date>20190115</xocs:start-date>
      </xocs:cover-date-orig>
      <xocs:cover-date-text>15 January 2019</xocs:cover-date-text>
      <xocs:cover-date-start>2019-01-15</xocs:cover-date-start>
      <xocs:cover-date-year>2019</xocs:cover-date-year>
      <xocs:hub-sec>
         <xocs:hub-sec-title>Research paper</xocs:hub-sec-title>
      </xocs:hub-sec>
      <xocs:document-type>article</xocs:document-type>
      <xocs:document-subtype>fla</xocs:document-subtype>
      <xocs:copyright-line>© 2018 Elsevier Masson SAS. All rights reserved.</xocs:copyright-line>
      <xocs:normalized-article-title>ANOVELSERIESNAPABUCASINDERIVATIVESORALLYACTIVEINHIBITORSSIGNALTRANSDUCERACTIVATORTRANSCRIPTION3STAT3</xocs:normalized-article-title>
      <xocs:normalized-first-auth-surname>LI</xocs:normalized-first-auth-surname>
      <xocs:normalized-first-auth-initial>C</xocs:normalized-first-auth-initial>
      <xocs:item-toc>
         <xocs:item-toc-entry ref-elem="ce:sections">
            <xocs:item-toc-label>1</xocs:item-toc-label>
            <xocs:item-toc-section-title>Introduction</xocs:item-toc-section-title>
         </xocs:item-toc-entry>
         <xocs:item-toc-entry ref-elem="ce:sections">
            <xocs:item-toc-label>2</xocs:item-toc-label>
            <xocs:item-toc-section-title>Results and discussion</xocs:item-toc-section-title>
            <xocs:item-toc-entry ref-elem="ce:sections">
               <xocs:item-toc-label>2.1</xocs:item-toc-label>
               <xocs:item-toc-section-title>Chemistry</xocs:item-toc-section-title>
            </xocs:item-toc-entry>
            <xocs:item-toc-entry ref-elem="ce:sections">
               <xocs:item-toc-label>2.2</xocs:item-toc-label>
               <xocs:item-toc-section-title>
                  <ce:italic>In vitro</ce:italic> cell growth inhibitory activity</xocs:item-toc-section-title>
            </xocs:item-toc-entry>
            <xocs:item-toc-entry ref-elem="ce:sections">
               <xocs:item-toc-label>2.3</xocs:item-toc-label>
               <xocs:item-toc-section-title>Molecular docking</xocs:item-toc-section-title>
            </xocs:item-toc-entry>
            <xocs:item-toc-entry ref-elem="ce:sections">
               <xocs:item-toc-label>2.4</xocs:item-toc-label>
               <xocs:item-toc-section-title>The physicochemical properties of several final compounds</xocs:item-toc-section-title>
            </xocs:item-toc-entry>
            <xocs:item-toc-entry ref-elem="ce:sections">
               <xocs:item-toc-label>2.5</xocs:item-toc-label>
               <xocs:item-toc-section-title>
                  <ce:italic>In vivo</ce:italic> antitumor activity evaluation</xocs:item-toc-section-title>
            </xocs:item-toc-entry>
            <xocs:item-toc-entry ref-elem="ce:sections">
               <xocs:item-toc-label>2.6</xocs:item-toc-label>
               <xocs:item-toc-section-title>Preliminary safety profile of compound 8q</xocs:item-toc-section-title>
            </xocs:item-toc-entry>
            <xocs:item-toc-entry ref-elem="ce:sections">
               <xocs:item-toc-label>2.7</xocs:item-toc-label>
               <xocs:item-toc-section-title>Compound 8q decrease protein expression of total STAT3 and p-STAT3<ce:sup loc="post">Y705</ce:sup>
               </xocs:item-toc-section-title>
            </xocs:item-toc-entry>
            <xocs:item-toc-entry ref-elem="ce:sections">
               <xocs:item-toc-label>2.8</xocs:item-toc-label>
               <xocs:item-toc-section-title>Binding of compound 8q with STAT3</xocs:item-toc-section-title>
            </xocs:item-toc-entry>
         </xocs:item-toc-entry>
         <xocs:item-toc-entry ref-elem="ce:sections">
            <xocs:item-toc-label>3</xocs:item-toc-label>
            <xocs:item-toc-section-title>Conclusion</xocs:item-toc-section-title>
         </xocs:item-toc-entry>
         <xocs:item-toc-entry ref-elem="ce:sections">
            <xocs:item-toc-label>4</xocs:item-toc-label>
            <xocs:item-toc-section-title>Experimental section</xocs:item-toc-section-title>
            <xocs:item-toc-entry ref-elem="ce:sections">
               <xocs:item-toc-label>4.1</xocs:item-toc-label>
               <xocs:item-toc-section-title>Chemistry</xocs:item-toc-section-title>
               <xocs:item-toc-entry ref-elem="ce:sections">
                  <xocs:item-toc-label>4.1.1</xocs:item-toc-label>
                  <xocs:item-toc-section-title>General procedures for the preparation of <ce:bold>2a-d</ce:bold>
                  </xocs:item-toc-section-title>
                  <xocs:item-toc-entry ref-elem="ce:sections">
                     <xocs:item-toc-label>4.1.1.1</xocs:item-toc-label>
                     <xocs:item-toc-section-title>(E)-2-cinnamoylnaphtho[2,3-b]furan-4,9-dione(<ce:bold>2a</ce:bold>)</xocs:item-toc-section-title>
                  </xocs:item-toc-entry>
                  <xocs:item-toc-entry ref-elem="ce:sections">
                     <xocs:item-toc-label>4.1.1.2</xocs:item-toc-label>
                     <xocs:item-toc-section-title>(E)-2-(3-(1-methyl-1H-pyrrol-2-yl)acryloyl)naphtho[2,3-b]furan-4,9-dione(<ce:bold>2b</ce:bold>)</xocs:item-toc-section-title>
                  </xocs:item-toc-entry>
                  <xocs:item-toc-entry ref-elem="ce:sections">
                     <xocs:item-toc-label>4.1.1.3</xocs:item-toc-label>
                     <xocs:item-toc-section-title>(E)-2-(3-(thiophen-2-yl)acryloyl)naphtho[2,3-b]furan-4,9-dione(<ce:bold>2c</ce:bold>)</xocs:item-toc-section-title>
                  </xocs:item-toc-entry>
                  <xocs:item-toc-entry ref-elem="ce:sections">
                     <xocs:item-toc-label>4.1.1.4</xocs:item-toc-label>
                     <xocs:item-toc-section-title>(E)-2-(3-([1,1′-biphenyl]-4-yl)acryloyl)naphtho[2,3-b]furan-4,9-dione(<ce:bold>2d</ce:bold>)</xocs:item-toc-section-title>
                  </xocs:item-toc-entry>
               </xocs:item-toc-entry>
               <xocs:item-toc-entry ref-elem="ce:sections">
                  <xocs:item-toc-label>4.1.2</xocs:item-toc-label>
                  <xocs:item-toc-section-title>Synthesis of 3-phenyliodonio-1, 2, 4-trioxo-1,2,3,4-tetrahydronaphthalenide (<ce:bold>4</ce:bold>)</xocs:item-toc-section-title>
               </xocs:item-toc-entry>
               <xocs:item-toc-entry ref-elem="ce:sections">
                  <xocs:item-toc-label>4.1.3</xocs:item-toc-label>
                  <xocs:item-toc-section-title>Synthesis of 2-hydroxymethyl-naphtho[2,3-b]furan-4,9-dione (<ce:bold>5</ce:bold>)</xocs:item-toc-section-title>
               </xocs:item-toc-entry>
               <xocs:item-toc-entry ref-elem="ce:sections">
                  <xocs:item-toc-label>4.1.4</xocs:item-toc-label>
                  <xocs:item-toc-section-title>Synthesis of 2-formyl-4,9-dihydronaphtho[2,3-b]-furan-4,9-dione (<ce:bold>6</ce:bold>)</xocs:item-toc-section-title>
               </xocs:item-toc-entry>
               <xocs:item-toc-entry ref-elem="ce:sections">
                  <xocs:item-toc-label>4.1.5</xocs:item-toc-label>
                  <xocs:item-toc-section-title>Synthesis of 4,9-dioxo-4,9-dihydronaphtho[2,3-b]furan-2-carboxylic acid (<ce:bold>7</ce:bold>)</xocs:item-toc-section-title>
               </xocs:item-toc-entry>
               <xocs:item-toc-entry ref-elem="ce:sections">
                  <xocs:item-toc-label>4.1.6</xocs:item-toc-label>
                  <xocs:item-toc-section-title>General procedures for the preparation of <ce:bold>8a-u</ce:bold>
                  </xocs:item-toc-section-title>
                  <xocs:item-toc-entry ref-elem="ce:sections">
                     <xocs:item-toc-label>4.1.6.1</xocs:item-toc-label>
                     <xocs:item-toc-section-title>2-(Pyrrolidine-1-carbonyl)naphtho[2,3-b]furan-4,9-dione(<ce:bold>8a</ce:bold>)</xocs:item-toc-section-title>
                  </xocs:item-toc-entry>
                  <xocs:item-toc-entry ref-elem="ce:sections">
                     <xocs:item-toc-label>4.1.6.2</xocs:item-toc-label>
                     <xocs:item-toc-section-title>2-(Piperidine-1-carbonyl)naphtho[2,3-b]furan-4,9-dione (<ce:bold>8b</ce:bold>)</xocs:item-toc-section-title>
                  </xocs:item-toc-entry>
                  <xocs:item-toc-entry ref-elem="ce:sections">
                     <xocs:item-toc-label>4.1.6.3</xocs:item-toc-label>
                     <xocs:item-toc-section-title>2-(Morpholine-4-carbonyl)naphtho[2,3-b]furan-4,9-dione (<ce:bold>8c</ce:bold>)</xocs:item-toc-section-title>
                  </xocs:item-toc-entry>
                  <xocs:item-toc-entry ref-elem="ce:sections">
                     <xocs:item-toc-label>4.1.6.4</xocs:item-toc-label>
                     <xocs:item-toc-section-title>2-(Thiomorpholine-4-carbonyl)naphtho[2,3-b]furan-4,9-dione (<ce:bold>8d</ce:bold>)</xocs:item-toc-section-title>
                  </xocs:item-toc-entry>
                  <xocs:item-toc-entry ref-elem="ce:sections">
                     <xocs:item-toc-label>4.1.6.5</xocs:item-toc-label>
                     <xocs:item-toc-section-title>2-(4-Methylpiperazine-1-carbonyl)naphtho[2,3-b]furan-4,9-dione (<ce:bold>8e</ce:bold>)</xocs:item-toc-section-title>
                  </xocs:item-toc-entry>
                  <xocs:item-toc-entry ref-elem="ce:sections">
                     <xocs:item-toc-label>4.1.6.6</xocs:item-toc-label>
                     <xocs:item-toc-section-title>2-(4-Ethylpiperazine-1-carbonyl)naphtho[2,3-b]furan-4,9-dione (<ce:bold>8f</ce:bold>)</xocs:item-toc-section-title>
                  </xocs:item-toc-entry>
                  <xocs:item-toc-entry ref-elem="ce:sections">
                     <xocs:item-toc-label>4.1.6.7</xocs:item-toc-label>
                     <xocs:item-toc-section-title>2-(4-Oxopiperidine-1-carbonyl)naphtho[2,3-b]furan-4,9-dione (<ce:bold>8g</ce:bold>)</xocs:item-toc-section-title>
                  </xocs:item-toc-entry>
                  <xocs:item-toc-entry ref-elem="ce:sections">
                     <xocs:item-toc-label>4.1.6.8</xocs:item-toc-label>
                     <xocs:item-toc-section-title>Methyl-2-(1-(4,9-dioxo-4,9-dihydronaphtho[2,3-b]furan-2-carbonyl)piperidin-4-yl)acetate (<ce:bold>8h</ce:bold>)</xocs:item-toc-section-title>
                  </xocs:item-toc-entry>
                  <xocs:item-toc-entry ref-elem="ce:sections">
                     <xocs:item-toc-label>4.1.6.9</xocs:item-toc-label>
                     <xocs:item-toc-section-title>2-(4-(3-chlorophenyl)piperidine-1-carbonyl)naphtho[2,3-b]furan-4,9-dione (<ce:bold>8i</ce:bold>)</xocs:item-toc-section-title>
                  </xocs:item-toc-entry>
                  <xocs:item-toc-entry ref-elem="ce:sections">
                     <xocs:item-toc-label>4.1.6.10</xocs:item-toc-label>
                     <xocs:item-toc-section-title>2-(4-(4-fluorophenyl)piperidine-1-carbonyl)naphtho[2,3-b]furan-4,9-dione (<ce:bold>8j</ce:bold>)</xocs:item-toc-section-title>
                  </xocs:item-toc-entry>
                  <xocs:item-toc-entry ref-elem="ce:sections">
                     <xocs:item-toc-label>4.1.6.11</xocs:item-toc-label>
                     <xocs:item-toc-section-title>2-(4-(4-methoxyphenyl)piperidine-1-carbonyl)naphtho[2,3-b]furan-4,9-dione(<ce:bold>8k</ce:bold>)</xocs:item-toc-section-title>
                  </xocs:item-toc-entry>
                  <xocs:item-toc-entry ref-elem="ce:sections">
                     <xocs:item-toc-label>4.1.6.12</xocs:item-toc-label>
                     <xocs:item-toc-section-title>2-(4-(3-(trifluoromethyl)phenyl)piperazine-1-carbonyl)naphtho[2,3-b]furan-4,9-dione (<ce:bold>8l</ce:bold>)</xocs:item-toc-section-title>
                  </xocs:item-toc-entry>
                  <xocs:item-toc-entry ref-elem="ce:sections">
                     <xocs:item-toc-label>4.1.6.13</xocs:item-toc-label>
                     <xocs:item-toc-section-title>
                        <ce:italic>N</ce:italic>-(4,4-dimethylcyclohexyl)-4,9-dioxo-4,9-dihydronaphtho[2,3-b]furan-2-carboxamide (<ce:bold>8m</ce:bold>)</xocs:item-toc-section-title>
                  </xocs:item-toc-entry>
                  <xocs:item-toc-entry ref-elem="ce:sections">
                     <xocs:item-toc-label>4.1.6.14</xocs:item-toc-label>
                     <xocs:item-toc-section-title>
                        <ce:italic>N</ce:italic>-(adamantan-1-yl)-4,9-dioxo-4,9-dihydronaphtho[2,3-b]furan-2-carboxamide (<ce:bold>8n</ce:bold>)</xocs:item-toc-section-title>
                  </xocs:item-toc-entry>
                  <xocs:item-toc-entry ref-elem="ce:sections">
                     <xocs:item-toc-label>4.1.6.15</xocs:item-toc-label>
                     <xocs:item-toc-section-title>
                        <ce:italic>N</ce:italic>-cyclohexyl-4,9-dioxo-4,9-dihydronaphtho[2,3-b]furan-2-carboxamide (<ce:bold>8o</ce:bold>)</xocs:item-toc-section-title>
                  </xocs:item-toc-entry>
                  <xocs:item-toc-entry ref-elem="ce:sections">
                     <xocs:item-toc-label>4.1.6.16</xocs:item-toc-label>
                     <xocs:item-toc-section-title>4,9-Dioxo-<ce:italic>N</ce:italic>-(2-(pyrrolidin-1-yl)ethyl)-4,9-dihydronaphtho[2,3-b]furan-2-carboxamide(<ce:bold>8p</ce:bold>)</xocs:item-toc-section-title>
                  </xocs:item-toc-entry>
                  <xocs:item-toc-entry ref-elem="ce:sections">
                     <xocs:item-toc-label>4.1.6.17</xocs:item-toc-label>
                     <xocs:item-toc-section-title>4,9-Dioxo-<ce:italic>N</ce:italic>-(2-(piperidin-1-yl)ethyl)-4,9-dihydronaphtho[2,3-b]furan-2-carboxamide(<ce:bold>8q</ce:bold>)</xocs:item-toc-section-title>
                  </xocs:item-toc-entry>
                  <xocs:item-toc-entry ref-elem="ce:sections">
                     <xocs:item-toc-label>4.1.6.18</xocs:item-toc-label>
                     <xocs:item-toc-section-title>
                        <ce:italic>N</ce:italic>-(2-morpholinoethyl)-4,9-dioxo-4,9-dihydronaphtho[2,3-b]furan-2-carboxamide (<ce:bold>8r</ce:bold>)</xocs:item-toc-section-title>
                  </xocs:item-toc-entry>
                  <xocs:item-toc-entry ref-elem="ce:sections">
                     <xocs:item-toc-label>4.1.6.19</xocs:item-toc-label>
                     <xocs:item-toc-section-title>4,9-Dioxo-<ce:italic>N</ce:italic>-phenethyl-4,9-dihydronaphtho[2,3-b]furan-2-carboxamide (<ce:bold>8s</ce:bold>)</xocs:item-toc-section-title>
                  </xocs:item-toc-entry>
                  <xocs:item-toc-entry ref-elem="ce:sections">
                     <xocs:item-toc-label>4.1.6.20</xocs:item-toc-label>
                     <xocs:item-toc-section-title>
                        <ce:italic>N</ce:italic>-(4-chlorophenethyl)-4,9-dioxo-4,9-dihydronaphtho[2,3-b]furan-2-carboxamide (<ce:bold>8t</ce:bold>)</xocs:item-toc-section-title>
                  </xocs:item-toc-entry>
                  <xocs:item-toc-entry ref-elem="ce:sections">
                     <xocs:item-toc-label>4.1.6.21</xocs:item-toc-label>
                     <xocs:item-toc-section-title>
                        <ce:italic>N</ce:italic>-(4-methoxyphenethyl)-4,9-dioxo-4,9-dihydronaphtho[2,3-b]furan-2-carboxamide(<ce:bold>8u</ce:bold>)</xocs:item-toc-section-title>
                  </xocs:item-toc-entry>
               </xocs:item-toc-entry>
            </xocs:item-toc-entry>
            <xocs:item-toc-entry ref-elem="ce:sections">
               <xocs:item-toc-label>4.2</xocs:item-toc-label>
               <xocs:item-toc-section-title>
                  <ce:italic>In vitro</ce:italic> inhibitory activity</xocs:item-toc-section-title>
            </xocs:item-toc-entry>
            <xocs:item-toc-entry ref-elem="ce:sections">
               <xocs:item-toc-label>4.3</xocs:item-toc-label>
               <xocs:item-toc-section-title>Molecular docking</xocs:item-toc-section-title>
            </xocs:item-toc-entry>
            <xocs:item-toc-entry ref-elem="ce:sections">
               <xocs:item-toc-label>4.4</xocs:item-toc-label>
               <xocs:item-toc-section-title>The determination of aqueous solubility</xocs:item-toc-section-title>
            </xocs:item-toc-entry>
            <xocs:item-toc-entry ref-elem="ce:sections">
               <xocs:item-toc-label>4.5</xocs:item-toc-label>
               <xocs:item-toc-section-title>
                  <ce:italic>In vivo</ce:italic> antitumor activity evaluation</xocs:item-toc-section-title>
            </xocs:item-toc-entry>
            <xocs:item-toc-entry ref-elem="ce:sections">
               <xocs:item-toc-label>4.6</xocs:item-toc-label>
               <xocs:item-toc-section-title>Western blot and immunofluorescence analysis</xocs:item-toc-section-title>
            </xocs:item-toc-entry>
            <xocs:item-toc-entry ref-elem="ce:sections">
               <xocs:item-toc-label>4.7</xocs:item-toc-label>
               <xocs:item-toc-section-title>Total STAT3 and p-STAT3<ce:sup loc="post">Y705</ce:sup> sandwich enzyme-linked immunosorbent assay</xocs:item-toc-section-title>
            </xocs:item-toc-entry>
            <xocs:item-toc-entry ref-elem="ce:sections">
               <xocs:item-toc-label>4.8</xocs:item-toc-label>
               <xocs:item-toc-section-title>Electrophoretic mobility shift assay (EMSA)</xocs:item-toc-section-title>
            </xocs:item-toc-entry>
            <xocs:item-toc-entry ref-elem="ce:sections">
               <xocs:item-toc-label>4.9</xocs:item-toc-label>
               <xocs:item-toc-section-title>Purification of STAT3 and surface plasmon resonance (SPR) analysis</xocs:item-toc-section-title>
            </xocs:item-toc-entry>
         </xocs:item-toc-entry>
         <xocs:item-toc-entry ref-elem="ce:sections">
            <xocs:item-toc-section-title>Conflicts of interest</xocs:item-toc-section-title>
         </xocs:item-toc-entry>
         <xocs:item-toc-entry ref-elem="ce:acknowledgment">
            <xocs:item-toc-section-title>Acknowledgments</xocs:item-toc-section-title>
         </xocs:item-toc-entry>
         <xocs:item-toc-entry ref-elem="ce:appendices">
            <xocs:item-toc-label>Appendix A</xocs:item-toc-label>
            <xocs:item-toc-section-title>Supplementary data</xocs:item-toc-section-title>
         </xocs:item-toc-entry>
         <xocs:item-toc-entry ref-elem="ce:bibliography">
            <xocs:item-toc-section-title>References</xocs:item-toc-section-title>
         </xocs:item-toc-entry>
      </xocs:item-toc>
      <xocs:references>
         <xocs:ref-info refid="sref1">
            <xocs:ref-normalized-surname>DARNELL</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>1997</xocs:ref-pub-year>
            <xocs:ref-first-fp>1630</xocs:ref-first-fp>
            <xocs:ref-last-lp>1635</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>J</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="sref2">
            <xocs:ref-normalized-surname>HAFTCHENARY</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2011</xocs:ref-pub-year>
            <xocs:ref-first-fp>115</xocs:ref-first-fp>
            <xocs:ref-last-lp>127</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>S</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="sref3">
            <xocs:ref-normalized-surname>FLETCHER</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2008</xocs:ref-pub-year>
            <xocs:ref-first-fp>1159</xocs:ref-first-fp>
            <xocs:ref-last-lp>1168</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>S</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="sref4">
            <xocs:ref-normalized-surname>YU</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2014</xocs:ref-pub-year>
            <xocs:ref-first-fp>736</xocs:ref-first-fp>
            <xocs:ref-last-lp>746</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>H</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="sref5">
            <xocs:ref-normalized-surname>XIONG</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2014</xocs:ref-pub-year>
            <xocs:ref-first-fp>926</xocs:ref-first-fp>
            <xocs:ref-last-lp>957</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>A</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="sref6">
            <xocs:ref-normalized-surname>CHEN</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2013</xocs:ref-pub-year>
            <xocs:ref-first-fp>498</xocs:ref-first-fp>
            <xocs:ref-last-lp>507</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>H</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="sref7">
            <xocs:ref-normalized-surname>SCHUST</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2006</xocs:ref-pub-year>
            <xocs:ref-first-fp>1235</xocs:ref-first-fp>
            <xocs:ref-last-lp>1242</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>J</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="sref8">
            <xocs:ref-normalized-surname>MATSUNO</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2010</xocs:ref-pub-year>
            <xocs:ref-first-fp>371</xocs:ref-first-fp>
            <xocs:ref-last-lp>375</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>K</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="sref9">
            <xocs:ref-normalized-surname>SONG</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2005</xocs:ref-pub-year>
            <xocs:ref-first-fp>4700</xocs:ref-first-fp>
            <xocs:ref-last-lp>4705</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>H</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="sref10">
            <xocs:ref-normalized-surname>CHEN</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2013</xocs:ref-pub-year>
            <xocs:ref-first-fp>180</xocs:ref-first-fp>
            <xocs:ref-last-lp>185</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>H</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="sref11">
            <xocs:ref-normalized-surname>YUWANG</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2017</xocs:ref-pub-year>
            <xocs:ref-first-fp>578</xocs:ref-first-fp>
            <xocs:ref-last-lp>590</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>S</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="sref12">
            <xocs:ref-normalized-surname>CHEN</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2014</xocs:ref-pub-year>
            <xocs:ref-first-fp>195</xocs:ref-first-fp>
            <xocs:ref-last-lp>203</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>H</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="sref13">
            <xocs:ref-normalized-surname>LIN</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2010</xocs:ref-pub-year>
            <xocs:ref-normalized-initial>L</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="sref14">
            <xocs:ref-normalized-surname>YU</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2013</xocs:ref-pub-year>
            <xocs:ref-first-fp>4402</xocs:ref-first-fp>
            <xocs:ref-last-lp>4412</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>W</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="sref15">
            <xocs:ref-normalized-surname>FIORITO</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2014</xocs:ref-pub-year>
            <xocs:ref-first-fp>454</xocs:ref-first-fp>
            <xocs:ref-last-lp>457</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>S</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="sref16">
            <xocs:ref-normalized-surname>EYONG</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2008</xocs:ref-pub-year>
            <xocs:ref-first-fp>5387</xocs:ref-first-fp>
            <xocs:ref-last-lp>5390</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>K</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="sref17">
            <xocs:ref-normalized-surname>BANNWITZ</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2014</xocs:ref-pub-year>
            <xocs:ref-first-fp>6226</xocs:ref-first-fp>
            <xocs:ref-last-lp>6239</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>S</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="sref18">
            <xocs:ref-normalized-surname>HUBBARD</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2017</xocs:ref-pub-year>
            <xocs:ref-first-fp>1091</xocs:ref-first-fp>
            <xocs:ref-last-lp>1103</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>J</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="sref19">
            <xocs:ref-normalized-surname>REICHSTEIN</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2012</xocs:ref-pub-year>
            <xocs:ref-first-fp>7273</xocs:ref-first-fp>
            <xocs:ref-last-lp>7284</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>A</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="sref20">
            <xocs:ref-normalized-surname>ZHOU</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2018</xocs:ref-pub-year>
            <xocs:ref-first-fp>39</xocs:ref-first-fp>
            <xocs:ref-last-lp>50</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>Q</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="sref21">
            <xocs:ref-normalized-surname>ZHIWEIJIANG</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2013</xocs:ref-pub-year>
            <xocs:ref-normalized-initial>A</xocs:ref-normalized-initial>
            <xocs:ref-normalized-srctitle>NOVELESTERS49DIHYDROXYNAPHTHO23BFURANSFORDISEASETHERAPIES</xocs:ref-normalized-srctitle>
         </xocs:ref-info>
         <xocs:ref-info refid="sref22">
            <xocs:ref-normalized-surname>KORTYLEWSKI</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2005</xocs:ref-pub-year>
            <xocs:ref-first-fp>1314</xocs:ref-first-fp>
            <xocs:ref-last-lp>1321</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>M</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="sref23">
            <xocs:ref-normalized-surname>CHONGMINGWU</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>1999</xocs:ref-pub-year>
            <xocs:ref-normalized-initial>R</xocs:ref-normalized-initial>
         </xocs:ref-info>
      </xocs:references>
      <xocs:refkeys>
         <xocs:refkey3>LIX2019X543</xocs:refkey3>
         <xocs:refkey4lp>LIX2019X543X554</xocs:refkey4lp>
         <xocs:refkey4ai>LIX2019X543XC</xocs:refkey4ai>
         <xocs:refkey5>LIX2019X543X554XC</xocs:refkey5>
      </xocs:refkeys>
      <xocs:open-access>
         <xocs:oa-article-status is-open-access="0" is-open-archive="0"/></xocs:oa-article-status>
      </xocs:open-access>
      <xocs:open-research>
         <xocs:or-embargo-opening-date>2020-11-23T00:00:00.000Z</xocs:or-embargo-opening-date>
      </xocs:open-research>
      <xocs:self-archiving>
         <xocs:sa-start-date>2020-11-23T00:00:00.000Z</xocs:sa-start-date>
         <xocs:sa-user-license>http://creativecommons.org/licenses/by-nc-nd/4.0/</xocs:sa-user-license>
      </xocs:self-archiving>
      <xocs:copyright-info>
         <xocs:cp-notices>
            <xocs:cp-notice lang="en">© 2018 Elsevier Masson SAS. All rights reserved.</xocs:cp-notice>
         </xocs:cp-notices>
      </xocs:copyright-info>
      <xocs:funding-list has-funding-info="1">
         <xocs:funding-addon-generated-timestamp>2020-03-08T13:46:20.309Z</xocs:funding-addon-generated-timestamp>
         <xocs:funding-addon-type>http://vtw.elsevier.com/data/voc/AddOnTypes/50.7/nlp</xocs:funding-addon-type>
         <xocs:funding-source-document source-document-type="pii">S0223523418309449</xocs:funding-source-document>
         <xocs:funding>
            <xocs:funding-agency-matched-string>National Natural Science Foundation of China</xocs:funding-agency-matched-string>
            <xocs:funding-id>81473253</xocs:funding-id>
            <xocs:funding-agency-acronym>NSFC</xocs:funding-agency-acronym>
            <xocs:funding-agency>National Natural Science Foundation of China</xocs:funding-agency>
            <xocs:funding-agency-id>http://data.elsevier.com/vocabulary/SciValFunders/501100001809</xocs:funding-agency-id>
            <xocs:funding-agency-country>http://sws.geonames.org/1814991/</xocs:funding-agency-country>
         </xocs:funding>
         <xocs:funding>
            <xocs:funding-agency-matched-string>National Mega-projects of China for Innovative Drugs</xocs:funding-agency-matched-string>
            <xocs:funding-id>2018ZX09721001-001-001</xocs:funding-id>
         </xocs:funding>
         <xocs:funding-text>This work was supported by the National Natural Science Foundation of China (No. 81473253 ), the National Mega-projects of China for Innovative Drugs ( 2018ZX09721001-001-001 ).  </xocs:funding-text>
      </xocs:funding-list>
      <xocs:attachment-metadata-doc>
         <xocs:attachment-set-type>item</xocs:attachment-set-type>
         <xocs:pii-formatted>S0223-5234(18)30944-9</xocs:pii-formatted>
         <xocs:pii-unformatted>S0223523418309449</xocs:pii-unformatted>
         <xocs:eid>1-s2.0-S0223523418309449</xocs:eid>
         <xocs:doi>10.1016/j.ejmech.2018.10.067</xocs:doi>
         <xocs:cid>271932</xocs:cid>
         <xocs:timestamp>2020-12-25T02:14:46.288903Z</xocs:timestamp>
         <xocs:cover-date-start>2019-01-15</xocs:cover-date-start>
         <xocs:attachments>
            <xocs:web-pdf>
               <xocs:attachment-eid>1-s2.0-S0223523418309449-main.pdf</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523418309449/MAIN/application/pdf/fb1513297f0769acca15f4f7d252a205/main.pdf</xocs:ucs-locator>
               <xocs:filename>main.pdf</xocs:filename>
               <xocs:extension>pdf</xocs:extension>
               <xocs:pdf-optimized>true</xocs:pdf-optimized>
               <xocs:filesize>2475037</xocs:filesize>
               <xocs:web-pdf-purpose>MAIN</xocs:web-pdf-purpose>
               <xocs:web-pdf-page-count>12</xocs:web-pdf-page-count>
               <xocs:web-pdf-images>
                  <xocs:web-pdf-image>
                     <xocs:attachment-eid>1-s2.0-S0223523418309449-main_1.png</xocs:attachment-eid>
                     <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523418309449/PREVIEW/image/png/f6f934d2f520e855101403f694c4f473/main_1.png</xocs:ucs-locator>
                     <xocs:filename>main_1.png</xocs:filename>
                     <xocs:extension>png</xocs:extension>
                     <xocs:filesize>58361</xocs:filesize>
                     <xocs:pixel-height>849</xocs:pixel-height>
                     <xocs:pixel-width>656</xocs:pixel-width>
                     <xocs:attachment-type>IMAGE-WEB-PDF</xocs:attachment-type>
                     <xocs:pdf-page-num>1</xocs:pdf-page-num>
                  </xocs:web-pdf-image>
               </xocs:web-pdf-images>
            </xocs:web-pdf>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523418309449-figs1.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523418309449/figs1/DOWNSAMPLED/image/jpeg/c226a26aafc425c31a3c95edb3246123/figs1.jpg</xocs:ucs-locator>
               <xocs:file-basename>figs1</xocs:file-basename>
               <xocs:filename>figs1.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>5979</xocs:filesize>
               <xocs:pixel-height>88</xocs:pixel-height>
               <xocs:pixel-width>176</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-DOWNSAMPLED</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523418309449-fx1.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523418309449/fx1/DOWNSAMPLED/image/jpeg/100b74afa76a2f91da611ca0a968dfaf/fx1.jpg</xocs:ucs-locator>
               <xocs:file-basename>fx1</xocs:file-basename>
               <xocs:abstract-attachment>true</xocs:abstract-attachment>
               <xocs:filename>fx1.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>17547</xocs:filesize>
               <xocs:pixel-height>129</xocs:pixel-height>
               <xocs:pixel-width>500</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-DOWNSAMPLED</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523418309449-fx10.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523418309449/fx10/DOWNSAMPLED/image/jpeg/61c88c3f1dda23e78e30e5f6ba550b02/fx10.jpg</xocs:ucs-locator>
               <xocs:file-basename>fx10</xocs:file-basename>
               <xocs:filename>fx10.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>939</xocs:filesize>
               <xocs:pixel-height>37</xocs:pixel-height>
               <xocs:pixel-width>30</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-DOWNSAMPLED</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523418309449-fx11.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523418309449/fx11/DOWNSAMPLED/image/jpeg/443ef77c8c5ef57be02ac4a597a73176/fx11.jpg</xocs:ucs-locator>
               <xocs:file-basename>fx11</xocs:file-basename>
               <xocs:filename>fx11.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>995</xocs:filesize>
               <xocs:pixel-height>45</xocs:pixel-height>
               <xocs:pixel-width>29</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-DOWNSAMPLED</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523418309449-fx12.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523418309449/fx12/DOWNSAMPLED/image/jpeg/61ae767355994d12f1ffc4ee45844cfd/fx12.jpg</xocs:ucs-locator>
               <xocs:file-basename>fx12</xocs:file-basename>
               <xocs:filename>fx12.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>891</xocs:filesize>
               <xocs:pixel-height>40</xocs:pixel-height>
               <xocs:pixel-width>38</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-DOWNSAMPLED</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523418309449-fx13.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523418309449/fx13/DOWNSAMPLED/image/jpeg/3bfe4e774c5efe38a45b3fbfba0cd1a0/fx13.jpg</xocs:ucs-locator>
               <xocs:file-basename>fx13</xocs:file-basename>
               <xocs:filename>fx13.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>947</xocs:filesize>
               <xocs:pixel-height>44</xocs:pixel-height>
               <xocs:pixel-width>30</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-DOWNSAMPLED</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523418309449-fx14.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523418309449/fx14/DOWNSAMPLED/image/jpeg/0960257ed1216df0d729247fcedf27fc/fx14.jpg</xocs:ucs-locator>
               <xocs:file-basename>fx14</xocs:file-basename>
               <xocs:filename>fx14.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>970</xocs:filesize>
               <xocs:pixel-height>46</xocs:pixel-height>
               <xocs:pixel-width>48</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-DOWNSAMPLED</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523418309449-fx15.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523418309449/fx15/DOWNSAMPLED/image/jpeg/6b6b56ae950ba2a19903cff6d82fd4a4/fx15.jpg</xocs:ucs-locator>
               <xocs:file-basename>fx15</xocs:file-basename>
               <xocs:filename>fx15.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>1301</xocs:filesize>
               <xocs:pixel-height>44</xocs:pixel-height>
               <xocs:pixel-width>65</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-DOWNSAMPLED</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523418309449-fx16.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523418309449/fx16/DOWNSAMPLED/image/jpeg/9cf515a18d4f33c14b6d2226e9ab8e60/fx16.jpg</xocs:ucs-locator>
               <xocs:file-basename>fx16</xocs:file-basename>
               <xocs:filename>fx16.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>1289</xocs:filesize>
               <xocs:pixel-height>47</xocs:pixel-height>
               <xocs:pixel-width>62</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-DOWNSAMPLED</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523418309449-fx17.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523418309449/fx17/DOWNSAMPLED/image/jpeg/fdf5c3f7132202ced40c1dbc4b0917f6/fx17.jpg</xocs:ucs-locator>
               <xocs:file-basename>fx17</xocs:file-basename>
               <xocs:filename>fx17.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>1322</xocs:filesize>
               <xocs:pixel-height>45</xocs:pixel-height>
               <xocs:pixel-width>66</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-DOWNSAMPLED</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523418309449-fx18.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523418309449/fx18/DOWNSAMPLED/image/jpeg/2b2abad9a6ad7bd5955b02f541a9252f/fx18.jpg</xocs:ucs-locator>
               <xocs:file-basename>fx18</xocs:file-basename>
               <xocs:filename>fx18.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>1376</xocs:filesize>
               <xocs:pixel-height>42</xocs:pixel-height>
               <xocs:pixel-width>72</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-DOWNSAMPLED</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523418309449-fx19.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523418309449/fx19/DOWNSAMPLED/image/jpeg/f9f0e22ea7a1578d0250722b4507d4b8/fx19.jpg</xocs:ucs-locator>
               <xocs:file-basename>fx19</xocs:file-basename>
               <xocs:filename>fx19.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>1121</xocs:filesize>
               <xocs:pixel-height>26</xocs:pixel-height>
               <xocs:pixel-width>64</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-DOWNSAMPLED</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523418309449-fx2.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523418309449/fx2/DOWNSAMPLED/image/jpeg/562b7de42b60df12bc8c75dc695d9a6d/fx2.jpg</xocs:ucs-locator>
               <xocs:file-basename>fx2</xocs:file-basename>
               <xocs:filename>fx2.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>3789</xocs:filesize>
               <xocs:pixel-height>71</xocs:pixel-height>
               <xocs:pixel-width>195</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-DOWNSAMPLED</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523418309449-fx20.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523418309449/fx20/DOWNSAMPLED/image/jpeg/1531eb8dbf10254626e8e526b33a7e9b/fx20.jpg</xocs:ucs-locator>
               <xocs:file-basename>fx20</xocs:file-basename>
               <xocs:filename>fx20.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>1226</xocs:filesize>
               <xocs:pixel-height>34</xocs:pixel-height>
               <xocs:pixel-width>54</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-DOWNSAMPLED</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523418309449-fx21.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523418309449/fx21/DOWNSAMPLED/image/jpeg/8c1c75461f3fe3195bb86978d13f4d80/fx21.jpg</xocs:ucs-locator>
               <xocs:file-basename>fx21</xocs:file-basename>
               <xocs:filename>fx21.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>1125</xocs:filesize>
               <xocs:pixel-height>28</xocs:pixel-height>
               <xocs:pixel-width>54</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-DOWNSAMPLED</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523418309449-fx22.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523418309449/fx22/DOWNSAMPLED/image/jpeg/e06bb1612d07acb0a644527576cf2a13/fx22.jpg</xocs:ucs-locator>
               <xocs:file-basename>fx22</xocs:file-basename>
               <xocs:filename>fx22.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>1159</xocs:filesize>
               <xocs:pixel-height>35</xocs:pixel-height>
               <xocs:pixel-width>61</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-DOWNSAMPLED</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523418309449-fx23.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523418309449/fx23/DOWNSAMPLED/image/jpeg/e943894228b2aa05ac9521fe3634e365/fx23.jpg</xocs:ucs-locator>
               <xocs:file-basename>fx23</xocs:file-basename>
               <xocs:filename>fx23.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>1140</xocs:filesize>
               <xocs:pixel-height>35</xocs:pixel-height>
               <xocs:pixel-width>65</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-DOWNSAMPLED</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523418309449-fx24.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523418309449/fx24/DOWNSAMPLED/image/jpeg/5bd7e2ec7ec2a6a1966e7ae1781cb7e9/fx24.jpg</xocs:ucs-locator>
               <xocs:file-basename>fx24</xocs:file-basename>
               <xocs:filename>fx24.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>1137</xocs:filesize>
               <xocs:pixel-height>34</xocs:pixel-height>
               <xocs:pixel-width>66</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-DOWNSAMPLED</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523418309449-fx25.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523418309449/fx25/DOWNSAMPLED/image/jpeg/859e2eb363d00df70abb3a073e8d5404/fx25.jpg</xocs:ucs-locator>
               <xocs:file-basename>fx25</xocs:file-basename>
               <xocs:filename>fx25.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>1097</xocs:filesize>
               <xocs:pixel-height>37</xocs:pixel-height>
               <xocs:pixel-width>65</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-DOWNSAMPLED</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523418309449-fx26.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523418309449/fx26/DOWNSAMPLED/image/jpeg/8efc3e16ffc7a20122fce032ce790737/fx26.jpg</xocs:ucs-locator>
               <xocs:file-basename>fx26</xocs:file-basename>
               <xocs:filename>fx26.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>1311</xocs:filesize>
               <xocs:pixel-height>35</xocs:pixel-height>
               <xocs:pixel-width>79</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-DOWNSAMPLED</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523418309449-fx27.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523418309449/fx27/DOWNSAMPLED/image/jpeg/9a0e598c89b78c9b9093a1c3a17fb27b/fx27.jpg</xocs:ucs-locator>
               <xocs:file-basename>fx27</xocs:file-basename>
               <xocs:filename>fx27.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>1359</xocs:filesize>
               <xocs:pixel-height>34</xocs:pixel-height>
               <xocs:pixel-width>78</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-DOWNSAMPLED</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523418309449-fx28.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523418309449/fx28/DOWNSAMPLED/image/jpeg/55a47515e1d7af59ee7a985b1343b03c/fx28.jpg</xocs:ucs-locator>
               <xocs:file-basename>fx28</xocs:file-basename>
               <xocs:filename>fx28.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>1335</xocs:filesize>
               <xocs:pixel-height>43</xocs:pixel-height>
               <xocs:pixel-width>65</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-DOWNSAMPLED</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523418309449-fx29.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523418309449/fx29/DOWNSAMPLED/image/jpeg/033a81f0e256e3ad41f58a7525acd8d6/fx29.jpg</xocs:ucs-locator>
               <xocs:file-basename>fx29</xocs:file-basename>
               <xocs:filename>fx29.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>1378</xocs:filesize>
               <xocs:pixel-height>42</xocs:pixel-height>
               <xocs:pixel-width>64</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-DOWNSAMPLED</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523418309449-fx3.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523418309449/fx3/DOWNSAMPLED/image/jpeg/12f027c153735da099782b34513f7d70/fx3.jpg</xocs:ucs-locator>
               <xocs:file-basename>fx3</xocs:file-basename>
               <xocs:filename>fx3.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>898</xocs:filesize>
               <xocs:pixel-height>29</xocs:pixel-height>
               <xocs:pixel-width>34</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-DOWNSAMPLED</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523418309449-fx30.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523418309449/fx30/DOWNSAMPLED/image/jpeg/12dbc18ba260a297e0b6a44288bcb9ff/fx30.jpg</xocs:ucs-locator>
               <xocs:file-basename>fx30</xocs:file-basename>
               <xocs:filename>fx30.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>1412</xocs:filesize>
               <xocs:pixel-height>48</xocs:pixel-height>
               <xocs:pixel-width>66</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-DOWNSAMPLED</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523418309449-fx31.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523418309449/fx31/DOWNSAMPLED/image/jpeg/a858e04403376f376a0724b70c46f954/fx31.jpg</xocs:ucs-locator>
               <xocs:file-basename>fx31</xocs:file-basename>
               <xocs:filename>fx31.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>1435</xocs:filesize>
               <xocs:pixel-height>47</xocs:pixel-height>
               <xocs:pixel-width>70</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-DOWNSAMPLED</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523418309449-fx32.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523418309449/fx32/DOWNSAMPLED/image/jpeg/41982356f5570e00ab5b367cbd70bb4e/fx32.jpg</xocs:ucs-locator>
               <xocs:file-basename>fx32</xocs:file-basename>
               <xocs:filename>fx32.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>1436</xocs:filesize>
               <xocs:pixel-height>49</xocs:pixel-height>
               <xocs:pixel-width>68</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-DOWNSAMPLED</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523418309449-fx33.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523418309449/fx33/DOWNSAMPLED/image/jpeg/6ff3f3adfb49b2f0e991e3bd7c6010e1/fx33.jpg</xocs:ucs-locator>
               <xocs:file-basename>fx33</xocs:file-basename>
               <xocs:filename>fx33.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>1479</xocs:filesize>
               <xocs:pixel-height>39</xocs:pixel-height>
               <xocs:pixel-width>88</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-DOWNSAMPLED</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523418309449-fx34.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523418309449/fx34/DOWNSAMPLED/image/jpeg/88be69af6a76a464dadfeaf48e2441e6/fx34.jpg</xocs:ucs-locator>
               <xocs:file-basename>fx34</xocs:file-basename>
               <xocs:filename>fx34.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>1530</xocs:filesize>
               <xocs:pixel-height>40</xocs:pixel-height>
               <xocs:pixel-width>88</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-DOWNSAMPLED</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523418309449-fx35.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523418309449/fx35/DOWNSAMPLED/image/jpeg/7781fb82868746f57268dc996e9c648a/fx35.jpg</xocs:ucs-locator>
               <xocs:file-basename>fx35</xocs:file-basename>
               <xocs:filename>fx35.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>1128</xocs:filesize>
               <xocs:pixel-height>36</xocs:pixel-height>
               <xocs:pixel-width>56</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-DOWNSAMPLED</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523418309449-fx4.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523418309449/fx4/DOWNSAMPLED/image/jpeg/7948dfa5013463b4f4bc53350cf2e441/fx4.jpg</xocs:ucs-locator>
               <xocs:file-basename>fx4</xocs:file-basename>
               <xocs:filename>fx4.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>916</xocs:filesize>
               <xocs:pixel-height>35</xocs:pixel-height>
               <xocs:pixel-width>33</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-DOWNSAMPLED</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523418309449-fx5.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523418309449/fx5/DOWNSAMPLED/image/jpeg/c106e9287fdc075a7c08798a58e03aad/fx5.jpg</xocs:ucs-locator>
               <xocs:file-basename>fx5</xocs:file-basename>
               <xocs:filename>fx5.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>884</xocs:filesize>
               <xocs:pixel-height>34</xocs:pixel-height>
               <xocs:pixel-width>36</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-DOWNSAMPLED</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523418309449-fx6.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523418309449/fx6/DOWNSAMPLED/image/jpeg/4edddf53dcda06df3c5b184ab48b041d/fx6.jpg</xocs:ucs-locator>
               <xocs:file-basename>fx6</xocs:file-basename>
               <xocs:filename>fx6.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>1090</xocs:filesize>
               <xocs:pixel-height>40</xocs:pixel-height>
               <xocs:pixel-width>56</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-DOWNSAMPLED</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523418309449-fx7.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523418309449/fx7/DOWNSAMPLED/image/jpeg/0b6faa862b8a2087932e47ebbda2785d/fx7.jpg</xocs:ucs-locator>
               <xocs:file-basename>fx7</xocs:file-basename>
               <xocs:filename>fx7.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>887</xocs:filesize>
               <xocs:pixel-height>35</xocs:pixel-height>
               <xocs:pixel-width>29</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-DOWNSAMPLED</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523418309449-fx8.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523418309449/fx8/DOWNSAMPLED/image/jpeg/20232022e3f34a64bfaf230c242897d6/fx8.jpg</xocs:ucs-locator>
               <xocs:file-basename>fx8</xocs:file-basename>
               <xocs:filename>fx8.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>834</xocs:filesize>
               <xocs:pixel-height>33</xocs:pixel-height>
               <xocs:pixel-width>30</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-DOWNSAMPLED</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523418309449-fx9.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523418309449/fx9/DOWNSAMPLED/image/jpeg/8c86843643c26a26d82f49394ab8af9d/fx9.jpg</xocs:ucs-locator>
               <xocs:file-basename>fx9</xocs:file-basename>
               <xocs:filename>fx9.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>842</xocs:filesize>
               <xocs:pixel-height>35</xocs:pixel-height>
               <xocs:pixel-width>29</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-DOWNSAMPLED</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523418309449-gr1.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523418309449/gr1/DOWNSAMPLED/image/jpeg/d6fc94712c6583c5b90ca269bca56520/gr1.jpg</xocs:ucs-locator>
               <xocs:file-basename>gr1</xocs:file-basename>
               <xocs:filename>gr1.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>30993</xocs:filesize>
               <xocs:pixel-height>253</xocs:pixel-height>
               <xocs:pixel-width>649</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-DOWNSAMPLED</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523418309449-gr2.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523418309449/gr2/DOWNSAMPLED/image/jpeg/a6008461cb8085daa218ea35218dd6a9/gr2.jpg</xocs:ucs-locator>
               <xocs:file-basename>gr2</xocs:file-basename>
               <xocs:filename>gr2.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>13929</xocs:filesize>
               <xocs:pixel-height>130</xocs:pixel-height>
               <xocs:pixel-width>650</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-DOWNSAMPLED</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523418309449-gr3.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523418309449/gr3/DOWNSAMPLED/image/jpeg/17623c3a9fea323bc90d461db7d6a8db/gr3.jpg</xocs:ucs-locator>
               <xocs:file-basename>gr3</xocs:file-basename>
               <xocs:filename>gr3.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>14994</xocs:filesize>
               <xocs:pixel-height>260</xocs:pixel-height>
               <xocs:pixel-width>377</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-DOWNSAMPLED</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523418309449-gr4.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523418309449/gr4/DOWNSAMPLED/image/jpeg/92df1f89bedc493221a1d500ae57a1dd/gr4.jpg</xocs:ucs-locator>
               <xocs:file-basename>gr4</xocs:file-basename>
               <xocs:filename>gr4.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>69578</xocs:filesize>
               <xocs:pixel-height>400</xocs:pixel-height>
               <xocs:pixel-width>657</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-DOWNSAMPLED</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523418309449-gr5.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523418309449/gr5/DOWNSAMPLED/image/jpeg/1ed53e8d2d68af0bfff19d5109927fce/gr5.jpg</xocs:ucs-locator>
               <xocs:file-basename>gr5</xocs:file-basename>
               <xocs:filename>gr5.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>21752</xocs:filesize>
               <xocs:pixel-height>153</xocs:pixel-height>
               <xocs:pixel-width>521</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-DOWNSAMPLED</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523418309449-gr6.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523418309449/gr6/DOWNSAMPLED/image/jpeg/b33fc94150d9ec88841f5b4c8b5b846a/gr6.jpg</xocs:ucs-locator>
               <xocs:file-basename>gr6</xocs:file-basename>
               <xocs:filename>gr6.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>111642</xocs:filesize>
               <xocs:pixel-height>257</xocs:pixel-height>
               <xocs:pixel-width>795</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-DOWNSAMPLED</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523418309449-gr7.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523418309449/gr7/DOWNSAMPLED/image/jpeg/c0fc2eb3fe3e52995d420666a6ced136/gr7.jpg</xocs:ucs-locator>
               <xocs:file-basename>gr7</xocs:file-basename>
               <xocs:filename>gr7.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>45615</xocs:filesize>
               <xocs:pixel-height>363</xocs:pixel-height>
               <xocs:pixel-width>528</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-DOWNSAMPLED</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523418309449-gr8.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523418309449/gr8/DOWNSAMPLED/image/jpeg/26cd065322c03c98804c31a6071c761d/gr8.jpg</xocs:ucs-locator>
               <xocs:file-basename>gr8</xocs:file-basename>
               <xocs:filename>gr8.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>26092</xocs:filesize>
               <xocs:pixel-height>239</xocs:pixel-height>
               <xocs:pixel-width>532</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-DOWNSAMPLED</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523418309449-sc1.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523418309449/sc1/DOWNSAMPLED/image/jpeg/53bd1824062a812f0c8ff1fc0027b1dc/sc1.jpg</xocs:ucs-locator>
               <xocs:file-basename>sc1</xocs:file-basename>
               <xocs:filename>sc1.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>14616</xocs:filesize>
               <xocs:pixel-height>198</xocs:pixel-height>
               <xocs:pixel-width>522</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-DOWNSAMPLED</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523418309449-sc2.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523418309449/sc2/DOWNSAMPLED/image/jpeg/d6f49f18df33f930bb36ca8875d6cff4/sc2.jpg</xocs:ucs-locator>
               <xocs:file-basename>sc2</xocs:file-basename>
               <xocs:filename>sc2.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>19268</xocs:filesize>
               <xocs:pixel-height>227</xocs:pixel-height>
               <xocs:pixel-width>661</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-DOWNSAMPLED</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523418309449-figs1.sml</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523418309449/figs1/THUMBNAIL/image/gif/b4d54c5920f521d08c53c9ffe0dbde11/figs1.sml</xocs:ucs-locator>
               <xocs:file-basename>figs1</xocs:file-basename>
               <xocs:filename>figs1.sml</xocs:filename>
               <xocs:extension>sml</xocs:extension>
               <xocs:filesize>5100</xocs:filesize>
               <xocs:pixel-height>109</xocs:pixel-height>
               <xocs:pixel-width>219</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-THUMBNAIL</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523418309449-fx1.sml</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523418309449/fx1/THUMBNAIL/image/gif/d8920027a673f4483ce1fdf83b89c3e6/fx1.sml</xocs:ucs-locator>
               <xocs:file-basename>fx1</xocs:file-basename>
               <xocs:abstract-attachment>true</xocs:abstract-attachment>
               <xocs:filename>fx1.sml</xocs:filename>
               <xocs:extension>sml</xocs:extension>
               <xocs:filesize>4215</xocs:filesize>
               <xocs:pixel-height>57</xocs:pixel-height>
               <xocs:pixel-width>219</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-THUMBNAIL</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523418309449-fx10.sml</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523418309449/fx10/THUMBNAIL/image/gif/ee8add8f62421732a03525733691c91a/fx10.sml</xocs:ucs-locator>
               <xocs:file-basename>fx10</xocs:file-basename>
               <xocs:filename>fx10.sml</xocs:filename>
               <xocs:extension>sml</xocs:extension>
               <xocs:filesize>2537</xocs:filesize>
               <xocs:pixel-height>167</xocs:pixel-height>
               <xocs:pixel-width>137</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-THUMBNAIL</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523418309449-fx11.sml</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523418309449/fx11/THUMBNAIL/image/gif/53862c0d141c87a07218aeb5d4babbbe/fx11.sml</xocs:ucs-locator>
               <xocs:file-basename>fx11</xocs:file-basename>
               <xocs:filename>fx11.sml</xocs:filename>
               <xocs:extension>sml</xocs:extension>
               <xocs:filesize>2831</xocs:filesize>
               <xocs:pixel-height>202</xocs:pixel-height>
               <xocs:pixel-width>131</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-THUMBNAIL</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523418309449-fx12.sml</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523418309449/fx12/THUMBNAIL/image/gif/519a4e992072eb5d81bf71769343a2e4/fx12.sml</xocs:ucs-locator>
               <xocs:file-basename>fx12</xocs:file-basename>
               <xocs:filename>fx12.sml</xocs:filename>
               <xocs:extension>sml</xocs:extension>
               <xocs:filesize>2565</xocs:filesize>
               <xocs:pixel-height>178</xocs:pixel-height>
               <xocs:pixel-width>169</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-THUMBNAIL</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523418309449-fx13.sml</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523418309449/fx13/THUMBNAIL/image/gif/bd63a5186d65b21db2bce14e35a3c7e2/fx13.sml</xocs:ucs-locator>
               <xocs:file-basename>fx13</xocs:file-basename>
               <xocs:filename>fx13.sml</xocs:filename>
               <xocs:extension>sml</xocs:extension>
               <xocs:filesize>2791</xocs:filesize>
               <xocs:pixel-height>202</xocs:pixel-height>
               <xocs:pixel-width>137</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-THUMBNAIL</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523418309449-fx14.sml</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523418309449/fx14/THUMBNAIL/image/gif/d8b1d1def22693562cd4bd3d1cc97de9/fx14.sml</xocs:ucs-locator>
               <xocs:file-basename>fx14</xocs:file-basename>
               <xocs:filename>fx14.sml</xocs:filename>
               <xocs:extension>sml</xocs:extension>
               <xocs:filesize>3125</xocs:filesize>
               <xocs:pixel-height>208</xocs:pixel-height>
               <xocs:pixel-width>216</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-THUMBNAIL</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523418309449-fx15.sml</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523418309449/fx15/THUMBNAIL/image/gif/f4f61e2502a0269040615437d3eb40bf/fx15.sml</xocs:ucs-locator>
               <xocs:file-basename>fx15</xocs:file-basename>
               <xocs:filename>fx15.sml</xocs:filename>
               <xocs:extension>sml</xocs:extension>
               <xocs:filesize>4151</xocs:filesize>
               <xocs:pixel-height>147</xocs:pixel-height>
               <xocs:pixel-width>219</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-THUMBNAIL</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523418309449-fx16.sml</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523418309449/fx16/THUMBNAIL/image/gif/9084721771f053f193f4d5d16a549897/fx16.sml</xocs:ucs-locator>
               <xocs:file-basename>fx16</xocs:file-basename>
               <xocs:filename>fx16.sml</xocs:filename>
               <xocs:extension>sml</xocs:extension>
               <xocs:filesize>4350</xocs:filesize>
               <xocs:pixel-height>164</xocs:pixel-height>
               <xocs:pixel-width>218</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-THUMBNAIL</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523418309449-fx17.sml</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523418309449/fx17/THUMBNAIL/image/gif/5551e40ef64481a9bb9974a5e733511b/fx17.sml</xocs:ucs-locator>
               <xocs:file-basename>fx17</xocs:file-basename>
               <xocs:filename>fx17.sml</xocs:filename>
               <xocs:extension>sml</xocs:extension>
               <xocs:filesize>4188</xocs:filesize>
               <xocs:pixel-height>150</xocs:pixel-height>
               <xocs:pixel-width>219</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-THUMBNAIL</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523418309449-fx18.sml</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523418309449/fx18/THUMBNAIL/image/gif/12627e5b49f3d4f992c7d0921ddbe02d/fx18.sml</xocs:ucs-locator>
               <xocs:file-basename>fx18</xocs:file-basename>
               <xocs:filename>fx18.sml</xocs:filename>
               <xocs:extension>sml</xocs:extension>
               <xocs:filesize>4208</xocs:filesize>
               <xocs:pixel-height>128</xocs:pixel-height>
               <xocs:pixel-width>219</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-THUMBNAIL</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523418309449-fx19.sml</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523418309449/fx19/THUMBNAIL/image/gif/3f60ad6ac9a7c41bea65e93f69bb8ee8/fx19.sml</xocs:ucs-locator>
               <xocs:file-basename>fx19</xocs:file-basename>
               <xocs:filename>fx19.sml</xocs:filename>
               <xocs:extension>sml</xocs:extension>
               <xocs:filesize>3310</xocs:filesize>
               <xocs:pixel-height>90</xocs:pixel-height>
               <xocs:pixel-width>219</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-THUMBNAIL</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523418309449-fx2.sml</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523418309449/fx2/THUMBNAIL/image/gif/9ecdd0dff1830eb7feb51555ef0cd70a/fx2.sml</xocs:ucs-locator>
               <xocs:file-basename>fx2</xocs:file-basename>
               <xocs:filename>fx2.sml</xocs:filename>
               <xocs:extension>sml</xocs:extension>
               <xocs:filesize>3314</xocs:filesize>
               <xocs:pixel-height>80</xocs:pixel-height>
               <xocs:pixel-width>219</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-THUMBNAIL</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523418309449-fx20.sml</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523418309449/fx20/THUMBNAIL/image/gif/eeb765b85b269c1f7cbb6c1f39b780b7/fx20.sml</xocs:ucs-locator>
               <xocs:file-basename>fx20</xocs:file-basename>
               <xocs:filename>fx20.sml</xocs:filename>
               <xocs:extension>sml</xocs:extension>
               <xocs:filesize>5263</xocs:filesize>
               <xocs:pixel-height>136</xocs:pixel-height>
               <xocs:pixel-width>219</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-THUMBNAIL</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523418309449-fx21.sml</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523418309449/fx21/THUMBNAIL/image/gif/1a2554c0fc38f06f18aa22ce4903f489/fx21.sml</xocs:ucs-locator>
               <xocs:file-basename>fx21</xocs:file-basename>
               <xocs:filename>fx21.sml</xocs:filename>
               <xocs:extension>sml</xocs:extension>
               <xocs:filesize>3819</xocs:filesize>
               <xocs:pixel-height>115</xocs:pixel-height>
               <xocs:pixel-width>219</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-THUMBNAIL</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523418309449-fx22.sml</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523418309449/fx22/THUMBNAIL/image/gif/0ed7dd62ce960b4663afb453ee7575bf/fx22.sml</xocs:ucs-locator>
               <xocs:file-basename>fx22</xocs:file-basename>
               <xocs:filename>fx22.sml</xocs:filename>
               <xocs:extension>sml</xocs:extension>
               <xocs:filesize>3533</xocs:filesize>
               <xocs:pixel-height>127</xocs:pixel-height>
               <xocs:pixel-width>219</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-THUMBNAIL</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523418309449-fx23.sml</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523418309449/fx23/THUMBNAIL/image/gif/951c1f82430b745f279f2f55a0716536/fx23.sml</xocs:ucs-locator>
               <xocs:file-basename>fx23</xocs:file-basename>
               <xocs:filename>fx23.sml</xocs:filename>
               <xocs:extension>sml</xocs:extension>
               <xocs:filesize>3239</xocs:filesize>
               <xocs:pixel-height>117</xocs:pixel-height>
               <xocs:pixel-width>219</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-THUMBNAIL</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523418309449-fx24.sml</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523418309449/fx24/THUMBNAIL/image/gif/48d912a48bc087d44baf557641bc0bd6/fx24.sml</xocs:ucs-locator>
               <xocs:file-basename>fx24</xocs:file-basename>
               <xocs:filename>fx24.sml</xocs:filename>
               <xocs:extension>sml</xocs:extension>
               <xocs:filesize>3203</xocs:filesize>
               <xocs:pixel-height>113</xocs:pixel-height>
               <xocs:pixel-width>219</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-THUMBNAIL</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523418309449-fx25.sml</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523418309449/fx25/THUMBNAIL/image/gif/cb9fe366b563982de2fe6e583d66a5ad/fx25.sml</xocs:ucs-locator>
               <xocs:file-basename>fx25</xocs:file-basename>
               <xocs:filename>fx25.sml</xocs:filename>
               <xocs:extension>sml</xocs:extension>
               <xocs:filesize>3316</xocs:filesize>
               <xocs:pixel-height>123</xocs:pixel-height>
               <xocs:pixel-width>219</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-THUMBNAIL</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523418309449-fx26.sml</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523418309449/fx26/THUMBNAIL/image/gif/6c1fc19dba9a6ee0c3e07914ef14a58f/fx26.sml</xocs:ucs-locator>
               <xocs:file-basename>fx26</xocs:file-basename>
               <xocs:filename>fx26.sml</xocs:filename>
               <xocs:extension>sml</xocs:extension>
               <xocs:filesize>3134</xocs:filesize>
               <xocs:pixel-height>97</xocs:pixel-height>
               <xocs:pixel-width>219</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-THUMBNAIL</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523418309449-fx27.sml</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523418309449/fx27/THUMBNAIL/image/gif/1238ffc7bc9147511f7ff3b526a8b835/fx27.sml</xocs:ucs-locator>
               <xocs:file-basename>fx27</xocs:file-basename>
               <xocs:filename>fx27.sml</xocs:filename>
               <xocs:extension>sml</xocs:extension>
               <xocs:filesize>3209</xocs:filesize>
               <xocs:pixel-height>96</xocs:pixel-height>
               <xocs:pixel-width>219</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-THUMBNAIL</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523418309449-fx28.sml</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523418309449/fx28/THUMBNAIL/image/gif/37a4b711baf37568b2296fb3326545a4/fx28.sml</xocs:ucs-locator>
               <xocs:file-basename>fx28</xocs:file-basename>
               <xocs:filename>fx28.sml</xocs:filename>
               <xocs:extension>sml</xocs:extension>
               <xocs:filesize>4967</xocs:filesize>
               <xocs:pixel-height>144</xocs:pixel-height>
               <xocs:pixel-width>219</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-THUMBNAIL</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523418309449-fx29.sml</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523418309449/fx29/THUMBNAIL/image/gif/534f473c95dc34b86ef2c62c74b873a0/fx29.sml</xocs:ucs-locator>
               <xocs:file-basename>fx29</xocs:file-basename>
               <xocs:filename>fx29.sml</xocs:filename>
               <xocs:extension>sml</xocs:extension>
               <xocs:filesize>4932</xocs:filesize>
               <xocs:pixel-height>143</xocs:pixel-height>
               <xocs:pixel-width>219</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-THUMBNAIL</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523418309449-fx3.sml</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523418309449/fx3/THUMBNAIL/image/gif/68bd7b2541701f80adc33766b34de23b/fx3.sml</xocs:ucs-locator>
               <xocs:file-basename>fx3</xocs:file-basename>
               <xocs:filename>fx3.sml</xocs:filename>
               <xocs:extension>sml</xocs:extension>
               <xocs:filesize>2576</xocs:filesize>
               <xocs:pixel-height>131</xocs:pixel-height>
               <xocs:pixel-width>152</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-THUMBNAIL</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523418309449-fx30.sml</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523418309449/fx30/THUMBNAIL/image/gif/162ce8b8cdee962f3f905367db1697d9/fx30.sml</xocs:ucs-locator>
               <xocs:file-basename>fx30</xocs:file-basename>
               <xocs:filename>fx30.sml</xocs:filename>
               <xocs:extension>sml</xocs:extension>
               <xocs:filesize>5027</xocs:filesize>
               <xocs:pixel-height>160</xocs:pixel-height>
               <xocs:pixel-width>219</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-THUMBNAIL</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523418309449-fx31.sml</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523418309449/fx31/THUMBNAIL/image/gif/61916d3a42186e3fd59d89eebe2ba535/fx31.sml</xocs:ucs-locator>
               <xocs:file-basename>fx31</xocs:file-basename>
               <xocs:filename>fx31.sml</xocs:filename>
               <xocs:extension>sml</xocs:extension>
               <xocs:filesize>4522</xocs:filesize>
               <xocs:pixel-height>146</xocs:pixel-height>
               <xocs:pixel-width>219</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-THUMBNAIL</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523418309449-fx32.sml</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523418309449/fx32/THUMBNAIL/image/gif/34f41065b5da5e48164a48e0ef8b460f/fx32.sml</xocs:ucs-locator>
               <xocs:file-basename>fx32</xocs:file-basename>
               <xocs:filename>fx32.sml</xocs:filename>
               <xocs:extension>sml</xocs:extension>
               <xocs:filesize>4943</xocs:filesize>
               <xocs:pixel-height>158</xocs:pixel-height>
               <xocs:pixel-width>219</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-THUMBNAIL</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523418309449-fx33.sml</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523418309449/fx33/THUMBNAIL/image/gif/2e1e51441a8f6dc71f07da1a531d0393/fx33.sml</xocs:ucs-locator>
               <xocs:file-basename>fx33</xocs:file-basename>
               <xocs:filename>fx33.sml</xocs:filename>
               <xocs:extension>sml</xocs:extension>
               <xocs:filesize>3614</xocs:filesize>
               <xocs:pixel-height>98</xocs:pixel-height>
               <xocs:pixel-width>219</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-THUMBNAIL</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523418309449-fx34.sml</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523418309449/fx34/THUMBNAIL/image/gif/928a9db2e29b0674b85008834638ce81/fx34.sml</xocs:ucs-locator>
               <xocs:file-basename>fx34</xocs:file-basename>
               <xocs:filename>fx34.sml</xocs:filename>
               <xocs:extension>sml</xocs:extension>
               <xocs:filesize>3543</xocs:filesize>
               <xocs:pixel-height>99</xocs:pixel-height>
               <xocs:pixel-width>219</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-THUMBNAIL</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523418309449-fx35.sml</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523418309449/fx35/THUMBNAIL/image/gif/fa1ac60110acbdd7e6020446d554d05c/fx35.sml</xocs:ucs-locator>
               <xocs:file-basename>fx35</xocs:file-basename>
               <xocs:filename>fx35.sml</xocs:filename>
               <xocs:extension>sml</xocs:extension>
               <xocs:filesize>4819</xocs:filesize>
               <xocs:pixel-height>142</xocs:pixel-height>
               <xocs:pixel-width>219</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-THUMBNAIL</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523418309449-fx4.sml</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523418309449/fx4/THUMBNAIL/image/gif/c657a007011b9e9b870f223bb14e13c9/fx4.sml</xocs:ucs-locator>
               <xocs:file-basename>fx4</xocs:file-basename>
               <xocs:filename>fx4.sml</xocs:filename>
               <xocs:extension>sml</xocs:extension>
               <xocs:filesize>2852</xocs:filesize>
               <xocs:pixel-height>158</xocs:pixel-height>
               <xocs:pixel-width>149</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-THUMBNAIL</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523418309449-fx5.sml</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523418309449/fx5/THUMBNAIL/image/gif/5669411307b3e4dcfee25e10dfd9f1a6/fx5.sml</xocs:ucs-locator>
               <xocs:file-basename>fx5</xocs:file-basename>
               <xocs:filename>fx5.sml</xocs:filename>
               <xocs:extension>sml</xocs:extension>
               <xocs:filesize>2815</xocs:filesize>
               <xocs:pixel-height>152</xocs:pixel-height>
               <xocs:pixel-width>161</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-THUMBNAIL</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523418309449-fx6.sml</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523418309449/fx6/THUMBNAIL/image/gif/34675a2f80585eb0b6f741ccb5ea5cc5/fx6.sml</xocs:ucs-locator>
               <xocs:file-basename>fx6</xocs:file-basename>
               <xocs:filename>fx6.sml</xocs:filename>
               <xocs:extension>sml</xocs:extension>
               <xocs:filesize>4672</xocs:filesize>
               <xocs:pixel-height>158</xocs:pixel-height>
               <xocs:pixel-width>219</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-THUMBNAIL</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523418309449-fx7.sml</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523418309449/fx7/THUMBNAIL/image/gif/68b78c182f0fc43cdbd52506f00203d7/fx7.sml</xocs:ucs-locator>
               <xocs:file-basename>fx7</xocs:file-basename>
               <xocs:filename>fx7.sml</xocs:filename>
               <xocs:extension>sml</xocs:extension>
               <xocs:filesize>2525</xocs:filesize>
               <xocs:pixel-height>158</xocs:pixel-height>
               <xocs:pixel-width>131</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-THUMBNAIL</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523418309449-fx8.sml</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523418309449/fx8/THUMBNAIL/image/gif/63e69c9261dd1fb04abc862abd667116/fx8.sml</xocs:ucs-locator>
               <xocs:file-basename>fx8</xocs:file-basename>
               <xocs:filename>fx8.sml</xocs:filename>
               <xocs:extension>sml</xocs:extension>
               <xocs:filesize>2326</xocs:filesize>
               <xocs:pixel-height>152</xocs:pixel-height>
               <xocs:pixel-width>137</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-THUMBNAIL</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523418309449-fx9.sml</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523418309449/fx9/THUMBNAIL/image/gif/982911cd2eb029fa37838cd4b51995f8/fx9.sml</xocs:ucs-locator>
               <xocs:file-basename>fx9</xocs:file-basename>
               <xocs:filename>fx9.sml</xocs:filename>
               <xocs:extension>sml</xocs:extension>
               <xocs:filesize>2450</xocs:filesize>
               <xocs:pixel-height>158</xocs:pixel-height>
               <xocs:pixel-width>131</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-THUMBNAIL</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523418309449-gr1.sml</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523418309449/gr1/THUMBNAIL/image/gif/030b9689a26fb71fe1c03656af604e98/gr1.sml</xocs:ucs-locator>
               <xocs:file-basename>gr1</xocs:file-basename>
               <xocs:filename>gr1.sml</xocs:filename>
               <xocs:extension>sml</xocs:extension>
               <xocs:filesize>4437</xocs:filesize>
               <xocs:pixel-height>85</xocs:pixel-height>
               <xocs:pixel-width>219</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-THUMBNAIL</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523418309449-gr2.sml</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523418309449/gr2/THUMBNAIL/image/gif/eec035dc3e93e7219a1c85b443956030/gr2.sml</xocs:ucs-locator>
               <xocs:file-basename>gr2</xocs:file-basename>
               <xocs:filename>gr2.sml</xocs:filename>
               <xocs:extension>sml</xocs:extension>
               <xocs:filesize>2537</xocs:filesize>
               <xocs:pixel-height>44</xocs:pixel-height>
               <xocs:pixel-width>219</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-THUMBNAIL</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523418309449-gr3.sml</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523418309449/gr3/THUMBNAIL/image/gif/a403845b60a704c4520302b6911d205b/gr3.sml</xocs:ucs-locator>
               <xocs:file-basename>gr3</xocs:file-basename>
               <xocs:filename>gr3.sml</xocs:filename>
               <xocs:extension>sml</xocs:extension>
               <xocs:filesize>4533</xocs:filesize>
               <xocs:pixel-height>151</xocs:pixel-height>
               <xocs:pixel-width>219</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-THUMBNAIL</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523418309449-gr4.sml</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523418309449/gr4/THUMBNAIL/image/gif/e0294d46d33f3561f0cd85a6e5cfc323/gr4.sml</xocs:ucs-locator>
               <xocs:file-basename>gr4</xocs:file-basename>
               <xocs:filename>gr4.sml</xocs:filename>
               <xocs:extension>sml</xocs:extension>
               <xocs:filesize>13645</xocs:filesize>
               <xocs:pixel-height>133</xocs:pixel-height>
               <xocs:pixel-width>219</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-THUMBNAIL</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523418309449-gr5.sml</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523418309449/gr5/THUMBNAIL/image/gif/dc786dd861e6624f2a53be599aeda135/gr5.sml</xocs:ucs-locator>
               <xocs:file-basename>gr5</xocs:file-basename>
               <xocs:filename>gr5.sml</xocs:filename>
               <xocs:extension>sml</xocs:extension>
               <xocs:filesize>7169</xocs:filesize>
               <xocs:pixel-height>64</xocs:pixel-height>
               <xocs:pixel-width>219</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-THUMBNAIL</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523418309449-gr6.sml</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523418309449/gr6/THUMBNAIL/image/gif/58a8188f25363a432970f405adc2c07b/gr6.sml</xocs:ucs-locator>
               <xocs:file-basename>gr6</xocs:file-basename>
               <xocs:filename>gr6.sml</xocs:filename>
               <xocs:extension>sml</xocs:extension>
               <xocs:filesize>16643</xocs:filesize>
               <xocs:pixel-height>71</xocs:pixel-height>
               <xocs:pixel-width>219</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-THUMBNAIL</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523418309449-gr7.sml</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523418309449/gr7/THUMBNAIL/image/gif/c4088b6fc72d8968e214bbac2380d108/gr7.sml</xocs:ucs-locator>
               <xocs:file-basename>gr7</xocs:file-basename>
               <xocs:filename>gr7.sml</xocs:filename>
               <xocs:extension>sml</xocs:extension>
               <xocs:filesize>12669</xocs:filesize>
               <xocs:pixel-height>150</xocs:pixel-height>
               <xocs:pixel-width>219</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-THUMBNAIL</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523418309449-gr8.sml</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523418309449/gr8/THUMBNAIL/image/gif/b9af440a69ab997d298298f2f5cffb58/gr8.sml</xocs:ucs-locator>
               <xocs:file-basename>gr8</xocs:file-basename>
               <xocs:filename>gr8.sml</xocs:filename>
               <xocs:extension>sml</xocs:extension>
               <xocs:filesize>6631</xocs:filesize>
               <xocs:pixel-height>99</xocs:pixel-height>
               <xocs:pixel-width>219</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-THUMBNAIL</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523418309449-sc1.sml</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523418309449/sc1/THUMBNAIL/image/gif/de256dfc23d60d72e019b99db7e11b26/sc1.sml</xocs:ucs-locator>
               <xocs:file-basename>sc1</xocs:file-basename>
               <xocs:filename>sc1.sml</xocs:filename>
               <xocs:extension>sml</xocs:extension>
               <xocs:filesize>3245</xocs:filesize>
               <xocs:pixel-height>83</xocs:pixel-height>
               <xocs:pixel-width>219</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-THUMBNAIL</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523418309449-sc2.sml</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523418309449/sc2/THUMBNAIL/image/gif/82e74676bb5807fbe5659d67eeefc059/sc2.sml</xocs:ucs-locator>
               <xocs:file-basename>sc2</xocs:file-basename>
               <xocs:filename>sc2.sml</xocs:filename>
               <xocs:extension>sml</xocs:extension>
               <xocs:filesize>3050</xocs:filesize>
               <xocs:pixel-height>75</xocs:pixel-height>
               <xocs:pixel-width>219</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-THUMBNAIL</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523418309449-figs1_lrg.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523418309449/figs1/HIGHRES/image/jpeg/42a8786bed1d994ee50cb114ccc23394/figs1_lrg.jpg</xocs:ucs-locator>
               <xocs:file-basename>figs1</xocs:file-basename>
               <xocs:filename>figs1_lrg.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>51206</xocs:filesize>
               <xocs:pixel-height>389</xocs:pixel-height>
               <xocs:pixel-width>781</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-HIGH-RES</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523418309449-fx1_lrg.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523418309449/fx1/HIGHRES/image/jpeg/53ba6978b4fd054f1d2929a30cfa05e3/fx1_lrg.jpg</xocs:ucs-locator>
               <xocs:file-basename>fx1</xocs:file-basename>
               <xocs:abstract-attachment>true</xocs:abstract-attachment>
               <xocs:filename>fx1_lrg.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>113666</xocs:filesize>
               <xocs:pixel-height>573</xocs:pixel-height>
               <xocs:pixel-width>2213</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-HIGH-RES</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523418309449-fx10_lrg.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523418309449/fx10/HIGHRES/image/jpeg/586627cdf4eccfa61e65657835d577a3/fx10_lrg.jpg</xocs:ucs-locator>
               <xocs:file-basename>fx10</xocs:file-basename>
               <xocs:filename>fx10_lrg.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>4513</xocs:filesize>
               <xocs:pixel-height>167</xocs:pixel-height>
               <xocs:pixel-width>137</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-HIGH-RES</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523418309449-fx11_lrg.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523418309449/fx11/HIGHRES/image/jpeg/579851fecd9ec14fd3e088bf121b80dc/fx11_lrg.jpg</xocs:ucs-locator>
               <xocs:file-basename>fx11</xocs:file-basename>
               <xocs:filename>fx11_lrg.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>4632</xocs:filesize>
               <xocs:pixel-height>202</xocs:pixel-height>
               <xocs:pixel-width>131</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-HIGH-RES</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523418309449-fx12_lrg.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523418309449/fx12/HIGHRES/image/jpeg/8b732ec79e247a45b43df64ffa88c9c8/fx12_lrg.jpg</xocs:ucs-locator>
               <xocs:file-basename>fx12</xocs:file-basename>
               <xocs:filename>fx12_lrg.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>4205</xocs:filesize>
               <xocs:pixel-height>178</xocs:pixel-height>
               <xocs:pixel-width>169</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-HIGH-RES</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523418309449-fx13_lrg.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523418309449/fx13/HIGHRES/image/jpeg/eaa788affebc93040e789b9e2cac178d/fx13_lrg.jpg</xocs:ucs-locator>
               <xocs:file-basename>fx13</xocs:file-basename>
               <xocs:filename>fx13_lrg.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>4729</xocs:filesize>
               <xocs:pixel-height>202</xocs:pixel-height>
               <xocs:pixel-width>137</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-HIGH-RES</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523418309449-fx14_lrg.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523418309449/fx14/HIGHRES/image/jpeg/e2e58bda62c625d0352a53354e6b5277/fx14_lrg.jpg</xocs:ucs-locator>
               <xocs:file-basename>fx14</xocs:file-basename>
               <xocs:filename>fx14_lrg.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>5792</xocs:filesize>
               <xocs:pixel-height>208</xocs:pixel-height>
               <xocs:pixel-width>216</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-HIGH-RES</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523418309449-fx15_lrg.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523418309449/fx15/HIGHRES/image/jpeg/40780192989434bebed1009eb1f32899/fx15_lrg.jpg</xocs:ucs-locator>
               <xocs:file-basename>fx15</xocs:file-basename>
               <xocs:filename>fx15_lrg.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>7337</xocs:filesize>
               <xocs:pixel-height>196</xocs:pixel-height>
               <xocs:pixel-width>292</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-HIGH-RES</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523418309449-fx16_lrg.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523418309449/fx16/HIGHRES/image/jpeg/f0cf3a71c6a7dbebc249333d83ba1e42/fx16_lrg.jpg</xocs:ucs-locator>
               <xocs:file-basename>fx16</xocs:file-basename>
               <xocs:filename>fx16_lrg.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>7299</xocs:filesize>
               <xocs:pixel-height>208</xocs:pixel-height>
               <xocs:pixel-width>277</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-HIGH-RES</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523418309449-fx17_lrg.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523418309449/fx17/HIGHRES/image/jpeg/52f4e62658ce3dc68a20fcf4110175a7/fx17_lrg.jpg</xocs:ucs-locator>
               <xocs:file-basename>fx17</xocs:file-basename>
               <xocs:filename>fx17_lrg.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>7543</xocs:filesize>
               <xocs:pixel-height>202</xocs:pixel-height>
               <xocs:pixel-width>295</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-HIGH-RES</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523418309449-fx18_lrg.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523418309449/fx18/HIGHRES/image/jpeg/24e256fe7ee6e96ed0cbadc6c294ea66/fx18_lrg.jpg</xocs:ucs-locator>
               <xocs:file-basename>fx18</xocs:file-basename>
               <xocs:filename>fx18_lrg.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>8368</xocs:filesize>
               <xocs:pixel-height>187</xocs:pixel-height>
               <xocs:pixel-width>319</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-HIGH-RES</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523418309449-fx19_lrg.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523418309449/fx19/HIGHRES/image/jpeg/9961b49fc2c90e6068a5a0d694d27e58/fx19_lrg.jpg</xocs:ucs-locator>
               <xocs:file-basename>fx19</xocs:file-basename>
               <xocs:filename>fx19_lrg.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>5565</xocs:filesize>
               <xocs:pixel-height>117</xocs:pixel-height>
               <xocs:pixel-width>286</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-HIGH-RES</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523418309449-fx2_lrg.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523418309449/fx2/HIGHRES/image/jpeg/d48fc2684a5931d9d46df0c1ffe9ab3b/fx2_lrg.jpg</xocs:ucs-locator>
               <xocs:file-basename>fx2</xocs:file-basename>
               <xocs:filename>fx2_lrg.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>28802</xocs:filesize>
               <xocs:pixel-height>316</xocs:pixel-height>
               <xocs:pixel-width>865</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-HIGH-RES</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523418309449-fx20_lrg.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523418309449/fx20/HIGHRES/image/jpeg/b85107ff0a22ccf0414751cd4e69172d/fx20_lrg.jpg</xocs:ucs-locator>
               <xocs:file-basename>fx20</xocs:file-basename>
               <xocs:filename>fx20_lrg.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>6710</xocs:filesize>
               <xocs:pixel-height>149</xocs:pixel-height>
               <xocs:pixel-width>240</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-HIGH-RES</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523418309449-fx21_lrg.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523418309449/fx21/HIGHRES/image/jpeg/bdf1aecf0cd75a322ab1218af419d07a/fx21_lrg.jpg</xocs:ucs-locator>
               <xocs:file-basename>fx21</xocs:file-basename>
               <xocs:filename>fx21_lrg.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>5011</xocs:filesize>
               <xocs:pixel-height>126</xocs:pixel-height>
               <xocs:pixel-width>240</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-HIGH-RES</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523418309449-fx22_lrg.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523418309449/fx22/HIGHRES/image/jpeg/c3448b4be8c043eae3c150d754df8677/fx22_lrg.jpg</xocs:ucs-locator>
               <xocs:file-basename>fx22</xocs:file-basename>
               <xocs:filename>fx22_lrg.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>5387</xocs:filesize>
               <xocs:pixel-height>157</xocs:pixel-height>
               <xocs:pixel-width>271</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-HIGH-RES</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523418309449-fx23_lrg.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523418309449/fx23/HIGHRES/image/jpeg/bc64002006502cb8984f35e54a706df2/fx23_lrg.jpg</xocs:ucs-locator>
               <xocs:file-basename>fx23</xocs:file-basename>
               <xocs:filename>fx23_lrg.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>5485</xocs:filesize>
               <xocs:pixel-height>155</xocs:pixel-height>
               <xocs:pixel-width>289</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-HIGH-RES</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523418309449-fx24_lrg.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523418309449/fx24/HIGHRES/image/jpeg/204cb2ddcd48c289d3bc57f0b5672d00/fx24_lrg.jpg</xocs:ucs-locator>
               <xocs:file-basename>fx24</xocs:file-basename>
               <xocs:filename>fx24_lrg.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>5581</xocs:filesize>
               <xocs:pixel-height>152</xocs:pixel-height>
               <xocs:pixel-width>295</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-HIGH-RES</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523418309449-fx25_lrg.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523418309449/fx25/HIGHRES/image/jpeg/d63a3ed54b3ed27ae7fd2a6b485c763a/fx25_lrg.jpg</xocs:ucs-locator>
               <xocs:file-basename>fx25</xocs:file-basename>
               <xocs:filename>fx25_lrg.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>6256</xocs:filesize>
               <xocs:pixel-height>164</xocs:pixel-height>
               <xocs:pixel-width>292</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-HIGH-RES</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523418309449-fx26_lrg.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523418309449/fx26/HIGHRES/image/jpeg/177c84e290550a71a37de6c788fc5e91/fx26_lrg.jpg</xocs:ucs-locator>
               <xocs:file-basename>fx26</xocs:file-basename>
               <xocs:filename>fx26_lrg.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>6876</xocs:filesize>
               <xocs:pixel-height>155</xocs:pixel-height>
               <xocs:pixel-width>350</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-HIGH-RES</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523418309449-fx27_lrg.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523418309449/fx27/HIGHRES/image/jpeg/9f45059f2cc13c460d5abfdaa1685d35/fx27_lrg.jpg</xocs:ucs-locator>
               <xocs:file-basename>fx27</xocs:file-basename>
               <xocs:filename>fx27_lrg.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>7154</xocs:filesize>
               <xocs:pixel-height>152</xocs:pixel-height>
               <xocs:pixel-width>348</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-HIGH-RES</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523418309449-fx28_lrg.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523418309449/fx28/HIGHRES/image/jpeg/920fe1b6a4d3457eea75f36b97b30c6d/fx28_lrg.jpg</xocs:ucs-locator>
               <xocs:file-basename>fx28</xocs:file-basename>
               <xocs:filename>fx28_lrg.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>8792</xocs:filesize>
               <xocs:pixel-height>190</xocs:pixel-height>
               <xocs:pixel-width>289</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-HIGH-RES</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523418309449-fx29_lrg.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523418309449/fx29/HIGHRES/image/jpeg/2d6fb696e90b89310f3bace1abd536c8/fx29_lrg.jpg</xocs:ucs-locator>
               <xocs:file-basename>fx29</xocs:file-basename>
               <xocs:filename>fx29_lrg.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>8552</xocs:filesize>
               <xocs:pixel-height>187</xocs:pixel-height>
               <xocs:pixel-width>286</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-HIGH-RES</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523418309449-fx3_lrg.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523418309449/fx3/HIGHRES/image/jpeg/1abaaabd6cd7288e217cdade91d8c7d5/fx3_lrg.jpg</xocs:ucs-locator>
               <xocs:file-basename>fx3</xocs:file-basename>
               <xocs:filename>fx3_lrg.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>4422</xocs:filesize>
               <xocs:pixel-height>131</xocs:pixel-height>
               <xocs:pixel-width>152</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-HIGH-RES</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523418309449-fx30_lrg.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523418309449/fx30/HIGHRES/image/jpeg/343ddbac339a7e77123db4c2769a19ee/fx30_lrg.jpg</xocs:ucs-locator>
               <xocs:file-basename>fx30</xocs:file-basename>
               <xocs:filename>fx30_lrg.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>9250</xocs:filesize>
               <xocs:pixel-height>216</xocs:pixel-height>
               <xocs:pixel-width>295</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-HIGH-RES</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523418309449-fx31_lrg.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523418309449/fx31/HIGHRES/image/jpeg/636099ada24bf47dd2ba3960a6c786d4/fx31_lrg.jpg</xocs:ucs-locator>
               <xocs:file-basename>fx31</xocs:file-basename>
               <xocs:filename>fx31_lrg.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>8761</xocs:filesize>
               <xocs:pixel-height>207</xocs:pixel-height>
               <xocs:pixel-width>310</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-HIGH-RES</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523418309449-fx32_lrg.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523418309449/fx32/HIGHRES/image/jpeg/3b9adbef58176e552e85c4bd19e7f342/fx32_lrg.jpg</xocs:ucs-locator>
               <xocs:file-basename>fx32</xocs:file-basename>
               <xocs:filename>fx32_lrg.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>9310</xocs:filesize>
               <xocs:pixel-height>219</xocs:pixel-height>
               <xocs:pixel-width>304</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-HIGH-RES</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523418309449-fx33_lrg.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523418309449/fx33/HIGHRES/image/jpeg/aee5ac54afca04397c5e17a2955bdd23/fx33_lrg.jpg</xocs:ucs-locator>
               <xocs:file-basename>fx33</xocs:file-basename>
               <xocs:filename>fx33_lrg.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>9467</xocs:filesize>
               <xocs:pixel-height>175</xocs:pixel-height>
               <xocs:pixel-width>391</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-HIGH-RES</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523418309449-fx34_lrg.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523418309449/fx34/HIGHRES/image/jpeg/abcd0b83844952ad7ebd7c5dd234d5cc/fx34_lrg.jpg</xocs:ucs-locator>
               <xocs:file-basename>fx34</xocs:file-basename>
               <xocs:filename>fx34_lrg.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>9592</xocs:filesize>
               <xocs:pixel-height>178</xocs:pixel-height>
               <xocs:pixel-width>392</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-HIGH-RES</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523418309449-fx35_lrg.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523418309449/fx35/HIGHRES/image/jpeg/03320f9e006bef8650de9eacfb0424bd/fx35_lrg.jpg</xocs:ucs-locator>
               <xocs:file-basename>fx35</xocs:file-basename>
               <xocs:filename>fx35_lrg.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>6808</xocs:filesize>
               <xocs:pixel-height>161</xocs:pixel-height>
               <xocs:pixel-width>248</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-HIGH-RES</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523418309449-fx4_lrg.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523418309449/fx4/HIGHRES/image/jpeg/13a9d5d1acf19828129585648c6ea1a4/fx4_lrg.jpg</xocs:ucs-locator>
               <xocs:file-basename>fx4</xocs:file-basename>
               <xocs:filename>fx4_lrg.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>4691</xocs:filesize>
               <xocs:pixel-height>158</xocs:pixel-height>
               <xocs:pixel-width>149</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-HIGH-RES</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523418309449-fx5_lrg.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523418309449/fx5/HIGHRES/image/jpeg/c7b8a866fe05de9a69eb534e84fa2e06/fx5_lrg.jpg</xocs:ucs-locator>
               <xocs:file-basename>fx5</xocs:file-basename>
               <xocs:filename>fx5_lrg.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>4886</xocs:filesize>
               <xocs:pixel-height>152</xocs:pixel-height>
               <xocs:pixel-width>161</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-HIGH-RES</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523418309449-fx6_lrg.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523418309449/fx6/HIGHRES/image/jpeg/b5cd3dd1f6ac314fed47e14288e868b5/fx6_lrg.jpg</xocs:ucs-locator>
               <xocs:file-basename>fx6</xocs:file-basename>
               <xocs:filename>fx6_lrg.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>6559</xocs:filesize>
               <xocs:pixel-height>181</xocs:pixel-height>
               <xocs:pixel-width>251</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-HIGH-RES</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523418309449-fx7_lrg.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523418309449/fx7/HIGHRES/image/jpeg/b54eca7eaac109b39997b89b71be21f6/fx7_lrg.jpg</xocs:ucs-locator>
               <xocs:file-basename>fx7</xocs:file-basename>
               <xocs:filename>fx7_lrg.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>3973</xocs:filesize>
               <xocs:pixel-height>158</xocs:pixel-height>
               <xocs:pixel-width>131</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-HIGH-RES</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523418309449-fx8_lrg.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523418309449/fx8/HIGHRES/image/jpeg/9d009f5010d15006732c5048a64bd578/fx8_lrg.jpg</xocs:ucs-locator>
               <xocs:file-basename>fx8</xocs:file-basename>
               <xocs:filename>fx8_lrg.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>3934</xocs:filesize>
               <xocs:pixel-height>152</xocs:pixel-height>
               <xocs:pixel-width>137</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-HIGH-RES</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523418309449-fx9_lrg.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523418309449/fx9/HIGHRES/image/jpeg/775307b5479ca7ef81d7d8c73d9ea608/fx9_lrg.jpg</xocs:ucs-locator>
               <xocs:file-basename>fx9</xocs:file-basename>
               <xocs:filename>fx9_lrg.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>4090</xocs:filesize>
               <xocs:pixel-height>158</xocs:pixel-height>
               <xocs:pixel-width>131</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-HIGH-RES</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523418309449-gr1_lrg.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523418309449/gr1/HIGHRES/image/jpeg/4bc5c388666b779a2bfb72cfab63e760/gr1_lrg.jpg</xocs:ucs-locator>
               <xocs:file-basename>gr1</xocs:file-basename>
               <xocs:filename>gr1_lrg.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>275210</xocs:filesize>
               <xocs:pixel-height>1121</xocs:pixel-height>
               <xocs:pixel-width>2873</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-HIGH-RES</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523418309449-gr2_lrg.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523418309449/gr2/HIGHRES/image/jpeg/68211bf350825db5d25f8e01294f97dc/gr2_lrg.jpg</xocs:ucs-locator>
               <xocs:file-basename>gr2</xocs:file-basename>
               <xocs:filename>gr2_lrg.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>117409</xocs:filesize>
               <xocs:pixel-height>575</xocs:pixel-height>
               <xocs:pixel-width>2877</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-HIGH-RES</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523418309449-gr3_lrg.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523418309449/gr3/HIGHRES/image/jpeg/5cfe96452cea8fc98f632dd6ccadd5bf/gr3_lrg.jpg</xocs:ucs-locator>
               <xocs:file-basename>gr3</xocs:file-basename>
               <xocs:filename>gr3_lrg.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>124554</xocs:filesize>
               <xocs:pixel-height>1153</xocs:pixel-height>
               <xocs:pixel-width>1671</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-HIGH-RES</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523418309449-gr4_lrg.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523418309449/gr4/HIGHRES/image/jpeg/33d144346fe2dd5dab92f3e1610f3add/gr4_lrg.jpg</xocs:ucs-locator>
               <xocs:file-basename>gr4</xocs:file-basename>
               <xocs:filename>gr4_lrg.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>604381</xocs:filesize>
               <xocs:pixel-height>1771</xocs:pixel-height>
               <xocs:pixel-width>2910</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-HIGH-RES</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523418309449-gr5_lrg.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523418309449/gr5/HIGHRES/image/jpeg/1197b08ce63f3b6a8dd6d1c42620b954/gr5_lrg.jpg</xocs:ucs-locator>
               <xocs:file-basename>gr5</xocs:file-basename>
               <xocs:filename>gr5_lrg.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>186378</xocs:filesize>
               <xocs:pixel-height>675</xocs:pixel-height>
               <xocs:pixel-width>2306</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-HIGH-RES</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523418309449-gr6_lrg.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523418309449/gr6/HIGHRES/image/jpeg/47862300aa19ec001359e61abebfdc58/gr6_lrg.jpg</xocs:ucs-locator>
               <xocs:file-basename>gr6</xocs:file-basename>
               <xocs:filename>gr6_lrg.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>1116493</xocs:filesize>
               <xocs:pixel-height>1136</xocs:pixel-height>
               <xocs:pixel-width>3520</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-HIGH-RES</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523418309449-gr7_lrg.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523418309449/gr7/HIGHRES/image/jpeg/a389f9d173e284c52bf71e36b9bd4c32/gr7_lrg.jpg</xocs:ucs-locator>
               <xocs:file-basename>gr7</xocs:file-basename>
               <xocs:filename>gr7_lrg.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>367091</xocs:filesize>
               <xocs:pixel-height>1607</xocs:pixel-height>
               <xocs:pixel-width>2340</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-HIGH-RES</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523418309449-gr8_lrg.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523418309449/gr8/HIGHRES/image/jpeg/3b39922b3409cf3fa772f5987e799610/gr8_lrg.jpg</xocs:ucs-locator>
               <xocs:file-basename>gr8</xocs:file-basename>
               <xocs:filename>gr8_lrg.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>228357</xocs:filesize>
               <xocs:pixel-height>1061</xocs:pixel-height>
               <xocs:pixel-width>2358</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-HIGH-RES</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523418309449-sc1_lrg.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523418309449/sc1/HIGHRES/image/jpeg/18e4678080c1c1ce80b94521d59eaf96/sc1_lrg.jpg</xocs:ucs-locator>
               <xocs:file-basename>sc1</xocs:file-basename>
               <xocs:filename>sc1_lrg.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>129104</xocs:filesize>
               <xocs:pixel-height>875</xocs:pixel-height>
               <xocs:pixel-width>2311</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-HIGH-RES</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523418309449-sc2_lrg.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523418309449/sc2/HIGHRES/image/jpeg/cd750abdbc9543286135724a3c7dc3c5/sc2_lrg.jpg</xocs:ucs-locator>
               <xocs:file-basename>sc2</xocs:file-basename>
               <xocs:filename>sc2_lrg.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>170816</xocs:filesize>
               <xocs:pixel-height>1004</xocs:pixel-height>
               <xocs:pixel-width>2926</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-HIGH-RES</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523418309449-am.pdf</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/egi:10G197FCP32/MAIN/application/pdf/9bd2830cf0e17e6a3f6c979d304d5425/am.pdf</xocs:ucs-locator>
               <xocs:ucs-locator>https://s3.amazonaws.com/prod-ucs-content-store-us-east/content/egi:10G197FCP32/MAIN/application/pdf/9bd2830cf0e17e6a3f6c979d304d5425/am.pdf</xocs:ucs-locator>
               <xocs:ucs-locator>https://ucs.elsevier.com/asset/25e273fb-d6f0-4d23-9265-e3f20f72f98c</xocs:ucs-locator>
               <xocs:file-basename>am</xocs:file-basename>
               <xocs:filename>am.pdf</xocs:filename>
               <xocs:extension>pdf</xocs:extension>
               <xocs:pdf-optimized>false</xocs:pdf-optimized>
               <xocs:filesize>9053041</xocs:filesize>
               <xocs:attachment-type>AAM-PDF</xocs:attachment-type>
            </xocs:attachment>
         </xocs:attachments>
      </xocs:attachment-metadata-doc>
   </xocs:meta><xocs:serial-item xmlns:xoe="http://www.elsevier.com/xml/xoe/dtd">
      <article xmlns="http://www.elsevier.com/xml/ja/dtd" docsubtype="fla" version="5.5" xml:lang="en">
         <item-info>
            <jid>EJMECH</jid>
            <aid>10853</aid>
            <ce:pii>S0223-5234(18)30944-9</ce:pii>
            <ce:doi>10.1016/j.ejmech.2018.10.067</ce:doi>
            <ce:copyright type="full-transfer" year="2018">Elsevier Masson SAS</ce:copyright>
         </item-info>
         <ce:floats>
            <ce:figure id="fig1">
               <ce:label>Fig. 1</ce:label>
               <ce:caption id="cap0010">
                  <ce:simple-para id="fspara0010" view="all">Representative small-molecule STAT3 inhibitors.</ce:simple-para>
               </ce:caption>
               <ce:alt-text role="short" id="alttext0020">Fig. 1</ce:alt-text>
               <ce:link locator="gr1" xlink:type="simple" xlink:role="http://data.elsevier.com/vocabulary/ElsevierContentTypes/23.4" xlink:href="pii:S0223523418309449/gr1"/></ce:link>
            </ce:figure>
            <ce:figure id="fig2">
               <ce:label>Fig. 2</ce:label>
               <ce:caption id="cap0015">
                  <ce:simple-para id="fspara0015" view="all">Representative napabucasin derivatives.</ce:simple-para>
               </ce:caption>
               <ce:alt-text role="short" id="alttext0025">Fig. 2</ce:alt-text>
               <ce:link locator="gr2" xlink:type="simple" xlink:role="http://data.elsevier.com/vocabulary/ElsevierContentTypes/23.4" xlink:href="pii:S0223523418309449/gr2"/></ce:link>
            </ce:figure>
            <ce:figure id="fig3">
               <ce:label>Fig. 3</ce:label>
               <ce:caption id="cap0020">
                  <ce:simple-para id="fspara0020" view="all">The design concept of the target compounds.</ce:simple-para>
               </ce:caption>
               <ce:alt-text role="short" id="alttext0030">Fig. 3</ce:alt-text>
               <ce:link locator="gr3" xlink:type="simple" xlink:role="http://data.elsevier.com/vocabulary/ElsevierContentTypes/23.4" xlink:href="pii:S0223523418309449/gr3"/></ce:link>
            </ce:figure>
            <ce:figure id="fig4">
               <ce:label>Fig. 4</ce:label>
               <ce:caption id="cap0025">
                  <ce:simple-para id="fspara0025" view="all">The binding mode of napabucasin, <ce:bold>8q</ce:bold> and STAT3 SH2 domain. <ce:bold>(A)</ce:bold> Napabucasin in 3D representation. <ce:bold>(B)</ce:bold> Napabucasin in 2D representation. <ce:bold>(C) 8q</ce:bold> in 3D representation <ce:bold>(D) 8q</ce:bold> in 2D representation. Hydrogen bond is shown in green and blue dash lines in 3D and 2D representation, respectively. (For interpretation of the references to color in this figure legend, the reader is referred to the Web version of this article.)</ce:simple-para>
               </ce:caption>
               <ce:alt-text role="short" id="alttext0035">Fig. 4</ce:alt-text>
               <ce:link locator="gr4" xlink:type="simple" xlink:role="http://data.elsevier.com/vocabulary/ElsevierContentTypes/23.4" xlink:href="pii:S0223523418309449/gr4"/></ce:link>
            </ce:figure>
            <ce:figure id="fig5">
               <ce:label>Fig. 5</ce:label>
               <ce:caption id="cap0030">
                  <ce:simple-para id="fspara0030" view="all">
                     <ce:bold>(A)</ce:bold> Anatomical mice's tumor tissues treated with <ce:bold>8q</ce:bold> and vehicle<ce:bold>. (B)</ce:bold> Growth curves of mice's tumor volume (Mean ± SD, n = 5; *, p < 0.05, **, p < 0.01).</ce:simple-para>
               </ce:caption>
               <ce:alt-text role="short" id="alttext0040">Fig. 5</ce:alt-text>
               <ce:link locator="gr5" xlink:type="simple" xlink:role="http://data.elsevier.com/vocabulary/ElsevierContentTypes/23.4" xlink:href="pii:S0223523418309449/gr5"/></ce:link>
            </ce:figure>
            <ce:figure id="fig6">
               <ce:label>Fig. 6</ce:label>
               <ce:caption id="cap0035">
                  <ce:simple-para id="fspara0035" view="all">Histological section of anatomical heart, liver, spleen, lung and kidney stained with H&E from colorectal cancer model mice treated with compound <ce:bold>8q</ce:bold>.</ce:simple-para>
               </ce:caption>
               <ce:alt-text role="short" id="alttext0045">Fig. 6</ce:alt-text>
               <ce:link locator="gr6" xlink:type="simple" xlink:role="http://data.elsevier.com/vocabulary/ElsevierContentTypes/23.4" xlink:href="pii:S0223523418309449/gr6"/></ce:link>
            </ce:figure>
            <ce:figure id="fig7">
               <ce:label>Fig. 7</ce:label>
               <ce:caption id="cap0040">
                  <ce:simple-para id="fspara0040" view="all">
                     <ce:bold>8q</ce:bold> treatment decrease protein expression level of total STAT3 and p-STAT3<ce:sup loc="post">Y705</ce:sup> 
                     <ce:italic>in vitro</ce:italic>. <ce:bold>(A)</ce:bold> Western blot analysis of STAT3 and p-STAT3<ce:sup loc="post">Y705</ce:sup> in U251 and HepG2 cells treated with <ce:bold>8q</ce:bold> (200 nM for U251 and 400 nM for HepG2 cells) for 24 and 48 h. <ce:bold>(B)</ce:bold> Immunofluorescence analysis of total STAT3 in HepG2 cells treated with <ce:bold>8q</ce:bold> (400 nM) for 24 h. Images were taken on a Zeiss inverted microscope with 20 × objective lens. BF, Bright-Field. Scale bar: 50 μm <ce:bold>(C, D)</ce:bold> Sandwich enzyme-linked immunosorbent assay of total and p-STAT3<ce:sup loc="post">Y705</ce:sup> in U251 and HepG2 cells treated with <ce:bold>8q</ce:bold> (200 nM for U251 and 400 nM for HepG2 cells) for 24 and 48 h. Error bars represent standard deviations. Paired <ce:italic>t</ce:italic>-test was used for statistical analyses of treatment groups compared with control group. *, p < 0.05; **, p < 0.01.</ce:simple-para>
               </ce:caption>
               <ce:alt-text role="short" id="alttext0050">Fig. 7</ce:alt-text>
               <ce:link locator="gr7" xlink:type="simple" xlink:role="http://data.elsevier.com/vocabulary/ElsevierContentTypes/23.4" xlink:href="pii:S0223523418309449/gr7"/></ce:link>
            </ce:figure>
            <ce:figure id="fig8">
               <ce:label>Fig. 8</ce:label>
               <ce:caption id="cap0045">
                  <ce:simple-para id="fspara0045" view="all">Electrophoretic mobility shift assay (EMSA) and surface plasmon resonance (SPR) analysis. <ce:bold>(A)</ce:bold> The effects of compound <ce:bold>8q</ce:bold> on the DNA binding activity of STAT3 was determined by EMSA with biotin-labeled DNA probe and Flag-tagged STAT3 pull-downed from HEK293T cells transiently transfected with full-length STAT3 cDNA. Ab, antibody; Pro, protein. <ce:bold>(B)</ce:bold> STAT3 and compound <ce:bold>8q</ce:bold> binding analyses with Biacore X100. The concentrations of <ce:bold>8q</ce:bold> are varied from 18.75 nM to 600 nM. The equilibrium dissociation constant (K<ce:inf loc="post">D</ce:inf>) was obtained by using the GE BIA evaluation 2.0 software.</ce:simple-para>
               </ce:caption>
               <ce:alt-text role="short" id="alttext0055">Fig. 8</ce:alt-text>
               <ce:link locator="gr8" xlink:type="simple" xlink:role="http://data.elsevier.com/vocabulary/ElsevierContentTypes/23.4" xlink:href="pii:S0223523418309449/gr8"/></ce:link>
            </ce:figure>
            <ce:figure id="sch1">
               <ce:label>Scheme 1</ce:label>
               <ce:caption id="cap0050">
                  <ce:simple-para id="fspara0050" view="all">Synthesis of <ce:bold>2a-d</ce:bold>. Reagents and conditions: (a) piperidine, EtOH, reflux, 6–12 h.</ce:simple-para>
               </ce:caption>
               <ce:alt-text role="short" id="alttext0060">Scheme 1</ce:alt-text>
               <ce:link locator="sc1" xlink:type="simple" xlink:role="http://data.elsevier.com/vocabulary/ElsevierContentTypes/23.4" xlink:href="pii:S0223523418309449/sc1"/></ce:link>
            </ce:figure>
            <ce:figure id="sch2">
               <ce:label>Scheme 2</ce:label>
               <ce:caption id="cap0055">
                  <ce:simple-para id="fspara0055" view="all">Synthesis of <ce:bold>8a-u</ce:bold>. Reagents and conditions: (a) PhI(OAc)<ce:inf loc="post">2</ce:inf>, CHCl<ce:inf loc="post">3</ce:inf>, 5 h. (b) Propargyl alcohol, Cu<ce:inf loc="post">2</ce:inf>O, 80 °C, 2 h (c) PCC, CH<ce:inf loc="post">2</ce:inf>Cl<ce:inf loc="post">2</ce:inf>, r.t., overnight. (d) H<ce:inf loc="post">2</ce:inf>O<ce:inf loc="post">2</ce:inf> 30%, AcOH, 75 °C, 4 h. (e) HATU, Et<ce:inf loc="post">3</ce:inf>N, r.t., 2 h.</ce:simple-para>
               </ce:caption>
               <ce:alt-text role="short" id="alttext0065">Scheme 2</ce:alt-text>
               <ce:link locator="sc2" xlink:type="simple" xlink:role="http://data.elsevier.com/vocabulary/ElsevierContentTypes/23.4" xlink:href="pii:S0223523418309449/sc2"/></ce:link>
            </ce:figure>
            <ce:table xmlns="http://www.elsevier.com/xml/common/cals/dtd" id="tbl1" frame="topbot" colsep="0" rowsep="0">
               <ce:label>Table 1</ce:label>
               <ce:caption id="cap0060">
                  <ce:simple-para id="tspara0010" view="all">Activity of compounds <ce:italic>in vitro</ce:italic>.</ce:simple-para>
               </ce:caption>
               <ce:alt-text role="short" id="alttext0070">Table 1</ce:alt-text>
               <ce:link locator="fx2" xlink:type="simple" xlink:role="http://data.elsevier.com/vocabulary/ElsevierContentTypes/23.4" xlink:href="pii:S0223523418309449/fx2"/></ce:link>
               <tgroup cols="7">
                  <colspec colnum="1" colname="col1"/></colspec>
                  <colspec colnum="2" colname="col2"/></colspec>
                  <colspec colnum="3" colname="col3"/></colspec>
                  <colspec colnum="4" colname="col4"/></colspec>
                  <colspec colnum="5" colname="col5"/></colspec>
                  <colspec colnum="6" colname="col6"/></colspec>
                  <colspec colnum="7" colname="col7"/></colspec>
                  <thead>
                     <row rowsep="1" valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" morerows="1">Cpd.</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" morerows="1">R<sup loc="post">1</sup>/R<sup loc="post">2</sup>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" namest="col3" nameend="col7">IC<inf loc="post">50</inf> ±SD<cross-ref refid="tbl1fna" id="crosref0180">
                              <sup loc="post">a</sup>
                           </cross-ref> (μM)</entry>
                     </row>
                     <row rowsep="1" valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">U251</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">HepG2</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">HT29</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">CT26</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">PC-3</entry>
                     </row>
                  </thead>
                  <tbody>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">
                           <bold>2a</bold>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">
                           <inline-figure baseline="0.0">
                              <link locator="fx3" xlink:type="simple" xlink:role="http://data.elsevier.com/vocabulary/ElsevierContentTypes/23.4" xlink:href="pii:S0223523418309449/fx3"/></link>
                              <alt-text role="short" id="alttext0075">Image 3</alt-text>
                           </inline-figure>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">>10</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">>10</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">>10</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">>10</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">>10</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">
                           <bold>2b</bold>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">
                           <inline-figure baseline="0.0">
                              <link locator="fx4" xlink:type="simple" xlink:role="http://data.elsevier.com/vocabulary/ElsevierContentTypes/23.4" xlink:href="pii:S0223523418309449/fx4"/></link>
                              <alt-text role="short" id="alttext0080">Image 4</alt-text>
                           </inline-figure>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">1.50 ± 0.25</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">>10</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">0.87 ± 0.01</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">2.48 ± 0.07</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">>10</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">
                           <bold>2c</bold>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">
                           <inline-figure baseline="0.0">
                              <link locator="fx5" xlink:type="simple" xlink:role="http://data.elsevier.com/vocabulary/ElsevierContentTypes/23.4" xlink:href="pii:S0223523418309449/fx5"/></link>
                              <alt-text role="short" id="alttext0085">Image 5</alt-text>
                           </inline-figure>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">2.20 ± 0.06</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">>10</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">1.52 ± 0.01</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">>10</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">>10</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">
                           <bold>2d</bold>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">
                           <inline-figure baseline="0.0">
                              <link locator="fx6" xlink:type="simple" xlink:role="http://data.elsevier.com/vocabulary/ElsevierContentTypes/23.4" xlink:href="pii:S0223523418309449/fx6"/></link>
                              <alt-text role="short" id="alttext0090">Image 6</alt-text>
                           </inline-figure>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">>10</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">>10</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">>10</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">>10</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">>10</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">
                           <bold>8a</bold>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">
                           <inline-figure baseline="0.0">
                              <link locator="fx7" xlink:type="simple" xlink:role="http://data.elsevier.com/vocabulary/ElsevierContentTypes/23.4" xlink:href="pii:S0223523418309449/fx7"/></link>
                              <alt-text role="short" id="alttext0095">Image 7</alt-text>
                           </inline-figure>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">2.18 ± 0.11</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">>10</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">1.08 ± 0.03</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">0.58 ± 0.05</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">9.65 ± 1.24</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">
                           <bold>8b</bold>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">
                           <inline-figure baseline="0.0">
                              <link locator="fx8" xlink:type="simple" xlink:role="http://data.elsevier.com/vocabulary/ElsevierContentTypes/23.4" xlink:href="pii:S0223523418309449/fx8"/></link>
                              <alt-text role="short" id="alttext0100">Image 8</alt-text>
                           </inline-figure>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">2.16 ± 0.11</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">>10</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">1.57 ± 0.01</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">0.95 ± 0.14</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">>10</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">
                           <bold>8c</bold>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">
                           <inline-figure baseline="0.0">
                              <link locator="fx9" xlink:type="simple" xlink:role="http://data.elsevier.com/vocabulary/ElsevierContentTypes/23.4" xlink:href="pii:S0223523418309449/fx9"/></link>
                              <alt-text role="short" id="alttext0105">Image 9</alt-text>
                           </inline-figure>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">2.19 ± 0.09</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">7.30 ± 0.06</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">0.86 ± 0.11</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">0.57 ± 0.04</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">6.84 ± 0.71</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">
                           <bold>8d</bold>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">
                           <inline-figure baseline="0.0">
                              <link locator="fx10" xlink:type="simple" xlink:role="http://data.elsevier.com/vocabulary/ElsevierContentTypes/23.4" xlink:href="pii:S0223523418309449/fx10"/></link>
                              <alt-text role="short" id="alttext0110">Image 10</alt-text>
                           </inline-figure>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">3.10 ± 0.04</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">9.63 ± 0.15</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">1.65 ± 0.13</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">1.35 ± 0.24</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">5.83 ± 0.74</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">
                           <bold>8e</bold>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">
                           <inline-figure baseline="0.0">
                              <link locator="fx11" xlink:type="simple" xlink:role="http://data.elsevier.com/vocabulary/ElsevierContentTypes/23.4" xlink:href="pii:S0223523418309449/fx11"/></link>
                              <alt-text role="short" id="alttext0115">Image 11</alt-text>
                           </inline-figure>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">1.37 ± 0.02</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">5.27 ± 0.13</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">0.39 ± 0.09</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">0.26 ± 0.05</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">4.58 ± 0.62</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">
                           <bold>8f</bold>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">
                           <inline-figure baseline="0.0">
                              <link locator="fx12" xlink:type="simple" xlink:role="http://data.elsevier.com/vocabulary/ElsevierContentTypes/23.4" xlink:href="pii:S0223523418309449/fx12"/></link>
                              <alt-text role="short" id="alttext0120">Image 12</alt-text>
                           </inline-figure>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">0.87 ± 0.03</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">>10</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">0.21 ± 0.01</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">0.59 ± 0.06</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">2.06 ± 0.30</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">
                           <bold>8g</bold>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">
                           <inline-figure baseline="0.0">
                              <link locator="fx13" xlink:type="simple" xlink:role="http://data.elsevier.com/vocabulary/ElsevierContentTypes/23.4" xlink:href="pii:S0223523418309449/fx13"/></link>
                              <alt-text role="short" id="alttext0125">Image 13</alt-text>
                           </inline-figure>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">0.58 ± 0.02</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">2.50 ± 0.05</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">1.13 ± 0.02</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">0.61 ± 0.03</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">>10</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">
                           <bold>8h</bold>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">
                           <inline-figure baseline="0.0">
                              <link locator="fx14" xlink:type="simple" xlink:role="http://data.elsevier.com/vocabulary/ElsevierContentTypes/23.4" xlink:href="pii:S0223523418309449/fx14"/></link>
                              <alt-text role="short" id="alttext0130">Image 14</alt-text>
                           </inline-figure>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">5.92 ± 0.43</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">9.66 ± 0.31</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">>10</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">–</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">>10</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">
                           <bold>8i</bold>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">
                           <inline-figure baseline="0.0">
                              <link locator="fx15" xlink:type="simple" xlink:role="http://data.elsevier.com/vocabulary/ElsevierContentTypes/23.4" xlink:href="pii:S0223523418309449/fx15"/></link>
                              <alt-text role="short" id="alttext0135">Image 15</alt-text>
                           </inline-figure>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">>10</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">>10</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">>10</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">–</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">>10</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">
                           <bold>8j</bold>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">
                           <inline-figure baseline="0.0">
                              <link locator="fx16" xlink:type="simple" xlink:role="http://data.elsevier.com/vocabulary/ElsevierContentTypes/23.4" xlink:href="pii:S0223523418309449/fx16"/></link>
                              <alt-text role="short" id="alttext0140">Image 16</alt-text>
                           </inline-figure>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">>10</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">>10</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">>10</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">–</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">>10</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">
                           <bold>8k</bold>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">
                           <inline-figure baseline="0.0">
                              <link locator="fx17" xlink:type="simple" xlink:role="http://data.elsevier.com/vocabulary/ElsevierContentTypes/23.4" xlink:href="pii:S0223523418309449/fx17"/></link>
                              <alt-text role="short" id="alttext0145">Image 17</alt-text>
                           </inline-figure>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">>10</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">>10</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">>10</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">–</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">9.64 ± 1.13</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">
                           <bold>8l</bold>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">
                           <inline-figure baseline="0.0">
                              <link locator="fx18" xlink:type="simple" xlink:role="http://data.elsevier.com/vocabulary/ElsevierContentTypes/23.4" xlink:href="pii:S0223523418309449/fx18"/></link>
                              <alt-text role="short" id="alttext0150">Image 18</alt-text>
                           </inline-figure>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">>10</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">>10</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">>10</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">–</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">>10</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">
                           <bold>8m</bold>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">
                           <inline-figure baseline="0.0">
                              <link locator="fx19" xlink:type="simple" xlink:role="http://data.elsevier.com/vocabulary/ElsevierContentTypes/23.4" xlink:href="pii:S0223523418309449/fx19"/></link>
                              <alt-text role="short" id="alttext0155">Image 19</alt-text>
                           </inline-figure>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">2.65 ± 0.43</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">11.25 ± 0.36</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">>10</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">–</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">>10</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">
                           <bold>8n</bold>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">
                           <inline-figure baseline="0.0">
                              <link locator="fx20" xlink:type="simple" xlink:role="http://data.elsevier.com/vocabulary/ElsevierContentTypes/23.4" xlink:href="pii:S0223523418309449/fx20"/></link>
                              <alt-text role="short" id="alttext0160">Image 20</alt-text>
                           </inline-figure>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">>10</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">>10</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">>10</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">–</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">>10</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">
                           <bold>8o</bold>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">
                           <inline-figure baseline="0.0">
                              <link locator="fx21" xlink:type="simple" xlink:role="http://data.elsevier.com/vocabulary/ElsevierContentTypes/23.4" xlink:href="pii:S0223523418309449/fx21"/></link>
                              <alt-text role="short" id="alttext0165">Image 21</alt-text>
                           </inline-figure>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">3.02 ± 0.09</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">>10</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">>10</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">–</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">>10</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">
                           <bold>8p</bold>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">
                           <inline-figure baseline="0.0">
                              <link locator="fx22" xlink:type="simple" xlink:role="http://data.elsevier.com/vocabulary/ElsevierContentTypes/23.4" xlink:href="pii:S0223523418309449/fx22"/></link>
                              <alt-text role="short" id="alttext0170">Image 22</alt-text>
                           </inline-figure>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">0.90 ± 0.08</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">1.75 ± 0.22</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">0.30 ± 0.38</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">0.20 ± 0.27</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">4.45 ± 0.69</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">
                           <bold>8q</bold>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">
                           <inline-figure baseline="0.0">
                              <link locator="fx23" xlink:type="simple" xlink:role="http://data.elsevier.com/vocabulary/ElsevierContentTypes/23.4" xlink:href="pii:S0223523418309449/fx23"/></link>
                              <alt-text role="short" id="alttext0175">Image 23</alt-text>
                           </inline-figure>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">0.22 ± 0.03</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">0.49 ± 0.04</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">0.07 ± 0.001</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">0.14 ± 0.01</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">4.13 ± 0.46</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">
                           <bold>8r</bold>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">
                           <inline-figure baseline="0.0">
                              <link locator="fx24" xlink:type="simple" xlink:role="http://data.elsevier.com/vocabulary/ElsevierContentTypes/23.4" xlink:href="pii:S0223523418309449/fx24"/></link>
                              <alt-text role="short" id="alttext0180">Image 24</alt-text>
                           </inline-figure>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">1.63 ± 0.33</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">>10</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">0.37 ± 0.01</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">0.05 ± 0.009</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">7.19 ± 0.82</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">
                           <bold>8s</bold>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">
                           <inline-figure baseline="0.0">
                              <link locator="fx25" xlink:type="simple" xlink:role="http://data.elsevier.com/vocabulary/ElsevierContentTypes/23.4" xlink:href="pii:S0223523418309449/fx25"/></link>
                              <alt-text role="short" id="alttext0185">Image 25</alt-text>
                           </inline-figure>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">>10</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">>10</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">>10</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">–</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">>10</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">
                           <bold>8t</bold>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">
                           <inline-figure baseline="0.0">
                              <link locator="fx26" xlink:type="simple" xlink:role="http://data.elsevier.com/vocabulary/ElsevierContentTypes/23.4" xlink:href="pii:S0223523418309449/fx26"/></link>
                              <alt-text role="short" id="alttext0190">Image 26</alt-text>
                           </inline-figure>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">3.36 ± 0.57</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">>10</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">>10</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">–</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">>10</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">
                           <bold>8u</bold>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">
                           <inline-figure baseline="0.0">
                              <link locator="fx27" xlink:type="simple" xlink:role="http://data.elsevier.com/vocabulary/ElsevierContentTypes/23.4" xlink:href="pii:S0223523418309449/fx27"/></link>
                              <alt-text role="short" id="alttext0195">Image 27</alt-text>
                           </inline-figure>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">6.32 ± 0.62</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">>10</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">>10</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">–</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">>10</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">
                           <bold>Napabucasin</bold>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">–</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">2.60 ± 0.38</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">6.60 ± 0.36</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">1.60 ± 0.11</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">2.50 ± 0.09</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">5.25 ± 0.57</entry>
                     </row>
                  </tbody>
               </tgroup>
               <ce:table-footnote id="tbl1fna">
                  <ce:label>a</ce:label>
                  <ce:note-para id="ntpara0015" view="all">Values were the average of at least three separate determinations (Mean ± SD). Dash (−) indicates not determined.</ce:note-para>
               </ce:table-footnote>
            </ce:table>
            <ce:table xmlns="http://www.elsevier.com/xml/common/cals/dtd" id="tbl2" frame="topbot" colsep="0" rowsep="0">
               <ce:label>Table 2</ce:label>
               <ce:caption id="cap0065">
                  <ce:simple-para id="tspara0015" view="all">Aqueous solubility of compounds <ce:bold>8c</ce:bold>-<ce:bold>g</ce:bold>, <ce:bold>8q</ce:bold> and <ce:bold>8r</ce:bold>.</ce:simple-para>
               </ce:caption>
               <ce:alt-text role="short" id="alttext0200">Table 2</ce:alt-text>
               <tgroup cols="5">
                  <colspec colnum="1" colname="col1"/></colspec>
                  <colspec colnum="2" colname="col2"/></colspec>
                  <colspec colnum="3" colname="col3"/></colspec>
                  <colspec colnum="4" colname="col4"/></colspec>
                  <colspec colnum="5" colname="col5"/></colspec>
                  <thead>
                     <row rowsep="1" valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">Cpd.</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">Structure</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">Clog P<cross-ref refid="tbl2fna" id="crosref0185">
                              <sup loc="post">a</sup>
                           </cross-ref>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">Aqueous solubility ±SD<cross-ref refid="tbl2fnb" id="crosref0190">
                              <sup loc="post">b</sup>
                           </cross-ref> (μg/mL)</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">Aqueous solubility ±SD (μM)</entry>
                     </row>
                  </thead>
                  <tbody>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">
                           <bold>8c</bold>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">
                           <inline-figure baseline="0.0">
                              <link locator="fx28" xlink:type="simple" xlink:role="http://data.elsevier.com/vocabulary/ElsevierContentTypes/23.4" xlink:href="pii:S0223523418309449/fx28"/></link>
                              <alt-text role="short" id="alttext0205">Image 28</alt-text>
                           </inline-figure>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">1.38</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">50.4 ± 0.95</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">162.1 ± 3.05</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">
                           <bold>8d</bold>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">
                           <inline-figure baseline="0.0">
                              <link locator="fx29" xlink:type="simple" xlink:role="http://data.elsevier.com/vocabulary/ElsevierContentTypes/23.4" xlink:href="pii:S0223523418309449/fx29"/></link>
                              <alt-text role="short" id="alttext0210">Image 29</alt-text>
                           </inline-figure>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">2.11</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left"><25.0</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left"><76.5</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">
                           <bold>8e</bold>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">
                           <inline-figure baseline="0.0">
                              <link locator="fx30" xlink:type="simple" xlink:role="http://data.elsevier.com/vocabulary/ElsevierContentTypes/23.4" xlink:href="pii:S0223523418309449/fx30"/></link>
                              <alt-text role="short" id="alttext0215">Image 30</alt-text>
                           </inline-figure>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">1.94</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">109.4 ± 3.76</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">337.4 ± 11.60</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">
                           <bold>8f</bold>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">
                           <inline-figure baseline="0.0">
                              <link locator="fx31" xlink:type="simple" xlink:role="http://data.elsevier.com/vocabulary/ElsevierContentTypes/23.4" xlink:href="pii:S0223523418309449/fx31"/></link>
                              <alt-text role="short" id="alttext0220">Image 31</alt-text>
                           </inline-figure>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">2.47</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">81.5 ± 0.98</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">240.9 ± 2.89</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">
                           <bold>8g</bold>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">
                           <inline-figure baseline="0.0">
                              <link locator="fx32" xlink:type="simple" xlink:role="http://data.elsevier.com/vocabulary/ElsevierContentTypes/23.4" xlink:href="pii:S0223523418309449/fx32"/></link>
                              <alt-text role="short" id="alttext0225">Image 32</alt-text>
                           </inline-figure>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">1.32</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">38.1 ± 2.38</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">117.7 ± 7.36</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">
                           <bold>8q</bold>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">
                           <inline-figure baseline="0.0">
                              <link locator="fx33" xlink:type="simple" xlink:role="http://data.elsevier.com/vocabulary/ElsevierContentTypes/23.4" xlink:href="pii:S0223523418309449/fx33"/></link>
                              <alt-text role="short" id="alttext0230">Image 33</alt-text>
                           </inline-figure>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">3.28</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">70.7 ± 0.50</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">200.9 ± 1.42</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">
                           <bold>8r</bold>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">
                           <inline-figure baseline="0.0">
                              <link locator="fx34" xlink:type="simple" xlink:role="http://data.elsevier.com/vocabulary/ElsevierContentTypes/23.4" xlink:href="pii:S0223523418309449/fx34"/></link>
                              <alt-text role="short" id="alttext0235">Image 34</alt-text>
                           </inline-figure>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">2.07</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left"><25.0</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left"><70.6</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">
                           <bold>Napabucasin</bold>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">
                           <inline-figure baseline="0.0">
                              <link locator="fx35" xlink:type="simple" xlink:role="http://data.elsevier.com/vocabulary/ElsevierContentTypes/23.4" xlink:href="pii:S0223523418309449/fx35"/></link>
                              <alt-text role="short" id="alttext0240">Image 35</alt-text>
                           </inline-figure>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">1.66</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left"><15.0</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left"><62.5</entry>
                     </row>
                  </tbody>
               </tgroup>
               <ce:table-footnote id="tbl2fna">
                  <ce:label>a</ce:label>
                  <ce:note-para id="ntpara0020" view="all">Octanol-water partition coefficient (log P) was calculated by ChemBioDraw Ultra 14.0.</ce:note-para>
               </ce:table-footnote>
               <ce:table-footnote id="tbl2fnb">
                  <ce:label>b</ce:label>
                  <ce:note-para id="ntpara0025" view="all">Values were the average of at least three separate determinations (Mean ± SD).</ce:note-para>
               </ce:table-footnote>
            </ce:table>
         </ce:floats>
         <head>
            <ce:dochead id="dhead0010">
               <ce:textfn>Research paper</ce:textfn>
            </ce:dochead>
            <ce:title id="title0010">A novel series of napabucasin derivatives as orally active inhibitors of signal transducer and activator of transcription 3 (STAT3)</ce:title>
            <ce:author-group id="augrp0010">
               <ce:author id="au1" author-id="S0223523418309449-0a169b1ca93193ad7029b473b58a2efa">
                  <ce:given-name>Chungen</ce:given-name>
                  <ce:surname>Li</ce:surname>
                  <ce:cross-ref refid="fn1" id="crosref0010">
                     <ce:sup loc="post">1</ce:sup>
                  </ce:cross-ref>
               </ce:author>
               <ce:author id="au2" author-id="S0223523418309449-d10d8138112908b4a1d372e33f4d4691">
                  <ce:given-name>Caili</ce:given-name>
                  <ce:surname>Chen</ce:surname>
                  <ce:cross-ref refid="fn1" id="crosref0015">
                     <ce:sup loc="post">1</ce:sup>
                  </ce:cross-ref>
               </ce:author>
               <ce:author id="au3" author-id="S0223523418309449-1faf81a7e58b8a3ae4b45b0544a0e591">
                  <ce:given-name>Qi</ce:given-name>
                  <ce:surname>An</ce:surname>
                  <ce:cross-ref refid="fn1" id="crosref0020">
                     <ce:sup loc="post">1</ce:sup>
                  </ce:cross-ref>
               </ce:author>
               <ce:author id="au4" author-id="S0223523418309449-512db3946ed6ed390946687b4b8b51d4">
                  <ce:given-name>Tao</ce:given-name>
                  <ce:surname>Yang</ce:surname>
               </ce:author>
               <ce:author id="au5" author-id="S0223523418309449-677b54c291de23fa48ab000184c0473f">
                  <ce:given-name>Zitai</ce:given-name>
                  <ce:surname>Sang</ce:surname>
               </ce:author>
               <ce:author id="au6" author-id="S0223523418309449-64f79001f781f4f0f7dbbfe48583799e">
                  <ce:given-name>Yang</ce:given-name>
                  <ce:surname>Yang</ce:surname>
               </ce:author>
               <ce:author id="au7" author-id="S0223523418309449-f5df78d5e749069f4fd0404b043bd6ef">
                  <ce:given-name>Yuan</ce:given-name>
                  <ce:surname>Ju</ce:surname>
               </ce:author>
               <ce:author id="au8" author-id="S0223523418309449-587f5cb18ca8a915c068528d58b38732">
                  <ce:given-name>Aiping</ce:given-name>
                  <ce:surname>Tong</ce:surname>
                  <ce:cross-ref refid="cor2" id="crosref0025">
                     <ce:sup loc="post">∗∗</ce:sup>
                  </ce:cross-ref>
                  
               </ce:author>
               <ce:author id="au9" author-id="S0223523418309449-95bb0c3d510ace3666dba7b47d863741">
                  <ce:given-name>Youfu</ce:given-name>
                  <ce:surname>Luo</ce:surname>
                  <ce:cross-ref refid="cor1" id="crosref0030">
                     <ce:sup loc="post">∗</ce:sup>
                  </ce:cross-ref>
                  
               </ce:author>
               <ce:affiliation id="aff1" affiliation-id="S0223523418309449-635d4c8b3ee14976c799f841b4e5f62f">
                  <ce:textfn>State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, West China Medical School, Sichuan University, and Collaborative Innovation Center for Biotherapy, Chengdu, 610041, China</ce:textfn>
                  <sa:affiliation>
                     <sa:organization>State Key Laboratory of Biotherapy and Cancer Center</sa:organization>
                     <sa:organization>West China Hospital</sa:organization>
                     <sa:organization>West China Medical School</sa:organization>
                     <sa:organization>Sichuan University, and Collaborative Innovation Center for Biotherapy</sa:organization>
                     <sa:city>Chengdu</sa:city>
                     <sa:postal-code>610041</sa:postal-code>
                     <sa:country>China</sa:country>
                  </sa:affiliation>
               </ce:affiliation>
               <ce:correspondence id="cor1">
                  <ce:label>∗</ce:label>
                  <ce:text>Corresponding author.</ce:text>
               </ce:correspondence>
               <ce:correspondence id="cor2">
                  <ce:label>∗∗</ce:label>
                  <ce:text>Corresponding author.</ce:text>
               </ce:correspondence>
               <ce:footnote id="fn1">
                  <ce:label>1</ce:label>
                  <ce:note-para id="ntpara0010" view="all">These authors contributed equally to this work.</ce:note-para>
               </ce:footnote>
            </ce:author-group>
            <ce:date-received day="30" month="7" year="2018"/></ce:date-received>
            <ce:date-revised day="29" month="10" year="2018"/></ce:date-revised>
            <ce:date-accepted day="30" month="10" year="2018"/></ce:date-accepted>
            <ce:abstract xml:lang="en" id="abs0010" view="all" class="author"><ce:abstract-sec id="abssec0010" view="all">
                  <ce:simple-para id="abspara0010" view="all">The transcription factor STAT3 is an attractive target for a variety of cancers therapy. Napabucasin, applied in phase III clinical trials for the treatment of a variety of cancers, was regarded as one of the most promising anticancer drug by targeting STAT3. Herein, a novel series of napabucasin derivatives were designed and synthesized, which presented a potent inhibitory activity on a variety of cancers cells. Among the derivatives compound <ce:bold>8q</ce:bold> exhibited potent inhibitory activity on U251, HepG2, HT29 and CT26 cells with the IC<ce:inf loc="post">50</ce:inf> values of 0.22, 0.49, 0.07 and 0.14 μM, respectively, which was over 10-fold more potent than napabucasin. Treatment with compound <ce:bold>8q</ce:bold> decreased protein expression level of total STAT3 and p-STAT3<ce:sup loc="post">Y705</ce:sup> 
                     <ce:italic>in vitro</ce:italic>. The binding of compound <ce:bold>8q</ce:bold> with STAT3 were further validated by electrophoretic mobility shift assay and surface plasmon resonance analysis. Compound <ce:bold>8q</ce:bold> has a K<ce:inf loc="post">D</ce:inf> of 110.2 nM for full-length STAT3 recombinant protein. Moreover, the aqueous solubility of <ce:bold>8q</ce:bold> was over 4.5-fold than that of napabucasin. In addition, compound <ce:bold>8q</ce:bold> 
                     <ce:italic>in vivo</ce:italic> significantly reduced tumor growth compared to untreated mice, and exhibited good safety profile, indicating its great potential as an efficacious drug candidate for oncotherapy.</ce:simple-para>
               </ce:abstract-sec></ce:abstract>
            <ce:abstract class="graphical" id="abs0015" view="all">
               <ce:section-title id="sectitle0015">Graphical abstract</ce:section-title>
               <ce:abstract-sec id="abssec0015" view="all">
                  <ce:simple-para id="abspara0015" view="all">
                     <ce:display>
                        <ce:figure id="undfig1">
                           <ce:alt-text role="short" id="alttext0010">Image 1</ce:alt-text>
                           <ce:link locator="fx1" xlink:type="simple" xlink:role="http://data.elsevier.com/vocabulary/ElsevierContentTypes/23.4" xlink:href="pii:S0223523418309449/fx1"/></ce:link>
                        </ce:figure>
                     </ce:display>
                  </ce:simple-para>
               </ce:abstract-sec>
            </ce:abstract>
            
            <ce:keywords xml:lang="en" id="kwrds0010" view="all" class="keyword">
               <ce:section-title id="sectitle0025">Keywords</ce:section-title>
               <ce:keyword id="kwrd0010">
                  <ce:text>Antitumor activity</ce:text>
               </ce:keyword>
               <ce:keyword id="kwrd0015">
                  <ce:text>STAT3 inhibitors</ce:text>
               </ce:keyword>
               <ce:keyword id="kwrd0020">
                  <ce:text>Napabucasin derivatives</ce:text>
               </ce:keyword>
            </ce:keywords>
         </head>
         <body view="all">
            <ce:sections>
               <ce:section id="sec1" role="introduction" view="all">
                  <ce:label>1</ce:label>
                  <ce:section-title id="sectitle0030">Introduction</ce:section-title>
                  <ce:para id="p0035" view="all">Signal transducer and activator of transcription 3 (STAT3), a STAT protein family member [<ce:cross-ref refid="bib1" id="crosref0035">1</ce:cross-ref>], is an oncogene being frequently activated in numerous cancers, such as glioma, lung, liver and other cancers [<ce:cross-ref refid="bib2" id="crosref0040">2</ce:cross-ref>]. It plays a critical role in some cellular processes such as cell growth and apoptosis by mediating the expression of target genes [<ce:cross-ref refid="bib3" id="crosref0045">3</ce:cross-ref>]. Furthermore, evidences from recent studies have indicated that STAT3 was related with the regulation of tumor microenvironment and tumor stem cell, suggesting an important role for STAT3 inhibitors in the self-renewal and differentiation of tumor stem cell and immunotherapy [<ce:cross-ref refid="bib4" id="crosref0050">4</ce:cross-ref>]. Thus, inhibiting the activation of STAT3 is an effective strategy in the cancer therapies, and the STAT3 may be used widely as one of the most promising anticancer target.</ce:para>
                  <ce:para id="p0040" view="all">Over the past few years, there were significant advances in the discovery of STAT3 inhibitors [<ce:cross-ref refid="bib5" id="crosref0055">5</ce:cross-ref>,<ce:cross-ref refid="bib6" id="crosref0060">6</ce:cross-ref>]. Several potent compounds have been discovered and promoted to early phase of drug development pipelines, such as <ce:bold>niclosamide</ce:bold>, <ce:bold>HJC0152</ce:bold>, <ce:bold>stattic</ce:bold>, <ce:bold>STX-0119</ce:bold>, <ce:bold>STA-21</ce:bold>, <ce:bold>LLL12</ce:bold>, <ce:bold>LY-5</ce:bold>, <ce:bold>napabucasin</ce:bold> [<ce:cross-refs refid="bib7 bib8 bib9 bib10 bib11 bib12 bib13 bib14" id="crosrefs0010">7–14</ce:cross-refs>] (<ce:cross-ref refid="fig1" id="crosref0065">Fig. 1</ce:cross-ref>
                     <ce:float-anchor refid="fig1"/></ce:float-anchor>).</ce:para>
                  <ce:para id="p0045" view="all">Napabucasin, an excellent STAT3 small molecule inhibitor by targeting and blocking cancer stem cell pathway activity, which was applied in phase III clinical trials for the treatment of a variety of cancers such as metastatic colorectal carcinoma, pancreatic cancer, gastric cancer and non-small cell lung cancer [<ce:cross-refs refid="bib15 bib16 bib17" id="crosrefs0015">15–17</ce:cross-refs>]. Napabucasin was regarded as one promising lead compound to generate novel STAT3 inhibitors [<ce:cross-ref refid="bib18" id="crosref0070">18</ce:cross-ref>]. Several new anticancer derivatives of napabucasin were developed through chemical structural modifications toward napabucasin in recent years [<ce:cross-refs refid="bib19 bib20 bib21" id="crosrefs0020">19–21</ce:cross-refs>] (<ce:cross-ref refid="fig2" id="crosref0075">Fig. 2</ce:cross-ref>
                     <ce:float-anchor refid="fig2"/></ce:float-anchor>).</ce:para>
                  <ce:para id="p0050" view="all">To seek napabucasin derivatives with enhanced physicochemical properties, it is necessary to identify the position suitable to modify in the scaffold. Napabucasin was docked into STAT3 protein (PDB code: <ce:inter-ref xlink:href="pdb:1BG1" id="intref0010" xlink:type="simple">1BG1</ce:inter-ref>). The acetyl group at 2-position of furan ring protrudes towards the receptor surface, indicating that it is a good site to conduct structural modification and the binding affinity will not decreases. In our first series of compounds, α, β-Unsaturated ketone was selected as a linker for its extensive application in antitumor drugs, for example curcumin (<ce:cross-ref refid="fig3" id="crosref0080">Fig. 3</ce:cross-ref>
                     <ce:float-anchor refid="fig3"/></ce:float-anchor>). The second series of napabucasin derivatives was introduced with hydrophilic groups, such as piperidyl, pyrazinyl, and substituted amino groups by an amidation reaction.</ce:para>
               </ce:section>
               <ce:section id="sec2" role="results" view="all">
                  <ce:label>2</ce:label>
                  <ce:section-title id="sectitle0035">Results and discussion</ce:section-title>
                  <ce:section id="sec2.1" view="all">
                     <ce:label>2.1</ce:label>
                     <ce:section-title id="sectitle0040">Chemistry</ce:section-title>
                     <ce:para id="p0055" view="all">The synthesis of <ce:bold>2a-d</ce:bold> was carried out following the procedures shown in <ce:cross-ref refid="sch1" id="crosref0085">Scheme 1</ce:cross-ref>
                        <ce:float-anchor refid="sch1"/></ce:float-anchor>. The compounds <ce:bold>2a-d</ce:bold> were prepared by aldol condensation reaction between commercially available 2-acetylnaphtho[2,3-b]furan-4,9-dione (<ce:bold>1</ce:bold>) and substituted aromatic aldehydes under the condition of piperidine in ethanol. As illustrated in <ce:cross-ref refid="sch2" id="crosref0090">Scheme 2</ce:cross-ref>
                        <ce:float-anchor refid="sch2"/></ce:float-anchor>, compounds <ce:bold>8a-u</ce:bold> were prepared starting from reaction of 2-hydroxy-1,4-naphthoquinone (<ce:bold>3</ce:bold>) with iodobenzene diacetate to give intermediate 3-phenyliodonio-1,2,4-trioxo-1,2,3,4-tetrahydronaphthalenide (<ce:bold>4</ce:bold>). Then cyclization reaction between <ce:bold>4</ce:bold> with propargyl alcohol afforded 2-hydroxymethyl-naphtho[2,3-<ce:italic>b</ce:italic>]furan-4,9-dione (<ce:bold>5</ce:bold>). The subsequent oxidation reaction of <ce:bold>5</ce:bold> with pyridinium chlorochromate (PCC) yielded 2-formyl-4,9-dihydronaphtho[2,3-<ce:italic>b</ce:italic>]-furan-4,9-dione (<ce:bold>6</ce:bold>), which was further oxidized to the 4,9-dioxo-4,9-dihydronaphtho[2,3-b]furan-2-carboxylic acid <ce:bold>(7)</ce:bold> by H<ce:inf loc="post">2</ce:inf>O<ce:inf loc="post">2</ce:inf> and glacial acetic acid. Finally, amidation reaction of intermediate compound <ce:bold>7</ce:bold> with different substituted alkyl amines or <ce:italic>N</ce:italic>-heterocycles to give target compounds <ce:bold>8a-u</ce:bold>.</ce:para>
                  </ce:section>
                  <ce:section id="sec2.2" view="all">
                     <ce:label>2.2</ce:label>
                     <ce:section-title id="sectitle0045">
                        <ce:italic>In vitro</ce:italic> cell growth inhibitory activity</ce:section-title>
                     <ce:para id="p0060" view="all">To evaluate the anticancer activities of the synthetic compounds, three STAT3 over-activated human cancer cell lines (U251, HepG2 and HT29 cells) and mice CT-26 cells were examined (<ce:cross-ref refid="tbl1" id="crosref0095">Table 1</ce:cross-ref>
                        <ce:float-anchor refid="tbl1"/></ce:float-anchor>). The inhibitory activity of compounds <ce:bold>2a</ce:bold> and <ce:bold>2d</ce:bold> were significantly decreased compared with that of napabucasin. <ce:bold>2b</ce:bold> and <ce:bold>2c</ce:bold>, which were substituted with heterocyclic groups, maintained the inhibitory activities in U251 and HT29 cells with the IC<ce:inf loc="post">50</ce:inf> values of 0.87–2.20 μM. But the activities of <ce:bold>2b</ce:bold> and <ce:bold>2c</ce:bold> had not been improved compared with that of napabucasin, indicating that aromatic substitution was adverse to improve activity, and substitution of heterocyclic groups was favorable for the inhibitory activity.</ce:para>
                     <ce:para id="p0065" view="all">Replaced with heterocyclic alkyl group at R<ce:sup loc="post">2</ce:sup> position (<ce:bold>8a</ce:bold>-<ce:bold>g)</ce:bold> was tolerated. The inhibitory activity of compound <ce:bold>8f</ce:bold>, substituted with the 4-ethylpiperazin-1-yl at R<ce:sup loc="post">2</ce:sup> position, was increased for U251, HT29 and CT26 cells with the IC<ce:inf loc="post">50</ce:inf> values of 0.87, 0.21, and 0.59 μM, respectively. However, the compounds <ce:bold>8h</ce:bold>-<ce:bold>l</ce:bold>, substituted with big size on the cyclic amine, exhibited declined inhibitory activity. It demonstrated that the substitutions with small size on the cyclic amine were beneficial to improve inhibitory activity.</ce:para>
                     <ce:para id="p0070" view="all">Compound <ce:bold>8q,</ce:bold> with 2-(piperidin-1-yl)ethylamino-group substituted at the R<ce:sup loc="post">2</ce:sup> position, inhibited the growth of U251, HepG2, HT29 and CT26 cells with the IC<ce:inf loc="post">50</ce:inf> values of 0.22, 0.49, 0.07 and 0.14 μM, respectively. The values were lowered over 10-fold compare with napabucasin. When the corresponding position transformed to aromatic alkyl amine (<ce:bold>8s</ce:bold>-<ce:bold>u</ce:bold>), the inhibitory activity declined obviously, suggesting that the aromatic alkyl substitution at R<ce:sup loc="post">2</ce:sup> position was not versatile to improve activity. Moreover, to evaluate the selectivity, the effects of the derivatives on STAT3-negative prostate cancer PC-3 cell line were examined. As a result, the IC<ce:inf loc="post">50</ce:inf> values of 16 derivatives were over 10 μM and the remaining 10 derivatives and napabucasin were over 2 μM.</ce:para>
                  </ce:section>
                  <ce:section id="sec2.3" view="all">
                     <ce:label>2.3</ce:label>
                     <ce:section-title id="sectitle0050">Molecular docking</ce:section-title>
                     <ce:para id="p0075" view="all">To explore the possible interaction modes of compounds with STAT3, molecular docking studies were performed in Discovery Studio (DS) 3.1. As shown in <ce:cross-ref refid="fig4" id="crosref0100">Fig. 4</ce:cross-ref>
                        <ce:float-anchor refid="fig4"/></ce:float-anchor>, napabucasin could bind to the STAT3 (PDB code: <ce:inter-ref xlink:href="pdb:1BG1" id="intref0015" xlink:type="simple">1BG1</ce:inter-ref>) SH2 domain by hydrogen bonds with Arg609 and Arg595 residues. Furthermore, napabucasin was formed cation-π interactions with Ser636 and Lys591 residues. The representative compound <ce:bold>8q</ce:bold> not only formed hydrogen bonds with Arg609 and Arg595 residues, but also new hydrogen bonds with Lys591 and Arg595 residues, and it also formed cation-π interactions with the Ser636 and Lys591 residues. The result of the docking study indicated that compound <ce:bold>8q</ce:bold> matched perfectly with the configuration of the SH2 domain of STAT3, providing a rationale explaining the excellent activity of compound <ce:bold>8q</ce:bold>.</ce:para>
                  </ce:section>
                  <ce:section id="sec2.4" view="all">
                     <ce:label>2.4</ce:label>
                     <ce:section-title id="sectitle0055">The physicochemical properties of several final compounds</ce:section-title>
                     <ce:para id="p0080" view="all">The aqueous solubility was tested by HPLC method, and the Clog P was calculated by ChemBioDraw Ultra 14.0. The aqueous and lipid solubility of most compounds were improved (<ce:cross-ref refid="tbl2" id="crosref0105">Table 2</ce:cross-ref>
                        <ce:float-anchor refid="tbl2"/></ce:float-anchor>). For example, the solubility of compound <ce:bold>8q</ce:bold> and <ce:bold>8e</ce:bold> was improved to 70.7 and 109.4 μg/mL, respectively. Compounds <ce:bold>8q</ce:bold> and <ce:bold>8e,</ce:bold> with introduction of basic amino groups to R<ce:sup loc="post">2</ce:sup> position, were beneficial to increase the water-solubility.</ce:para>
                  </ce:section>
                  <ce:section id="sec2.5" view="all">
                     <ce:label>2.5</ce:label>
                     <ce:section-title id="sectitle0060">
                        <ce:italic>In vivo</ce:italic> antitumor activity evaluation</ce:section-title>
                     <ce:para id="p0085" view="all">The amino acid sequence of STAT3 is conserved between human and mice. And the antitumor effects of STAT3 inhibitor is partly depend on its regulation of the immune systems [<ce:cross-ref refid="bib22" id="crosref0110">22</ce:cross-ref>]. Thus, to evaluate the effects of STAT3 inhibitors, immunocompetent mice are always used as animal model. Consistently, our data also show that STAT3 inhibitor exhibit efficacy both in human colorectal cancer cell line HT29 and in mouse colorectal cancer cell line CT26 (<ce:cross-ref refid="tbl1" id="crosref0115">Table 1</ce:cross-ref>). To further investigate the antitumor potential <ce:italic>in vivo</ce:italic>, we evaluated the effects of compound <ce:bold>8q</ce:bold> in CT26 mouse tumor model. As shown in <ce:cross-ref refid="fig5" id="crosref0120">Fig. 5</ce:cross-ref>
                        <ce:float-anchor refid="fig5"/></ce:float-anchor>, compound <ce:bold>8q</ce:bold> exhibited potent oral antitumor activity compared with the control. The tumor growth delay induced by <ce:bold>8q</ce:bold> was visualized by the final tumor tissue size in <ce:cross-ref refid="fig5" id="crosref0125">Fig. 5</ce:cross-ref>A and the tumor growth curve in <ce:cross-ref refid="fig5" id="crosref0130">Fig. 5</ce:cross-ref>B. The TGI (tumor growth inhibition) and T/C (relative increment ratio) with <ce:bold>8q</ce:bold> at 50 mg/kg were 63% and 28%, respectively.</ce:para>
                  </ce:section>
                  <ce:section id="sec2.6" view="all">
                     <ce:label>2.6</ce:label>
                     <ce:section-title id="sectitle0065">Preliminary safety profile of compound 8q</ce:section-title>
                     <ce:para id="p0090" view="all">Compound <ce:bold>8q</ce:bold> was well tolerated and no significant difference of body weights was observed between control and <ce:bold>8q</ce:bold> treated mice (<ce:cross-ref refid="appsec1" id="crosref0135">Figure S1</ce:cross-ref>). All mice survived without apparent behavioral alterations or other side effects.</ce:para>
                     <ce:para id="p0095" view="all">Furthermore, the pathological change in major organs was examined by H&E staining. As shown in <ce:cross-ref refid="fig6" id="crosref0140">Fig. 6</ce:cross-ref>
                        <ce:float-anchor refid="fig6"/></ce:float-anchor>, the histology of the heart, liver, spleen, lung and kidney indicated that the cells of organ tissues from the <ce:bold>8q</ce:bold> treated group kept a complete morphology, without obvious cellular inflammatory, edema or necrosis, implying no noticeable toxicity to the five major organs.</ce:para>
                  </ce:section>
                  <ce:section id="sec2.7" view="all">
                     <ce:label>2.7</ce:label>
                     <ce:section-title id="sectitle0070">Compound 8q decrease protein expression of total STAT3 and p-STAT3<ce:sup loc="post">Y705</ce:sup>
                     </ce:section-title>
                     <ce:para id="p0100" view="all">To gain insight into the mechanism of compound <ce:bold>8q</ce:bold>, we conducted western blot, immunofluorescence and sandwich enzyme-linked immunosorbent assays to examine the protein expression level of total and p-STAT3<ce:sup loc="post">Y705</ce:sup> in U251 and HepG2 after treatment. As shown in <ce:cross-ref refid="fig7" id="crosref0145">Fig. 7</ce:cross-ref>
                        <ce:float-anchor refid="fig7"/></ce:float-anchor>A, decrease of both total STAT3 and p-STAT3<ce:sup loc="post">Y705</ce:sup> was observed at 200 nM concentrations after 24 h of treatment in U251 and HepG2 cells. Through immunofluorescence staining, the expression of total STAT3 decreased obviously in HepG2 cells treated with <ce:bold>8q</ce:bold> (400 nM) for 24 h (<ce:cross-ref refid="fig7" id="crosref0150">Fig. 7</ce:cross-ref>B). Furthermore, we evaluated the total and p-STAT3<ce:sup loc="post">Y705</ce:sup> levels in U251 and HepG2 cells by sandwich enzyme-linked immunosorbent assay. As shown, both total STAT3 and p-STAT3<ce:sup loc="post">Y705</ce:sup> decreased significantly after treatment with <ce:bold>8q</ce:bold> (200 nM for U251 and 400 nM for HepG2 cells) for 24 h or 48 h (<ce:cross-ref refid="fig7" id="crosref0155">Fig. 7</ce:cross-ref>C and D).</ce:para>
                  </ce:section>
                  <ce:section id="sec2.8" view="all">
                     <ce:label>2.8</ce:label>
                     <ce:section-title id="sectitle0075">Binding of compound 8q with STAT3</ce:section-title>
                     <ce:para id="p0105" view="all">Furthermore, we validate the binding of compound <ce:bold>8q</ce:bold> with STAT3 using EMSA and SPR analysis. As shown in <ce:cross-ref refid="fig8" id="crosref0160">Fig. 8</ce:cross-ref>
                        <ce:float-anchor refid="fig8"/></ce:float-anchor>A, compound <ce:bold>8q</ce:bold> incubation at 100 nM and 200 nM concentration dramatically decreased the binding of STAT3 with biotin-labeled DNA probe. SPR analyses with Biacore X100 also show that compound <ce:bold>8q</ce:bold> has a K<ce:inf loc="post">D</ce:inf> of 110.2 nM for full-length STAT3 recombinant protein (<ce:cross-ref refid="fig8" id="crosref0165">Fig. 8</ce:cross-ref>B).</ce:para>
                  </ce:section>
               </ce:section>
               <ce:section id="sec3" role="conclusion" view="all">
                  <ce:label>3</ce:label>
                  <ce:section-title id="sectitle0080">Conclusion</ce:section-title>
                  <ce:para id="p0110" view="all">In summary, a novel series of napabucasin derivatives were designed, synthesized and biologically evaluated. Most of the designed compounds exerted promising inhibitory activity on U251, HepG2, HT29 and CT26 cells, and exhibited improved solubility compared with napabucasin. The most potent compound <ce:bold>8q</ce:bold> exhibited remarkable inhibitory activity on U251, HepG2, HT29 and CT26 cells with the IC<ce:inf loc="post">50</ce:inf> values of 0.22, 0.49, 0.07 and 0.14 μM, respectively. In mouse model of colorectal cancer, <ce:bold>8q</ce:bold> significantly inhibited tumor growth. Treatment with compound <ce:bold>8q</ce:bold> decreased protein expression level of total STAT3 and p-STAT3<ce:sup loc="post">Y705</ce:sup> 
                     <ce:italic>in vitro</ce:italic>. The binding of compound <ce:bold>8q</ce:bold> with STAT3 were validated by EMSA and SPR analysis. Compound <ce:bold>8q</ce:bold> has a K<ce:inf loc="post">D</ce:inf> of 110.2 nM for full-length STAT3 recombinant protein. Molecular docking suggested that compound <ce:bold>8q</ce:bold> bound to the SH2 domain of STAT3. Together, compound <ce:bold>8q</ce:bold> is worth of further investigations toward the discovery of STAT3 inhibitor as a drug candidate for oncotherapy.</ce:para>
               </ce:section>
               <ce:section id="sec4" view="all">
                  <ce:label>4</ce:label>
                  <ce:section-title id="sectitle0085">Experimental section</ce:section-title>
                  <ce:section id="sec4.1" view="all">
                     <ce:label>4.1</ce:label>
                     <ce:section-title id="sectitle0090">Chemistry</ce:section-title>
                     <ce:para id="p0115" view="all">All common reagents and solvents were obtained from commercial suppliers and used without further purification. Reaction progress was monitored using analytical thin layer chromatography (TLC) on precoated silica gel 60 F254 plates (0.25 mm, Qingdao Haiyang Inc.) and components were visualized by ultraviolet light (254 nm). All the NMR spectra were recorded on Bruker Avance (Varian Unity Inova) spectrometer in CDCl<ce:inf loc="post">3</ce:inf> or DMSO‑<ce:italic>d</ce:italic>
                        <ce:inf loc="post">6</ce:inf> with TMS as internal standard. <ce:sup loc="pre">1</ce:sup>H NMR and <ce:sup loc="pre">13</ce:sup>C NMR spectra were recorded respectively at 400 MHz and 100 MHz, analyzed by using MestReNova Software. Chemical shifts were reported in ppm. Splitting patterns were expressed as s, singlet; d, doublet; t, triplet; q, quartet; dd, doublet of doublets; m, multiplet; brs, broad singlet. High resolution mass spectrometry (HRMS) was performed on an Agilent LC/MSD TOF system G3250AA. Silicycle silica gel 300–400 (particle size 40–63 μm) mesh was used for all flash column chromatography experiments.</ce:para>
                     <ce:section id="sec4.1.1" view="all">
                        <ce:label>4.1.1</ce:label>
                        <ce:section-title id="sectitle0095">General procedures for the preparation of <ce:bold>2a-d</ce:bold>
                        </ce:section-title>
                        <ce:para id="p0120" view="all">To a solution of 2-acetylnaphtho[2,3-b]furan-4,9-dione <ce:bold>(1)</ce:bold> (0.42 mmol) in EtOH (5 mL), piperidine (1.25 mmol) and aromatic aldehydes (0.62 mmol) were added. The reaction mixture was heated to reflux and stirred for 7 h, then cooled to room temperature. The mixture was filtered and the filter cake was washed with 10 mL of EtOH for three times, and dried under vacuum to give compounds <ce:bold>2a-d</ce:bold>.</ce:para>
                        <ce:section id="sec4.1.1.1" view="all">
                           <ce:label>4.1.1.1</ce:label>
                           <ce:section-title id="sectitle0100">(E)-2-cinnamoylnaphtho[2,3-b]furan-4,9-dione(<ce:bold>2a</ce:bold>)</ce:section-title>
                           <ce:para id="p0125" view="all">
                              <ce:sup loc="pre">1</ce:sup>H NMR (400 MHz, DMSO) δ 8.53 (s, 1H), 8.19–8.13 (m, 2H), 7.99–7.90 (m, 5H), 7.87 (d, <ce:italic>J</ce:italic> = 15.6 Hz, 1H), 7.52–7.48 (m, 3H).<ce:sup loc="post">13</ce:sup>C NMR (100 MHz, Pyr) δ 179.8, 178.0, 174.0, 156.3, 153.5, 145.6, 134.6, 134.3, 134.2, 133.4, 133.0, 131.3, 130.9, 129.2 (2C), 129.2 (2C), 127.0, 126.9, 121.0, 113.7. HRMS (Q-TOF): calculated for C<ce:inf loc="post">21</ce:inf>H<ce:inf loc="post">12</ce:inf>O<ce:inf loc="post">4</ce:inf> 329.0736 [M + H]<ce:sup loc="post">+</ce:sup>, found 329.0815. Purity ≥95.0%.</ce:para>
                        </ce:section>
                        <ce:section id="sec4.1.1.2" view="all">
                           <ce:label>4.1.1.2</ce:label>
                           <ce:section-title id="sectitle0105">(E)-2-(3-(1-methyl-1H-pyrrol-2-yl)acryloyl)naphtho[2,3-b]furan-4,9-dione(<ce:bold>2b</ce:bold>)</ce:section-title>
                           <ce:para id="p0130" view="all">
                              <ce:sup loc="pre">1</ce:sup>H NMR (400 MHz, DMSO) δ 8.30 (s, 1H), 8.19–8.13 (m, 2H), 7.95–7.90 (m, 2H), 7.80 (d, <ce:italic>J</ce:italic> = 15.2 Hz, 1H), 7.52 (d, <ce:italic>J</ce:italic> = 15.2 Hz, 1H), 7.17 (d, <ce:italic>J</ce:italic> = 3.2 Hz, 2H), 6.25–6.23 (m, 1H), 3.80 (s, 3H).<ce:sup loc="post">13</ce:sup>C NMR (100 MHz, DMSO) δ 180.4, 177.1, 174.1, 156.5, 153.7, 134.9 (2C), 133.4, 133.3, 133.0, 130.8, 130.6, 130.1, 127.1, 127.0, 115.4, 115.4, 114.0, 110.5, 34.5. HRMS (Q-TOF): calculated for C<ce:inf loc="post">21</ce:inf>H<ce:inf loc="post">13</ce:inf>NO<ce:inf loc="post">4</ce:inf> 332.0845 [M + H]<ce:sup loc="post">+</ce:sup>, found 332.0905. Purity ≥95.0%.</ce:para>
                        </ce:section>
                        <ce:section id="sec4.1.1.3" view="all">
                           <ce:label>4.1.1.3</ce:label>
                           <ce:section-title id="sectitle0110">(E)-2-(3-(thiophen-2-yl)acryloyl)naphtho[2,3-b]furan-4,9-dione(<ce:bold>2c</ce:bold>)</ce:section-title>
                           <ce:para id="p0135" view="all">
                              <ce:sup loc="pre">1</ce:sup>H NMR (400 MHz, DMSO) δ 8.44 (s, 1H), 8.20–8.13 (m, 2H), 8.05 (d, <ce:italic>J</ce:italic> = 15.4 Hz, 1H), 7.96–7.91 (m, 2H), 7.88 (d, <ce:italic>J</ce:italic> = 5.0 Hz, 1H), 7.79 (d, <ce:italic>J</ce:italic> = 3.4 Hz, 1H), 7.61 (d, <ce:italic>J</ce:italic> = 15.4 Hz, 1H), 7.24 (m, 1H).<ce:sup loc="post">13</ce:sup>C NMR (100 MHz, DMSO) δ 180.2, 177.6, 174.1, 155.8, 153.9, 139.8, 138.1, 135.0, 134.9, 134.3, 133.4, 133.0, 132.2, 130.8, 129.4, 127.2, 127.0, 120.1, 115.0. HRMS (Q-TOF): calculated for C<ce:inf loc="post">19</ce:inf>H<ce:inf loc="post">14</ce:inf>O<ce:inf loc="post">4</ce:inf>S 335.0300 [M + H]<ce:sup loc="post">+</ce:sup>, found 335.0385. Purity ≥95.0%.</ce:para>
                        </ce:section>
                        <ce:section id="sec4.1.1.4" view="all">
                           <ce:label>4.1.1.4</ce:label>
                           <ce:section-title id="sectitle0115">(E)-2-(3-([1,1′-biphenyl]-4-yl)acryloyl)naphtho[2,3-b]furan-4,9-dione(<ce:bold>2d</ce:bold>)</ce:section-title>
                           <ce:para id="p0140" view="all">
                              <ce:sup loc="pre">1</ce:sup>H NMR (400 MHz, DMSO) δ 8.55 (s, 1H), 8.19–8.14 (m, 2H), 8.04 (m, 2H), 7.97 (d, <ce:italic>J</ce:italic> = 14.0 Hz, 1H), 7.94 (m, 2H), 7.90 (d, <ce:italic>J</ce:italic> = 10.2 Hz, 1H), 7.79 (m, 4H), 7.51 (t, <ce:italic>J</ce:italic> = 7.6 Hz, 2H), 7.42 (t, <ce:italic>J</ce:italic> = 7.4 Hz, 1H). <ce:sup loc="pre">13</ce:sup>C NMR (100 MHz, DMSO) δ 180.3, 177.9, 174.2, 155.9, 154.1, 144.9, 143.2, 139.6, 135.0, 134.9, 133.8, 133.5, 133.1, 130.8, 130.4, 129.5, 128.6, 127.6, 127.3, 127.2, 127.1, 121.9, 115.5. HRMS (Q-TOF): calculated for C<ce:inf loc="post">27</ce:inf>H<ce:inf loc="post">16</ce:inf>O<ce:inf loc="post">4</ce:inf> 406.1082 [M + H]<ce:sup loc="post">+</ce:sup>, found 406.2045. Purity ≥95.0%.</ce:para>
                        </ce:section>
                     </ce:section>
                     <ce:section id="sec4.1.2" view="all">
                        <ce:label>4.1.2</ce:label>
                        <ce:section-title id="sectitle0120">Synthesis of 3-phenyliodonio-1, 2, 4-trioxo-1,2,3,4-tetrahydronaphthalenide (<ce:bold>4</ce:bold>)</ce:section-title>
                        <ce:para id="p0145" view="all">The synthesis of compound <ce:bold>4</ce:bold> was carried out according to the previously reported procedure [<ce:cross-ref refid="bib23" id="crosref0170">23</ce:cross-ref>].To a solution of 2-hydroxy-1,4-naphthoquinone <ce:bold>(3)</ce:bold> (5 g, 28.7 mmol) in CHCl<ce:inf loc="post">3</ce:inf> (60 mL), iodobenzene diacetate (15 g, 46.6 mmol) was added at room temperature. After the reaction mixture stirred at this temperature for 6 h, the mixture was filtered to give an orange precipitate, washed with CHCl<ce:inf loc="post">3</ce:inf> for three times and dried to afford compound <ce:bold>4</ce:bold> as orange solid (9.8 g, 91.0%).</ce:para>
                     </ce:section>
                     <ce:section id="sec4.1.3" view="all">
                        <ce:label>4.1.3</ce:label>
                        <ce:section-title id="sectitle0125">Synthesis of 2-hydroxymethyl-naphtho[2,3-b]furan-4,9-dione (<ce:bold>5</ce:bold>)</ce:section-title>
                        <ce:para id="p0150" view="all">To a stirred solution of <ce:bold>4</ce:bold> (5.0 g, 13.3 mmol) in pyridine (60 mL), cuprous oxide (5.0 g) was added at room temperature. Then the reaction mixture was heated to 80 °C. The mixture solution was added propargyl alcohol (10 mL) slowly, and stirred at this temperature for 2.5 h. The solution was cooled to room temperature, filtered and diluted with 400 mL of 10% aqueous HCl. The acidic solution was extracted three times with 50 mL of EtOAc. The organic layer was washed with saturated copper sulfate solution and dried over anhydrous Na<ce:inf loc="post">2</ce:inf>SO<ce:inf loc="post">4</ce:inf>, filtered and concentrated under reduced pressure. The residue was purified by chromatography on Si gel column with DCM- MeOH to obtain compound <ce:bold>5</ce:bold> as an orange solid (540 mg, 17.8%).<ce:sup loc="post">1</ce:sup>H NMR (400 MHz, DMSO) δ 8.14–8.04 (m, 2H), 7.94–7.81 (m, 2H), 6.94 (s, 1H), 5.72 (t, <ce:italic>J</ce:italic> = 4.8 Hz, 1H), 4.61 (d, <ce:italic>J</ce:italic> = 4.8 Hz, 2H).</ce:para>
                     </ce:section>
                     <ce:section id="sec4.1.4" view="all">
                        <ce:label>4.1.4</ce:label>
                        <ce:section-title id="sectitle0130">Synthesis of 2-formyl-4,9-dihydronaphtho[2,3-b]-furan-4,9-dione (<ce:bold>6</ce:bold>)</ce:section-title>
                        <ce:para id="p0155" view="all">To a solution of <ce:bold>5</ce:bold> (500 mg, 2.19 mmol) in DCM (5 mL), pyridinium chlorochromate (1.5 g) was added. The mixture was stirred at room temperature for overnight. Then the solution was diluted with H<ce:inf loc="post">2</ce:inf>O and extracted with DCM for three times. The combined organic phase was washed with brine and dried over anhydrous Na<ce:inf loc="post">2</ce:inf>SO<ce:inf loc="post">4</ce:inf>, filtered and concentrated under reduced pressure. The residue was purified by chromatography on Si gel column with DCM to give compound <ce:bold>6</ce:bold> as a yellow solid (398 mg, 80.4%).<ce:sup loc="post">1</ce:sup>H NMR (400 MHz, DMSO) δ 9.91 (s, 1H), 8.23–8.09 (m, 2H), 8.04 (s, 1H), 7.98–7.86 (m, 2H).</ce:para>
                     </ce:section>
                     <ce:section id="sec4.1.5" view="all">
                        <ce:label>4.1.5</ce:label>
                        <ce:section-title id="sectitle0135">Synthesis of 4,9-dioxo-4,9-dihydronaphtho[2,3-b]furan-2-carboxylic acid (<ce:bold>7</ce:bold>)</ce:section-title>
                        <ce:para id="p0160" view="all">The synthesis of intermediate compound 7 was carried out according to the previously reported procedure [<ce:cross-ref refid="bib19" id="crosref0175">19</ce:cross-ref>].To a solution of 6 (300 mg, 1.33 mmol) in glacial HOAc (20 mL), H<ce:inf loc="post">2</ce:inf>O<ce:inf loc="post">2</ce:inf> (30%, 10 mL) was added at 75 °C, and the mixture was stirred at this temperature for 4 h. Then it was concentrated under reduced pressure, and the residue was filtered and washed with H<ce:inf loc="post">2</ce:inf>O for three times, and dried in a vacuum dryer to afford compound 7 as a yellow solid (289 mg, 90.0%).<ce:sup loc="post">1</ce:sup>H NMR (400 MHz, DMSO) δ 14.17 (brs, 1H), 8.40–8.05 (m, 2H), 8.02–7.84 (m, 2H), 7.68 (s, 1H).</ce:para>
                     </ce:section>
                     <ce:section id="sec4.1.6" view="all">
                        <ce:label>4.1.6</ce:label>
                        <ce:section-title id="sectitle0140">General procedures for the preparation of <ce:bold>8a-u</ce:bold>
                        </ce:section-title>
                        <ce:para id="p0165" view="all">The solution of intermediate compound 7 (0.20 mmol) in DCM (3 mL) was stirred with HATU (0.31 mmol) at room temperature for 10 min and then triethylamine (0.31 mmol), substituted alkyl amines or <ce:italic>N</ce:italic>-heterocycles (0.36 mmol) was added. After the reaction mixture stirred at room temperature for 2 h, the mixture was evaporated under vacuum, purified by chromatography on Si gel column with DCM to afford compounds <ce:bold>8a-u</ce:bold>.</ce:para>
                        <ce:section id="sec4.1.6.1" view="all">
                           <ce:label>4.1.6.1</ce:label>
                           <ce:section-title id="sectitle0145">2-(Pyrrolidine-1-carbonyl)naphtho[2,3-b]furan-4,9-dione(<ce:bold>8a</ce:bold>)</ce:section-title>
                           <ce:para id="p0170" view="all">
                              <ce:sup loc="pre">1</ce:sup>H NMR (400 MHz, CDCl<ce:inf loc="post">3</ce:inf>) δ 8.16–8.10 (m, 2H), 7.95–7.88 (m, 2H), 7.55 (s, 1H), 3.81 (t, <ce:italic>J</ce:italic> = 6.8 Hz, 2H), 3.52 (t, <ce:italic>J</ce:italic> = 6.8 Hz, 2H), 1.95 (m, 2H), 1.91–1.83 (m, 2H).<ce:sup loc="post">13</ce:sup>C NMR (100 MHz, DMSO) δ 180.4, 173.8, 156.4, 152.6, 152.5, 134.9, 134.9, 133.3, 132.8, 130.4, 127.1, 127.0, 111.7, 48.2, 47.5, 26.4, 23.8. HRMS (Q-TOF): calculated for C<ce:inf loc="post">17</ce:inf>H<ce:inf loc="post">13</ce:inf>NO<ce:inf loc="post">4</ce:inf> 318.0845 [M + Na]<ce:sup loc="post">+</ce:sup>, found 318.0705. Purity ≥ 95.0%.</ce:para>
                        </ce:section>
                        <ce:section id="sec4.1.6.2" view="all">
                           <ce:label>4.1.6.2</ce:label>
                           <ce:section-title id="sectitle0150">2-(Piperidine-1-carbonyl)naphtho[2,3-b]furan-4,9-dione (<ce:bold>8b</ce:bold>)</ce:section-title>
                           <ce:para id="p0175" view="all">
                              <ce:sup loc="pre">1</ce:sup>H NMR (400 MHz, DMSO) δ 8.17–8.09 (m, 2H), 7.95–7.88 (m, 2H), 7.44 (s, 1H), 3.71–3.54 (m, 4H), 1.61 (m, 6H).<ce:sup loc="post">13</ce:sup>C NMR (100 MHz, DMSO) δ 180.4, 173.7, 157.7, 152.3, 152.2, 134.9, 134.8, 133.3, 132.8, 130.2, 127.1, 126.9, 110.7, 47.9, 43.5, 26.7, 25.7, 24.3. HRMS (Q-TOF): calculated for C<ce:inf loc="post">18</ce:inf>H<ce:inf loc="post">15</ce:inf>NO<ce:inf loc="post">4</ce:inf> 310.1001 [M + H]<ce:sup loc="post">+</ce:sup>, found 310.1030. Purity ≥ 95.0%.</ce:para>
                        </ce:section>
                        <ce:section id="sec4.1.6.3" view="all">
                           <ce:label>4.1.6.3</ce:label>
                           <ce:section-title id="sectitle0155">2-(Morpholine-4-carbonyl)naphtho[2,3-b]furan-4,9-dione (<ce:bold>8c</ce:bold>)</ce:section-title>
                           <ce:para id="p0180" view="all">
                              <ce:sup loc="pre">1</ce:sup>H NMR (400 MHz, DMSO) δ 8.17–8.08 (m, 2H), 7.92–7.87 (m, 2H), 7.53 (s, 1H), 3.68 (s, 8H). <ce:sup loc="pre">13</ce:sup>C NMR (100 MHz, DMSO) δ 180.3, 173.7, 157.9, 152.5, 151.4, 134.9, 134.9, 133.3, 132.7, 130.2, 127.1, 126.9, 111.6, 66.6, 66.5, 66.5, 66.5. HRMS (Q-TOF): calculated for C<ce:inf loc="post">17</ce:inf>H<ce:inf loc="post">13</ce:inf>NO<ce:inf loc="post">5</ce:inf> 334.0794 [M + Na]<ce:sup loc="post">+</ce:sup>, found 334.0603. HPLC purity 100.0%.</ce:para>
                        </ce:section>
                        <ce:section id="sec4.1.6.4" view="all">
                           <ce:label>4.1.6.4</ce:label>
                           <ce:section-title id="sectitle0160">2-(Thiomorpholine-4-carbonyl)naphtho[2,3-b]furan-4,9-dione (<ce:bold>8d</ce:bold>)</ce:section-title>
                           <ce:para id="p0185" view="all">
                              <ce:sup loc="pre">1</ce:sup>H NMR (400 MHz, DMSO) δ 8.19–8.05 (m, 2H), 8.01–7.85 (m, 2H), 7.48 (s, 1H), 3.90 (m, 4H), 2.82–2.68 (m, 4H).<ce:sup loc="post">13</ce:sup>C NMR (100 MHz, DMSO) δ 180.3, 173.7, 158.2, 152.4, 151.6, 134.9, 134.9, 133.3, 132.7, 130.2, 127.1, 126.9, 111.2, 27.7, 27.5, 27.3, 27.2. HRMS (Q-TOF): calculated for C<ce:inf loc="post">17</ce:inf>H<ce:inf loc="post">13</ce:inf>NO<ce:inf loc="post">4</ce:inf>S 350.0564 [M + Na]<ce:sup loc="post">+</ce:sup>, found 350.0402. HPLC purity ≥ 99.3%.</ce:para>
                        </ce:section>
                        <ce:section id="sec4.1.6.5" view="all">
                           <ce:label>4.1.6.5</ce:label>
                           <ce:section-title id="sectitle0165">2-(4-Methylpiperazine-1-carbonyl)naphtho[2,3-b]furan-4,9-dione (<ce:bold>8e</ce:bold>)</ce:section-title>
                           <ce:para id="p0190" view="all">
                              <ce:sup loc="pre">1</ce:sup>H NMR (400 MHz, DMSO) δ 8.15–8.09 (m, 2H), 7.94–7.87 (m, 2H), 7.48 (s, 1H), 3.67 (s, 4H), 2.41–2.37 (m, 4H), 2.22 (s, 3H).<ce:sup loc="post">13</ce:sup>C NMR (100 MHz, DMSO) δ 180.3, 173.7, 157.7, 152.4, 151.7, 134.9, 134.8, 133.2, 132.7, 130.2, 127.1, 126.9, 111.3, 55.3, 54.6, 46.8, 46.0, 42.6. HRMS (Q-TOF): calculated for C<ce:inf loc="post">18</ce:inf>H<ce:inf loc="post">16</ce:inf>N<ce:inf loc="post">2</ce:inf>O<ce:inf loc="post">4</ce:inf> 347.1110 [M+ Na]<ce:sup loc="post">+</ce:sup>, found 347.0997. HPLC purity ≥ 99.5%</ce:para>
                        </ce:section>
                        <ce:section id="sec4.1.6.6" view="all">
                           <ce:label>4.1.6.6</ce:label>
                           <ce:section-title id="sectitle0170">2-(4-Ethylpiperazine-1-carbonyl)naphtho[2,3-b]furan-4,9-dione (<ce:bold>8f</ce:bold>)</ce:section-title>
                           <ce:para id="p0195" view="all">
                              <ce:sup loc="pre">1</ce:sup>H NMR (400 MHz, DMSO) δ 8.16–8.09 (m, 2H), 7.96–7.87 (m, 2H), 7.49 (s, 1H), 3.67 (s, 4H), 2.46–2.42 (m, 4H), 2.38 (q, <ce:italic>J</ce:italic> = 7.2 Hz, 2H), 1.02 (t, <ce:italic>J</ce:italic> = 7.2 Hz, 3H).<ce:sup loc="post">13</ce:sup>C NMR (100 MHz, DMSO) δ 180.3, 173.7, 157.7, 152.4, 151.7, 134.9, 134.8, 133.2, 132.7, 130.2, 127.1, 126.9, 111.3, 53.1, 52.3, 51.8, 47.0, 42.7, 12.3. HRMS (Q-TOF): calculated for C<ce:inf loc="post">19</ce:inf>H<ce:inf loc="post">18</ce:inf>N<ce:inf loc="post">2</ce:inf>O<ce:inf loc="post">4</ce:inf> 339.1267 [M + H]<ce:sup loc="post">+</ce:sup>, found: 339.1235. HPLC purity ≥ 99.8%</ce:para>
                        </ce:section>
                        <ce:section id="sec4.1.6.7" view="all">
                           <ce:label>4.1.6.7</ce:label>
                           <ce:section-title id="sectitle0175">2-(4-Oxopiperidine-1-carbonyl)naphtho[2,3-b]furan-4,9-dione (<ce:bold>8g</ce:bold>)</ce:section-title>
                           <ce:para id="p0200" view="all">
                              <ce:sup loc="pre">1</ce:sup>H NMR (400 MHz, DMSO) δ 8.17–8.10 (m, 2H), 7.94–7.87 (m, 2H), 7.57 (s, 1H), 3.96 (brs, 4H), 2.55 (t, <ce:italic>J</ce:italic> = 6.4 Hz,4H).<ce:sup loc="post">13</ce:sup>C NMR (100 MHz, DMSO) δ 207.3, 180.4, 173.7, 158.3, 152.5, 151.6, 134.9, 134.9, 133.3, 132.8, 130.2, 127.1, 126.9, 111.6, 44.6, 41.4, 40.8, 39.5. HRMS (Q-TOF): calculated for C<ce:inf loc="post">18</ce:inf>H<ce:inf loc="post">13</ce:inf>NO<ce:inf loc="post">5</ce:inf> 324.0794 [M + H]<ce:sup loc="post">+</ce:sup>, found 324.0898. HPLC purity ≥ 99.4%</ce:para>
                        </ce:section>
                        <ce:section id="sec4.1.6.8" view="all">
                           <ce:label>4.1.6.8</ce:label>
                           <ce:section-title id="sectitle0180">Methyl-2-(1-(4,9-dioxo-4,9-dihydronaphtho[2,3-b]furan-2-carbonyl)piperidin-4-yl)acetate (<ce:bold>8h</ce:bold>)</ce:section-title>
                           <ce:para id="p0205" view="all">
                              <ce:sup loc="pre">1</ce:sup>H NMR (400 MHz, DMSO) δ 8.16–8.10 (m, 2H), 7.91 (m, 2H), 7.44 (s, 1H), 4.39 (m, 1H), 4.09–4.00 (m, 1H), 3.60 (s, 3H), 3.25 (m, 1H), 2.94–2.83 (m, 1H), 2.32 (d, <ce:italic>J</ce:italic> = 7.0 Hz, 2H), 2.08–1.98 (m, 1H), 1.82–1.72 (m, 2H), 1.31–1.15 (m, 2H).<ce:sup loc="post">13</ce:sup>C NMR (100 MHz, DMSO) δ 180.4, 173.7, 172.7, 157.7, 152.3, 152.1, 134.9, 134.8, 133.3, 132.8, 130.2, 127.1, 126.9, 110.9, 51.7, 46.9, 42.6, 40.2, 32.8, 32.3, 31.4. HRMS (Q-TOF): calculated for C<ce:inf loc="post">21</ce:inf>H<ce:inf loc="post">19</ce:inf>NO<ce:inf loc="post">6</ce:inf> 382.1212 [M + H]<ce:sup loc="post">+</ce:sup>, found: 382.1282. Purity ≥95.0%.</ce:para>
                        </ce:section>
                        <ce:section id="sec4.1.6.9" view="all">
                           <ce:label>4.1.6.9</ce:label>
                           <ce:section-title id="sectitle0185">2-(4-(3-chlorophenyl)piperidine-1-carbonyl)naphtho[2,3-b]furan-4,9-dione (<ce:bold>8i</ce:bold>)</ce:section-title>
                           <ce:para id="p0210" view="all">
                              <ce:sup loc="pre">1</ce:sup>H NMR (400 MHz, CDCl<ce:inf loc="post">3</ce:inf>) δ 8.28–8.19 (m, 2H), 7.84–7.76 (m, 2H), 7.45 (s, 1H), 7.26 (s, 1H), 7.23–7.20 (m, 2H), 7.13–7.10 (m, 1H), 4.83 (brs, 1H), 4.44 (brs, 1H), 3.35 (brs, 1H), 2.93 (brs, 1H), 2.85 (m, 1H), 2.01 (m, 2H), 1.78 (m, 2H).<ce:sup loc="post">13</ce:sup>C NMR (100 MHz, DMSO) δ 180.4, 173.7, 157.8, 152.4, 152.0, 148.4, 134.9, 134.8, 133.6, 133.3, 132.8, 130.8, 130.3, 127.3, 127.1, 126.9, 126.8, 126.1, 110.9, 47.2, 44.4, 43.1, 41.8, 32.8. HRMS (Q-TOF): calculated for C<ce:inf loc="post">24</ce:inf>H<ce:inf loc="post">18</ce:inf>ClNO<ce:inf loc="post">4</ce:inf> 442.0924 [M + Na]<ce:sup loc="post">+</ce:sup>, found 442.0811. Purity ≥95.0%.</ce:para>
                        </ce:section>
                        <ce:section id="sec4.1.6.10" view="all">
                           <ce:label>4.1.6.10</ce:label>
                           <ce:section-title id="sectitle0190">2-(4-(4-fluorophenyl)piperidine-1-carbonyl)naphtho[2,3-b]furan-4,9-dione (<ce:bold>8j</ce:bold>)</ce:section-title>
                           <ce:para id="p0215" view="all">
                              <ce:sup loc="pre">1</ce:sup>H NMR (400 MHz, DMSO) δ 8.17–8.10 (m, 2H), 7.95–7.88 (m, 2H), 7.51 (s, 1H), 7.36–7.31 (m, 2H), 7.16–7.09 (m, 2H), 4.58 (brs, 1H), 4.20 (brs, 1H), 3.49 (brs, 1H), 2.92 (m, 2H), 1.85 (brs, 2H), 1.69 (brs, 2H).<ce:sup loc="post">13</ce:sup>C NMR (100 MHz, DMSO) δ 180.4, 173.7, 162.5, 160.1, 157.8, 152.4, 152.0, 142.0, 134.9, 133.3, 132.8, 130.2, 129.1, 129.0, 127.1, 126.9, 115.6, 115.4, 110.9, 47.6, 43.2, 41.3, 33.7, 33.2. HRMS (Q-TOF): calculated for C<ce:inf loc="post">24</ce:inf>H<ce:inf loc="post">18</ce:inf>FNO<ce:inf loc="post">4</ce:inf> 426.1220 [M + Na]<ce:sup loc="post">+</ce:sup>, found: 426.1106. Purity ≥95.0%.</ce:para>
                        </ce:section>
                        <ce:section id="sec4.1.6.11" view="all">
                           <ce:label>4.1.6.11</ce:label>
                           <ce:section-title id="sectitle0195">2-(4-(4-methoxyphenyl)piperidine-1-carbonyl)naphtho[2,3-b]furan-4,9-dione(<ce:bold>8k</ce:bold>)</ce:section-title>
                           <ce:para id="p0220" view="all">
                              <ce:sup loc="pre">1</ce:sup>H NMR (400 MHz, DMSO) δ 8.15–8.10 (m, 2H), 7.93–7.87 (m, 2H), 7.50 (s, 1H), 7.20 (d, <ce:italic>J</ce:italic> = 8.6 Hz, 2H), 6.87 (d, <ce:italic>J</ce:italic> = 8.6 Hz, 2H), 4.57 (brs, 1H), 4.19 (brs, 1H), 3.72 (s, 3H), 3.36 (brs, 1H), 2.94 (brs, 1H), 2.88–2.78 (m, 1H), 1.84 (m, 2H), 1.66 (m, 2H).<ce:sup loc="post">13</ce:sup>C NMR (100 MHz, DMSO) δ 180.4, 173.7, 158.2, 157.8, 152.3, 152.1, 137.8, 134.9, 134.8, 133.3, 132.8, 130.2, 128.1 (2C), 127.1, 126.9, 114.3 (2C), 110.9, 55.5, 47.6, 43.3, 41.2, 33.6, 33.4. HRMS (Q-TOF): calculated for C<ce:inf loc="post">25</ce:inf>H<ce:inf loc="post">21</ce:inf>NO<ce:inf loc="post">5</ce:inf> 438.1420 [M + Na]<ce:sup loc="post">+</ce:sup>, found: 438.1308. Purity ≥95.0%.</ce:para>
                        </ce:section>
                        <ce:section id="sec4.1.6.12" view="all">
                           <ce:label>4.1.6.12</ce:label>
                           <ce:section-title id="sectitle0200">2-(4-(3-(trifluoromethyl)phenyl)piperazine-1-carbonyl)naphtho[2,3-b]furan-4,9-dione (<ce:bold>8l</ce:bold>)</ce:section-title>
                           <ce:para id="p0225" view="all">
                              <ce:sup loc="pre">1</ce:sup>H NMR (400 MHz, DMSO) δ 8.17–8.10 (m, 2H), 7.94–7.88 (m, 2H), 7.56 (s, 1H), 7.46 (t, <ce:italic>J</ce:italic> = 7.6 Hz, 1H), 7.27 (d, <ce:italic>J</ce:italic> = 7.6 Hz, 1H), 7.23 (s, 1H), 7.11 (d, <ce:italic>J</ce:italic> = 7.6 Hz, 1H), 3.86 (s, 4H), 3.41–3.36 (m, 4H). <ce:sup loc="pre">13</ce:sup>C NMR (100 MHz, DMSO) δ 180.4, 173.7, 157.8, 152.5, 151.5, 151.2, 134.9, 134.9, 133.3, 132.8, 130.6, 130.3, 130.2, 127.1, 126.9, 119.6, 115.5, 111.8, 111.7, 48.2, 46.6, 42.4, 40.6. HRMS (Q-TOF): calculated for C<ce:inf loc="post">24</ce:inf>H<ce:inf loc="post">17</ce:inf>F<ce:inf loc="post">3</ce:inf>N<ce:inf loc="post">2</ce:inf>O<ce:inf loc="post">4</ce:inf> 455.1140 [M + H]<ce:sup loc="post">+</ce:sup>, found: 455.1151. Purity ≥95.0%.</ce:para>
                        </ce:section>
                        <ce:section id="sec4.1.6.13" view="all">
                           <ce:label>4.1.6.13</ce:label>
                           <ce:section-title id="sectitle0205">
                              <ce:italic>N</ce:italic>-(4,4-dimethylcyclohexyl)-4,9-dioxo-4,9-dihydronaphtho[2,3-b]furan-2-carboxamide (<ce:bold>8m</ce:bold>)</ce:section-title>
                           <ce:para id="p0230" view="all">
                              <ce:sup loc="pre">1</ce:sup>H NMR (400 MHz, DMSO) δ 8.72 (d, <ce:italic>J</ce:italic> = 8.0 Hz, 1H), 8.17–8.09 (m, 2H), 7.94–7.88 (m, 2H), 7.67 (s, 1H), 3.74 (m, 1H), 1.67–1.52 (m, 4H), 1.41 (m, 2H), 1.32–1.21 (m, 2H), 0.93 (d, <ce:italic>J</ce:italic> = 9.4 Hz, 6H).<ce:sup loc="post">13</ce:sup>C NMR (100 MHz, DMSO) δ 180.4, 173.8, 156.1, 152.7, 152.6, 134.9, 134.8, 133.3, 132.9, 130.8, 127.0, 127.0, 110.2, 48.8, 38.0 (2C), 32.6, 29.8, 28.2 (2C), 24.6. HRMS (Q-TOF): calculated for C<ce:inf loc="post">21</ce:inf>H<ce:inf loc="post">21</ce:inf>NO<ce:inf loc="post">4</ce:inf> 374.1471 [M + Na]<ce:sup loc="post">+</ce:sup>, found: 374.1358. Purity ≥95.0%.</ce:para>
                        </ce:section>
                        <ce:section id="sec4.1.6.14" view="all">
                           <ce:label>4.1.6.14</ce:label>
                           <ce:section-title id="sectitle0210">
                              <ce:italic>N</ce:italic>-(adamantan-1-yl)-4,9-dioxo-4,9-dihydronaphtho[2,3-b]furan-2-carboxamide (<ce:bold>8n</ce:bold>)</ce:section-title>
                           <ce:para id="p0235" view="all">
                              <ce:sup loc="pre">1</ce:sup>H NMR (400 MHz, DMSO) δ 8.19–8.07 (m, 2H), 8.02 (s, 1H), 7.91 (m, 2H), 7.75 (s, 1H), 2.08 (s, 9H), 1.67 (s, 6H).<ce:sup loc="post">13</ce:sup>C NMR (100 MHz, DMSO) δ 180.5, 173.7, 156.3, 152.9, 152.5, 134.9, 134.8, 133.3 (s), 132.9, 130.7, 127.0, 127.0, 110.1, 52.8, 41.1 (3C), 36.4 (2C), 29.3 (4C). HRMS (Q-TOF): calculated for C<ce:inf loc="post">23</ce:inf>H<ce:inf loc="post">21</ce:inf>NO<ce:inf loc="post">4</ce:inf> 376.1471 [M + H]<ce:sup loc="post">+</ce:sup>, found 376.1539. Purity ≥95.0%.</ce:para>
                        </ce:section>
                        <ce:section id="sec4.1.6.15" view="all">
                           <ce:label>4.1.6.15</ce:label>
                           <ce:section-title id="sectitle0215">
                              <ce:italic>N</ce:italic>-cyclohexyl-4,9-dioxo-4,9-dihydronaphtho[2,3-b]furan-2-carboxamide (<ce:bold>8o</ce:bold>)</ce:section-title>
                           <ce:para id="p0240" view="all">
                              <ce:sup loc="pre">1</ce:sup>H NMR (400 MHz, DMSO) δ 8.70 (d, <ce:italic>J</ce:italic> = 8.0 Hz, 1H), 8.17–8.08 (m, 2H), 7.94–7.88 (m, 2H), 7.68 (s, 1H), 3.77 (m, 1H), 1.82 (m, 1H), 1.77–1.71 (m, 2H), 1.61 (m, 2H), 1.37–1.31 (m, 3H), 1.23 (m, 2H).<ce:sup loc="post">13</ce:sup>C NMR (100 MHz, DMSO) δ 180.4, 173.8, 156.1, 152.7, 152.6, 134.9, 134.8, 133.3, 132.9, 130.7, 127.0, 127.0, 110.2, 48.9, 32.6 (2C), 25.3 (2C). HRMS (Q-TOF): calculated for C<ce:inf loc="post">19</ce:inf>H<ce:inf loc="post">17</ce:inf>NO<ce:inf loc="post">4</ce:inf> 324.1158 [M + H]<ce:sup loc="post">+</ce:sup>, found: 324.1235. Purity ≥95.0%.</ce:para>
                        </ce:section>
                        <ce:section id="sec4.1.6.16" view="all">
                           <ce:label>4.1.6.16</ce:label>
                           <ce:section-title id="sectitle0220">4,9-Dioxo-<ce:italic>N</ce:italic>-(2-(pyrrolidin-1-yl)ethyl)-4,9-dihydronaphtho[2,3-b]furan-2-carboxamide(<ce:bold>8p</ce:bold>)</ce:section-title>
                           <ce:para id="p0245" view="all">
                              <ce:sup loc="pre">1</ce:sup>H NMR (400 MHz, DMSO) δ 8.88 (t, <ce:italic>J</ce:italic> = 5.8 Hz, 1H), 8.18–8.08 (m, 2H), 7.96–7.86 (m, 2H), 7.63 (s, 1H), 3.40 (q, <ce:italic>J</ce:italic> = 6.6 Hz, 2H), 2.59 (t, <ce:italic>J</ce:italic> = 6.6 Hz, 2H), 2.49 (m, 4H), 1.76–1.60 (m, 4H).<ce:sup loc="post">13</ce:sup>C NMR (100 MHz, DMSO) δ 180.4, 173.8, 156.9, 152.7, 152.5, 134.9, 134.8, 133.3, 132.9, 130.7, 127.1, 127.0, 110.3, 55.1 (2C), 54.1, 38.8 (2C), 23.6. HRMS (Q-TOF): calculated for C<ce:inf loc="post">19</ce:inf>H<ce:inf loc="post">18</ce:inf>N<ce:inf loc="post">2</ce:inf>O<ce:inf loc="post">4</ce:inf> 339.1267 [M + H]<ce:sup loc="post">+</ce:sup>, found 339.1348. Purity ≥95.0%.</ce:para>
                        </ce:section>
                        <ce:section id="sec4.1.6.17" view="all">
                           <ce:label>4.1.6.17</ce:label>
                           <ce:section-title id="sectitle0225">4,9-Dioxo-<ce:italic>N</ce:italic>-(2-(piperidin-1-yl)ethyl)-4,9-dihydronaphtho[2,3-b]furan-2-carboxamide(<ce:bold>8q</ce:bold>)</ce:section-title>
                           <ce:para id="p0250" view="all">
                              <ce:sup loc="pre">1</ce:sup>H NMR (400 MHz, DMSO) δ 8.83 (t, <ce:italic>J</ce:italic> = 5.8 Hz, 1H), 8.18–8.08 (m, 2H), 7.94–7.86 (m, 2H), 7.62 (s, 1H), 3.39 (q, <ce:italic>J</ce:italic> = 6.6 Hz, 2H), 2.44 (t, <ce:italic>J</ce:italic> = 6.6 Hz, 2H), 2.38 (m, 4H), 1.49 (m, 4H), 1.41–1.34 (m, 2H).<ce:sup loc="post">13</ce:sup>C NMR (100 MHz, DMSO) δ 180.4, 173.8, 156.9, 152.7, 152.5, 134.9, 134.8, 133.3, 132.9, 130.7, 127.1, 127.0, 110.2, 57.9, 54.5 (2C), 37.1, 26.0 (2C), 24.5. HRMS (Q-TOF): calculated for C<ce:inf loc="post">20</ce:inf>H<ce:inf loc="post">20</ce:inf>N<ce:inf loc="post">2</ce:inf>O<ce:inf loc="post">4</ce:inf> 353.1423 [M + H]<ce:sup loc="post">+</ce:sup>, found 353.1504. HPLC purity ≥ 98.8%</ce:para>
                        </ce:section>
                        <ce:section id="sec4.1.6.18" view="all">
                           <ce:label>4.1.6.18</ce:label>
                           <ce:section-title id="sectitle0230">
                              <ce:italic>N</ce:italic>-(2-morpholinoethyl)-4,9-dioxo-4,9-dihydronaphtho[2,3-b]furan-2-carboxamide (<ce:bold>8r</ce:bold>)</ce:section-title>
                           <ce:para id="p0255" view="all">
                              <ce:sup loc="pre">1</ce:sup>H NMR (400 MHz, DMSO) δ 8.87 (t, <ce:italic>J</ce:italic> = 5.6 Hz, 1H), 8.19–8.09 (m, 2H), 7.96–7.87 (m, 2H), 7.63 (s, 1H), 3.61–3.54 (m, 4H), 3.41 (q, <ce:italic>J</ce:italic> = 6.6 Hz, 2H), 2.47 (t, <ce:italic>J</ce:italic> = 6.6 Hz, 2H), 2.42 (m, 4H).<ce:sup loc="post">13</ce:sup>C NMR (100 MHz, DMSO) δ 180.4, 173.8, 156.9, 152.7, 152.5, 134.9, 134.8, 133.3, 132.9, 130.7, 127.1, 127.0, 110.3, 66.7 (2C), 57.6, 53.7 (2C), 36.7. HRMS (Q-TOF): calculated for C<ce:inf loc="post">19</ce:inf>H<ce:inf loc="post">18</ce:inf>N<ce:inf loc="post">2</ce:inf>O<ce:inf loc="post">5</ce:inf> 355.1216 [M + H]<ce:sup loc="post">+</ce:sup>, found: 355.1290. HPLC purity ≥ 98.8%</ce:para>
                        </ce:section>
                        <ce:section id="sec4.1.6.19" view="all">
                           <ce:label>4.1.6.19</ce:label>
                           <ce:section-title id="sectitle0235">4,9-Dioxo-<ce:italic>N</ce:italic>-phenethyl-4,9-dihydronaphtho[2,3-b]furan-2-carboxamide (<ce:bold>8s</ce:bold>)</ce:section-title>
                           <ce:para id="p0260" view="all">
                              <ce:sup loc="pre">1</ce:sup>H NMR (400 MHz, DMSO) δ 9.03 (t, <ce:italic>J</ce:italic> = 5.6 Hz, 1H), 8.16–8.08 (m, 2H), 7.95–7.86 (m, 2H), 7.60 (s, 1H), 7.26 (m, 5H), 3.57–3.48 (q, <ce:italic>J</ce:italic> = 7.4 Hz, 2H), 2.87 (t, <ce:italic>J</ce:italic> = 7.4 Hz, 2H).<ce:sup loc="post">13</ce:sup>C NMR (100 MHz, DMSO) δ 180.3, 173.8, 156.9, 152.7, 152.5, 139.6, 134.9, 134.8, 133.3, 132.8, 130.7, 129.1 (2C), 128.9 (2C), 127.0, 127.0, 126.7, 110.2, 41.0, 35.3. HRMS (Q-TOF): calculated for C<ce:inf loc="post">21</ce:inf>H<ce:inf loc="post">15</ce:inf>NO<ce:inf loc="post">4</ce:inf> 368.1001 [M + Na]<ce:sup loc="post">+</ce:sup>, found: 368.0698. Purity ≥95.0%.</ce:para>
                        </ce:section>
                        <ce:section id="sec4.1.6.20" view="all">
                           <ce:label>4.1.6.20</ce:label>
                           <ce:section-title id="sectitle0240">
                              <ce:italic>N</ce:italic>-(4-chlorophenethyl)-4,9-dioxo-4,9-dihydronaphtho[2,3-b]furan-2-carboxamide (<ce:bold>8t</ce:bold>)</ce:section-title>
                           <ce:para id="p0265" view="all">
                              <ce:sup loc="pre">1</ce:sup>H NMR (400 MHz, DMSO) δ 9.01 (t, <ce:italic>J</ce:italic> = 5.6 Hz, 1H), 8.17–8.08 (m, 2H), 7.94–7.87 (m, 2H), 7.61 (s, 1H), 7.38–7.33 (m, 2H), 7.30–7.26 (m, 2H), 3.52 (q, 7.2 Hz, 2H), 2.86 (t, <ce:italic>J</ce:italic> = 7.2 Hz, 2H).<ce:sup loc="post">13</ce:sup>C NMR (100 MHz, DMSO) δ 180.4, 173.8, 156.9, 152.7, 152.4, 138.7, 134.9, 134.8, 133.3, 132.9, 131.3, 131.1 (2C), 130.7, 128.7 (2C), 127.1, 127.0, 110.3, 40.7, 34.5. HRMS (Q-TOF): calculated for C<ce:inf loc="post">21</ce:inf>H<ce:inf loc="post">14</ce:inf>ClNO<ce:inf loc="post">4</ce:inf> 380.0611 [M + H]<ce:sup loc="post">+</ce:sup>, found: 380.0690. Purity ≥95.0%.</ce:para>
                        </ce:section>
                        <ce:section id="sec4.1.6.21" view="all">
                           <ce:label>4.1.6.21</ce:label>
                           <ce:section-title id="sectitle0245">
                              <ce:italic>N</ce:italic>-(4-methoxyphenethyl)-4,9-dioxo-4,9-dihydronaphtho[2,3-b]furan-2-carboxamide(<ce:bold>8u</ce:bold>)</ce:section-title>
                           <ce:para id="p0270" view="all">
                              <ce:sup loc="pre">1</ce:sup>H NMR (400 MHz, DMSO) δ 8.99 (t, <ce:italic>J</ce:italic> = 5.6 Hz, 1H), 8.17–8.07 (m, 2H), 7.96–7.86 (m, 2H), 7.61 (s, 1H), 7.16 (d, <ce:italic>J</ce:italic> = 8.4 Hz, 2H), 6.86 (d, <ce:italic>J</ce:italic> = 8.4 Hz, 2H), 3.72 (s, 3H), 3.48 (q, <ce:italic>J</ce:italic> = 7.4 Hz, 2H), 2.80 (t, <ce:italic>J</ce:italic> = 7.4 Hz, 2H).<ce:sup loc="post">13</ce:sup>C NMR (100 MHz, DMSO) δ 180.4, 173.8, 158.2, 156.9, 152.7, 152.5, 134.9, 134.8, 133.3, 132.9, 131.5, 130.7, 130.1 (2C), 127.0, 127.0, 114.3 (2C), 110.2, 55.5, 41.2, 34.5. HRMS (Q-TOF): calculated for C<ce:inf loc="post">22</ce:inf>H<ce:inf loc="post">17</ce:inf>NO<ce:inf loc="post">5</ce:inf> 398.1107 [M + Na]<ce:sup loc="post">+</ce:sup>, found: 398.1009. Purity ≥95.0%.</ce:para>
                        </ce:section>
                     </ce:section>
                  </ce:section>
                  <ce:section id="sec4.2" view="all">
                     <ce:label>4.2</ce:label>
                     <ce:section-title id="sectitle0250">
                        <ce:italic>In vitro</ce:italic> inhibitory activity</ce:section-title>
                     <ce:para id="p0275" view="all">U251, HepG2, HT29, CT26 and PC-3 cells were seeded in 96-well plates at a density of 5 × 10<ce:sup loc="post">3</ce:sup> cells/well and cultured for 24 h. Following the addition of different concentrations of compounds, the cells were further cultured for 72 h, with 0.5% DMSO as the solvent control group. Then cells were incubated for 4 h with 5 mg/ml of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) solution, and the formazan crystals were dissolved with 150 μl of DMSO. After gentle shaking for 10min, the optical density (OD) was measured at 570 nm using a Spectra MAX M5 microplate spectrophotometer. Each treatment was performed in triplicate. Results were analyzed with GraphPad Prism 6 and data were shown as Mean ± SD.</ce:para>
                  </ce:section>
                  <ce:section id="sec4.3" view="all">
                     <ce:label>4.3</ce:label>
                     <ce:section-title id="sectitle0255">Molecular docking</ce:section-title>
                     <ce:para id="p0280" view="all">Molecular docking studies were carried out using the Discovery Studio (DS) 3.1 software. The protein was constructed based on the X-ray structure of STAT3, which was available through the RCSB Protein Data Bank (PDB code: <ce:inter-ref xlink:href="pdb:1BG1" id="intref0020" xlink:type="simple">1BG1</ce:inter-ref>). Both the compounds and the structure of STAT3 were prepared and optimized using Discovery Studio 3.1. The protein was prepared with adding hydrogens, deleting water molecules. The low energy clusters were identified and binding energies were evaluated.</ce:para>
                  </ce:section>
                  <ce:section id="sec4.4" view="all">
                     <ce:label>4.4</ce:label>
                     <ce:section-title id="sectitle0260">The determination of aqueous solubility</ce:section-title>
                     <ce:para id="p0285" view="all">The aqueous solubility of the compounds <ce:bold>8c-g, 8q</ce:bold> and <ce:bold>8r</ce:bold> were determined by HPLC method. The calibration standards were prepared with concentrations for 15, 25, 50, 75, 100, 125 μg/mL and used to assess calibration curves. The compounds (2 mg) were added into 1.5 mL EP tubes respectively. The pure water (1 mL) was added into each EP tube. Then the EP tubes were vortexed for 30s and swung at room temperature for 24 h to obtain saturated solution, which were disposed by HPLC system.</ce:para>
                  </ce:section>
                  <ce:section id="sec4.5" view="all">
                     <ce:label>4.5</ce:label>
                     <ce:section-title id="sectitle0265">
                        <ce:italic>In vivo</ce:italic> antitumor activity evaluation</ce:section-title>
                     <ce:para id="p0290" view="all">CT-26 cells (1 × 10<ce:sup loc="post">6</ce:sup>) were subcutaneously implanted in the right flanks of 6-week-old male BALB/c mice, which were purchased from DaShuo experimental animal Co. Ltd. (Chengdu, Sichuan, China). After the solid tumors volume were reached about 70 mm<ce:sup loc="post">3</ce:sup>, mice were randomized to two groups with five mice per group and were orally administrated with <ce:bold>8q</ce:bold> 50 mg/kg and vehicle per day. Compound <ce:bold>8q</ce:bold> was dissolved at 5% 1-methyl-2-pyrrolidinone in polyethylene glycol 400, and the blank control group received oral administration of equal volume of 5% NMP, 95% PEG. The tumors were measured every 3 days with a caliper. Tumor volume (V) was estimated using the equation V = ab<ce:sup loc="post">2</ce:sup>/2, where a and b stand for the longest and shortest diameter, respectively. After treatment, mice were sacrificed and dissected to weigh the tumor tissues and to examine the internal organ injury by macroscopic analysis. TGI and T/C were calculated according to the following formula:<ce:display>
                           <ce:formula id="ufd1">
                              <ce:chem>TGI = (the mean tumor weight of control group - the mean tumor weight of treated group)/ (the mean tumor weight of control group).</ce:chem>
                           </ce:formula>
                        </ce:display>
                        <ce:display>
                           <ce:formula id="ufd2">
                              <ce:chem>T /C = mean RTV of treated group/mean RTV of control group</ce:chem>
                           </ce:formula>
                        </ce:display>
                     </ce:para>
                     <ce:para id="p0295" view="all">RTV, namely, relative tumor volume, is V<ce:inf loc="post">t</ce:inf>/V<ce:inf loc="post">0</ce:inf> (Vt is the tumor volume measured at the end of treatment; V<ce:inf loc="post">0</ce:inf> is the tumor volume measured at the beginning of treatment).</ce:para>
                  </ce:section>
                  <ce:section id="sec4.6" view="all">
                     <ce:label>4.6</ce:label>
                     <ce:section-title id="sectitle0270">Western blot and immunofluorescence analysis</ce:section-title>
                     <ce:para id="p0300" view="all">Total cellular proteins were extracted in RIPA buffer (Beyotime Biotechnology) supplemented with protease inhibitor cocktail (Sigma-Aldrich). Protein concentrations were determined with BCA protein assay kit (Thermo Fisher Scientific). Equal amounts of protein were run out on 10% SDS-PAGE gel and subsequently transferred onto PVDF membranes (Millipore). Membranes were blocked in 5% skimmed milk and incubated with the following primary antibodies at 4 °C overnight: mouse monoclonal antibody to total STAT3 (Cell Signaling, 1:1000, #9139), rabbit monoclonal antibody to p-STAT3 (Tyr705) (Cell Signaling, 1:1,000, #9145) and rabbit polyclonal antibody to GADPH (BOSTER, 1:500, BA2913). Second antibodies were from Beyotime Biotech and used at a dilution of 1:2000. Enhanced chemiluminescence (ECL) and digital imaging (Clinx Science Instruments, Chemiscope 5300) were used for detection of target proteins. For immunofluorescence analysis, the primary antibody of total STAT3 was the same as used in western blot. Cell nucleus was stained with DAPI (Roche). Images were taken on a Zeiss microscope (Axio Observer).</ce:para>
                  </ce:section>
                  <ce:section id="sec4.7" view="all">
                     <ce:label>4.7</ce:label>
                     <ce:section-title id="sectitle0275">Total STAT3 and p-STAT3<ce:sup loc="post">Y705</ce:sup> sandwich enzyme-linked immunosorbent assay</ce:section-title>
                     <ce:para id="p0305" view="all">Whole-cell lysates were prepared using cell lysis buffer (Beyotime Biotechnology) containing protease inhibitor cocktail (Sigma-Aldrich). Protein concentrations were quantified with BCA protein assay kit (Thermo Fisher Scientific). Levels of total and p-STAT3<ce:sup loc="post">Y705</ce:sup> were measuring by using PathScan Total Stat3 and Phospho-Stat3 (Tyr705) Sandwich ELISA Kit (Cell Signaling, 7305 & 7300) according to the manufacturer's instructions. The measurements were repeated three times. For statistical analyses, treatment groups were compared with control group by paired <ce:italic>t</ce:italic>-test and data are represented as means ± S.D.</ce:para>
                  </ce:section>
                  <ce:section id="sec4.8" view="all">
                     <ce:label>4.8</ce:label>
                     <ce:section-title id="sectitle0280">Electrophoretic mobility shift assay (EMSA)</ce:section-title>
                     <ce:para id="p0310" view="all">HEK293T cells were transiently transfected with <ce:italic>N</ce:italic>-terminal FLAG-tagged STAT3 expression construct (10 μg/10 cm dish). Forty-eight hours post transfection, cells were harvested and dissolved in lysis buffer (500 μL/10 cm dish). After sonification and centrifugation, STAT3 were purified by Anti-FLAG M2 Magnetic Beads from Sigma (M8823) according to the instructions. Protein was eluted from beads with 200 μL flag peptide (200 μg/mL). EMSA was performed by using Chemiluminescent EMSA Kit (GS009, Beyotime) according to the instructions. Biotin labeled STAT3 probe, cold probe and nylon membranes were also purchased from Beyotime (GS083B, FFN10). 5 μL eluted protein and 1 μL probe were loaded with each lane. Anti-total STAT3 antibody is the same as used in western blot. Enhanced chemiluminescence (ECL) and digital imaging (Clinx Science Instruments, Chemiscope 5300) were used for detection of target proteins. Compond <ce:bold>8q</ce:bold> was added as indicated.</ce:para>
                  </ce:section>
                  <ce:section id="sec4.9" view="all">
                     <ce:label>4.9</ce:label>
                     <ce:section-title id="sectitle0285">Purification of STAT3 and surface plasmon resonance (SPR) analysis</ce:section-title>
                     <ce:para id="p0315" view="all">Full-length STAT3 with <ce:italic>N</ce:italic>-terminal His-tag was expressed by baculovirus in Sf9 insect cells. Briefly, STAT3 vector was co-transfected with Bac-<ce:italic>N</ce:italic>-Blue DNA into Sf9 cells. Recombinant virus was amplified in Sf9 cells and expressed in High Five cells. 2–3 d post-infection, cells were spun down and the medium was collected for purification. After filter, concentration and dialysis, protein was purified by Ni-NTA Agarose and gel-filtration columns. Protein purity (>90%) and concentration were determined by SDS-PAGE with Coomassie staining and UV spectrometry.</ce:para>
                     <ce:para id="p0320" view="all">STAT3 and compound <ce:bold>8q</ce:bold> binding analyses was performed by using Biacore X100 (GE Healthcare, UK) according to standard methods. Protein was covalently immobilized to the surface of a CM5 sensor chip using a amine coupling kit (GE Healthcare). Compound <ce:bold>8q</ce:bold> was diluted with 5% DMSO in PBS buffer. The concentrations were set at 600, 300, 150, 75, 37.5 and 18.75 nM. The equilibrium dissociation constant (KD) was obtained by using the BIAevaluation 2.0 software.</ce:para>
                  </ce:section>
               </ce:section>
               <ce:section id="sec5" view="all">
                  <ce:section-title id="sectitle0290">Conflicts of interest</ce:section-title>
                  <ce:para id="p0325" view="all">The authors declare no other conflicts of interest.</ce:para>
               </ce:section>
            </ce:sections>
            <ce:acknowledgment id="ack0010" view="all">
               <ce:section-title id="sectitle0295">Acknowledgments</ce:section-title>
               <ce:para id="p0330" view="all">This work was supported by the <ce:grant-sponsor id="gs1" sponsor-id="https://doi.org/10.13039/501100001809" xlink:type="simple" xlink:role="http://www.elsevier.com/xml/linking-roles/grant-sponsor">National Natural Science Foundation of China</ce:grant-sponsor> (No.<ce:grant-number refid="gs1">81473253</ce:grant-number>), the <ce:grant-sponsor id="gs2" xlink:type="simple" xlink:role="http://www.elsevier.com/xml/linking-roles/grant-sponsor">National Mega-projects of China for Innovative Drugs</ce:grant-sponsor> (<ce:grant-number refid="gs2">2018ZX09721001-001-001</ce:grant-number>).</ce:para>
            </ce:acknowledgment>
            <ce:appendices view="all">
               <ce:section id="appsec1" view="extended">
                  <ce:label>Appendix A</ce:label>
                  <ce:section-title id="sectitle0300">Supplementary data</ce:section-title>
                  <ce:para id="p0335" view="all">The following is the supplementary data to this article:<ce:display>
                        <ce:figure id="dfig1">
                           <ce:label>Fig. S1</ce:label>
                           <ce:alt-text role="short" id="alttext0015">Fig. S1</ce:alt-text>
                           <ce:link locator="figs1" xlink:type="simple" xlink:role="http://data.elsevier.com/vocabulary/ElsevierContentTypes/23.4" xlink:href="pii:S0223523418309449/figs1"/></ce:link>
                        </ce:figure>
                     </ce:display>
                  </ce:para>
               </ce:section>
               <ce:section id="appsec2" view="compact-standard">
                  <ce:label>Appendix A</ce:label>
                  <ce:section-title id="sectitle0305">Supplementary data</ce:section-title>
                  <ce:para id="p0340" view="all">Supplementary data to this article can be found online at <ce:inter-ref xlink:href="https://doi.org/10.1016/j.ejmech.2018.10.067" id="intref0025" xlink:type="simple">https://doi.org/10.1016/j.ejmech.2018.10.067</ce:inter-ref>.</ce:para>
               </ce:section>
            </ce:appendices>
         </body>
         <tail view="all">
            <ce:bibliography id="cebib0010" view="all">
               <ce:section-title id="sectitle0310">References</ce:section-title>
               <ce:bibliography-sec id="cebibsec0010" view="all">
                  <ce:bib-reference id="bib1">
                     <ce:label>[1]</ce:label>
                     <sb:reference id="sref1">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>J.E.</ce:given-name>
                                 <ce:surname>Darnell</ce:surname>
                                 <ce:suffix>Jr.</ce:suffix>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>STATs and gene regulation</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Science</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>277</sb:volume-nr>
                              </sb:series>
                              <sb:date>1997</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>1630</sb:first-page>
                              <sb:last-page>1635</sb:last-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib2">
                     <ce:label>[2]</ce:label>
                     <sb:reference id="sref2">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>S.</ce:given-name>
                                 <ce:surname>Haftchenary</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.</ce:given-name>
                                 <ce:surname>Avadisian</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>P.T.</ce:given-name>
                                 <ce:surname>Gunning</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Inhibiting aberrant Stat3 function with molecular therapeutics: a progress report</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Anti Canccer Drugs</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>22</sb:volume-nr>
                              </sb:series>
                              <sb:date>2011</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>115</sb:first-page>
                              <sb:last-page>127</sb:last-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib3">
                     <ce:label>[3]</ce:label>
                     <sb:reference id="sref3">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>S.</ce:given-name>
                                 <ce:surname>Fletcher</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.</ce:given-name>
                                 <ce:surname>Turkson</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>P.T.</ce:given-name>
                                 <ce:surname>Gunning</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Molecular approaches towards the inhibition of the signal transducer and activator of transcription 3 (Stat3) protein</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>ChemMedChem</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>3</sb:volume-nr>
                              </sb:series>
                              <sb:date>2008</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>1159</sb:first-page>
                              <sb:last-page>1168</sb:last-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib4">
                     <ce:label>[4]</ce:label>
                     <sb:reference id="sref4">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>H.</ce:given-name>
                                 <ce:surname>Yu</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>H.</ce:given-name>
                                 <ce:surname>Lee</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>A.</ce:given-name>
                                 <ce:surname>Herrmann</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>R.</ce:given-name>
                                 <ce:surname>Buettner</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>R.</ce:given-name>
                                 <ce:surname>Jove</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Revisiting STAT3 signalling in cancer: new and unexpected biological functions</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Nat. Rev. Canc.</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>14</sb:volume-nr>
                              </sb:series>
                              <sb:date>2014</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>736</sb:first-page>
                              <sb:last-page>746</sb:last-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib5">
                     <ce:label>[5]</ce:label>
                     <sb:reference id="sref5">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>A.</ce:given-name>
                                 <ce:surname>Xiong</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>Z.</ce:given-name>
                                 <ce:surname>Yang</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>Y.</ce:given-name>
                                 <ce:surname>Shen</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.</ce:given-name>
                                 <ce:surname>Zhou</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>Q.</ce:given-name>
                                 <ce:surname>Shen</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Transcription factor STAT3 as a novel molecular target for cancer prevention</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Cancers</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>6</sb:volume-nr>
                              </sb:series>
                              <sb:date>2014</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>926</sb:first-page>
                              <sb:last-page>957</sb:last-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib6">
                     <ce:label>[6]</ce:label>
                     <sb:reference id="sref6">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>H.</ce:given-name>
                                 <ce:surname>Chen</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>Z.</ce:given-name>
                                 <ce:surname>Yang</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>C.</ce:given-name>
                                 <ce:surname>Ding</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>L.</ce:given-name>
                                 <ce:surname>Chu</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>Y.</ce:given-name>
                                 <ce:surname>Zhang</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>K.</ce:given-name>
                                 <ce:surname>Terry</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>H.</ce:given-name>
                                 <ce:surname>Liu</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>Q.</ce:given-name>
                                 <ce:surname>Shen</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.</ce:given-name>
                                 <ce:surname>Zhou</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Fragment-based drug design and identification of HJC0123, a novel orally bioavailable STAT3 inhibitor for cancer therapy</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Eur. J. Med. Chem.</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>62</sb:volume-nr>
                              </sb:series>
                              <sb:date>2013</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>498</sb:first-page>
                              <sb:last-page>507</sb:last-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib7">
                     <ce:label>[7]</ce:label>
                     <sb:reference id="sref7">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>J.</ce:given-name>
                                 <ce:surname>Schust</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>B.</ce:given-name>
                                 <ce:surname>Sperl</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>A.</ce:given-name>
                                 <ce:surname>Hollis</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>T.U.</ce:given-name>
                                 <ce:surname>Mayer</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>T.</ce:given-name>
                                 <ce:surname>Berg</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Stattic: a small-molecule inhibitor of STAT3 activation and dimerization</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Chem. Biol. (Lond.)</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>13</sb:volume-nr>
                              </sb:series>
                              <sb:date>2006</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>1235</sb:first-page>
                              <sb:last-page>1242</sb:last-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib8">
                     <ce:label>[8]</ce:label>
                     <sb:reference id="sref8">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>K.</ce:given-name>
                                 <ce:surname>Matsuno</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>Y.</ce:given-name>
                                 <ce:surname>Masuda</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>Y.</ce:given-name>
                                 <ce:surname>Uehara</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>H.</ce:given-name>
                                 <ce:surname>Sato</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>A.</ce:given-name>
                                 <ce:surname>Muroya</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>O.</ce:given-name>
                                 <ce:surname>Takahashi</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>T.</ce:given-name>
                                 <ce:surname>Yokotagawa</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>T.</ce:given-name>
                                 <ce:surname>Furuya</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>T.</ce:given-name>
                                 <ce:surname>Okawara</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.</ce:given-name>
                                 <ce:surname>Otsuka</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>N.</ce:given-name>
                                 <ce:surname>Ogo</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>T.</ce:given-name>
                                 <ce:surname>Ashizawa</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>C.</ce:given-name>
                                 <ce:surname>Oshita</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>S.</ce:given-name>
                                 <ce:surname>Tai</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>H.</ce:given-name>
                                 <ce:surname>Ishii</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>Y.</ce:given-name>
                                 <ce:surname>Akiyama</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>A.</ce:given-name>
                                 <ce:surname>Asai</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Identification of a new series of STAT3 inhibitors by virtual screening</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>ACS Med. Chem. Lett.</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>1</sb:volume-nr>
                              </sb:series>
                              <sb:date>2010</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>371</sb:first-page>
                              <sb:last-page>375</sb:last-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib9">
                     <ce:label>[9]</ce:label>
                     <sb:reference id="sref9">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>H.</ce:given-name>
                                 <ce:surname>Song</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>R.</ce:given-name>
                                 <ce:surname>Wang</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>S.</ce:given-name>
                                 <ce:surname>Wang</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.</ce:given-name>
                                 <ce:surname>Lin</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>A low-molecular-weight compound discovered through virtual database screening inhibits Stat3 function in breast cancer cells</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Proc. Natl. Acad. Sci. U. S. A.</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>102</sb:volume-nr>
                              </sb:series>
                              <sb:date>2005</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>4700</sb:first-page>
                              <sb:last-page>4705</sb:last-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib10">
                     <ce:label>[10]</ce:label>
                     <sb:reference id="sref10">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>H.</ce:given-name>
                                 <ce:surname>Chen</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>Z.</ce:given-name>
                                 <ce:surname>Yang</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>C.</ce:given-name>
                                 <ce:surname>Ding</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>L.</ce:given-name>
                                 <ce:surname>Chu</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>Y.</ce:given-name>
                                 <ce:surname>Zhang</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>K.</ce:given-name>
                                 <ce:surname>Terry</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>H.</ce:given-name>
                                 <ce:surname>Liu</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>Q.</ce:given-name>
                                 <ce:surname>Shen</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.</ce:given-name>
                                 <ce:surname>Zhou</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Discovery of O-alkylamino tethered niclosamide derivatives as potent and orally bioavailable anticancer agents</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>ACS Med. Chem. Lett.</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>4</sb:volume-nr>
                              </sb:series>
                              <sb:date>2013</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>180</sb:first-page>
                              <sb:last-page>185</sb:last-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib11">
                     <ce:label>[11]</ce:label>
                     <sb:reference id="sref11">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>S.W.</ce:given-name>
                                 <ce:surname>Yu Wang</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>Yansheng</ce:given-name>
                                 <ce:surname>Wu</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>Yu</ce:given-name>
                                 <ce:surname>Ren</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>Zhaoqing</ce:given-name>
                                 <ce:surname>Li</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>Xiaofeng</ce:given-name>
                                 <ce:surname>Yao</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>Chao</ce:given-name>
                                 <ce:surname>Zhang</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>Na</ce:given-name>
                                 <ce:surname>Ye</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.D.</ce:given-name>
                                 <ce:surname>Chao Jing</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>Kailiang</ce:given-name>
                                 <ce:surname>Zhang</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>Shanshan</ce:given-name>
                                 <ce:surname>Sun</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>Minghui</ce:given-name>
                                 <ce:surname>Zhao</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>Wenyu</ce:given-name>
                                 <ce:surname>Guo</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>Xin</ce:given-name>
                                 <ce:surname>Qu</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>Yu</ce:given-name>
                                 <ce:surname>Qiao</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>L.K.</ce:given-name>
                                 <ce:surname>Haiying Chen</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>Rui</ce:given-name>
                                 <ce:surname>Jin</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>Xudong</ce:given-name>
                                 <ce:surname>Wang</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>Lun</ce:given-name>
                                 <ce:surname>Zhang</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>Zhou</ce:given-name>
                                 <ce:surname>Jia</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>Qiang</ce:given-name>
                                 <ce:surname>Shen</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>Xuan</ce:given-name>
                                 <ce:surname>Zhou</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Suppression of the growth and invasion of human head and neck squamous cell carcinomas via regulating STAT3 signaling and miR-21/β-catenin Axis with HJC0152</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Mol. Canc. Therapeut.</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>16</sb:volume-nr>
                              </sb:series>
                              <sb:issue-nr>4</sb:issue-nr>
                              <sb:date>2017</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>578</sb:first-page>
                              <sb:last-page>590</sb:last-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib12">
                     <ce:label>[12]</ce:label>
                     <sb:reference id="sref12">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>H.</ce:given-name>
                                 <ce:surname>Chen</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>Z.</ce:given-name>
                                 <ce:surname>Yang</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>C.</ce:given-name>
                                 <ce:surname>Ding</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>A.</ce:given-name>
                                 <ce:surname>Xiong</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>C.</ce:given-name>
                                 <ce:surname>Wild</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>L.</ce:given-name>
                                 <ce:surname>Wang</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>N.</ce:given-name>
                                 <ce:surname>Ye</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>G.</ce:given-name>
                                 <ce:surname>Cai</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>R.M.</ce:given-name>
                                 <ce:surname>Flores</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>Y.</ce:given-name>
                                 <ce:surname>Ding</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>Q.</ce:given-name>
                                 <ce:surname>Shen</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.</ce:given-name>
                                 <ce:surname>Zhou</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Discovery of potent anticancer agent HJC0416, an orally bioavailable small molecule inhibitor of signal transducer and activator of transcription 3 (STAT3)</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Eur. J. Med. Chem.</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>82</sb:volume-nr>
                              </sb:series>
                              <sb:date>2014</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>195</sb:first-page>
                              <sb:last-page>203</sb:last-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib13">
                     <ce:label>[13]</ce:label>
                     <sb:reference id="sref13">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>L.</ce:given-name>
                                 <ce:surname>Lin</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>B.</ce:given-name>
                                 <ce:surname>Hutzen</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>P.-K.</ce:given-name>
                                 <ce:surname>Li</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>S.</ce:given-name>
                                 <ce:surname>Ball</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.</ce:given-name>
                                 <ce:surname>Zuo</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>S.</ce:given-name>
                                 <ce:surname>DeAngelis</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>E.</ce:given-name>
                                 <ce:surname>Foust</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.</ce:given-name>
                                 <ce:surname>Sobo</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>L.</ce:given-name>
                                 <ce:surname>Friedman</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>D.</ce:given-name>
                                 <ce:surname>Bhasin</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>L.</ce:given-name>
                                 <ce:surname>Cen</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>C.</ce:given-name>
                                 <ce:surname>Li</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.</ce:given-name>
                                 <ce:surname>Lin</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>A novel small molecule, LLL12, inhibits STAT3 phosphorylation and activities and exhibits potent growth-suppressive activity in human cancer cells</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Neoplasia</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>12</sb:volume-nr>
                              </sb:series>
                              <sb:date>2010</sb:date>
                           </sb:issue>
                        </sb:host>
                        <sb:comment>39-IN35</sb:comment>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib14">
                     <ce:label>[14]</ce:label>
                     <sb:reference id="sref14">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>W.</ce:given-name>
                                 <ce:surname>Yu</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>H.</ce:given-name>
                                 <ce:surname>Xiao</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.</ce:given-name>
                                 <ce:surname>Lin</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>C.</ce:given-name>
                                 <ce:surname>Li</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Discovery of novel STAT3 small molecule inhibitors via in silico site-directed fragment-based drug design</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>J. Med. Chem.</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>56</sb:volume-nr>
                              </sb:series>
                              <sb:date>2013</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>4402</sb:first-page>
                              <sb:last-page>4412</sb:last-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib15">
                     <ce:label>[15]</ce:label>
                     <sb:reference id="sref15">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>S.</ce:given-name>
                                 <ce:surname>Fiorito</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>F.</ce:given-name>
                                 <ce:surname>Epifano</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>C.</ce:given-name>
                                 <ce:surname>Bruyere</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>V.</ce:given-name>
                                 <ce:surname>Mathieu</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>R.</ce:given-name>
                                 <ce:surname>Kiss</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>S.</ce:given-name>
                                 <ce:surname>Genovese</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Growth inhibitory activity for cancer cell lines of lapachol and its natural and semi-synthetic derivatives</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Bioorg. Med. Chem. Lett</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>24</sb:volume-nr>
                              </sb:series>
                              <sb:date>2014</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>454</sb:first-page>
                              <sb:last-page>457</sb:last-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib16">
                     <ce:label>[16]</ce:label>
                     <sb:reference id="sref16">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>K.O.</ce:given-name>
                                 <ce:surname>Eyong</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>P.S.</ce:given-name>
                                 <ce:surname>Kumar</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>V.</ce:given-name>
                                 <ce:surname>Kuete</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>G.N.</ce:given-name>
                                 <ce:surname>Folefoc</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>E.A.</ce:given-name>
                                 <ce:surname>Nkengfack</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>S.</ce:given-name>
                                 <ce:surname>Baskaran</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Semisynthesis and antitumoral activity of 2-acetylfuranonaphthoquinone and other naphthoquinone derivatives from lapachol</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Bioorg. Med. Chem. Lett</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>18</sb:volume-nr>
                              </sb:series>
                              <sb:date>2008</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>5387</sb:first-page>
                              <sb:last-page>5390</sb:last-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib17">
                     <ce:label>[17]</ce:label>
                     <sb:reference id="sref17">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>S.</ce:given-name>
                                 <ce:surname>Bannwitz</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>D.</ce:given-name>
                                 <ce:surname>Krane</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>S.</ce:given-name>
                                 <ce:surname>Vortherms</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>T.</ce:given-name>
                                 <ce:surname>Kalin</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>C.</ce:given-name>
                                 <ce:surname>Lindenschmidt</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>N.</ce:given-name>
                                 <ce:surname>Zahedi Golpayegani</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.</ce:given-name>
                                 <ce:surname>Tentrop</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>H.</ce:given-name>
                                 <ce:surname>Prinz</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>K.</ce:given-name>
                                 <ce:surname>Muller</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Synthesis and structure-activity relationships of lapacho analogues. 2. Modification of the basic naphtho[2,3-b]furan-4,9-dione, redox activation, and suppression of human keratinocyte hyperproliferation by 8-hydroxynaphtho[2,3-b]thiophene-4,9-diones</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>J. Med. Chem.</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>57</sb:volume-nr>
                              </sb:series>
                              <sb:date>2014</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>6226</sb:first-page>
                              <sb:last-page>6239</sb:last-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib18">
                     <ce:label>[18]</ce:label>
                     <sb:reference id="sref18">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>J.M.</ce:given-name>
                                 <ce:surname>Hubbard</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>A.</ce:given-name>
                                 <ce:surname>Grothey</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Napabucasin: an update on the first-in-class cancer stemness inhibitor</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Drugs</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>77</sb:volume-nr>
                              </sb:series>
                              <sb:date>2017</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>1091</sb:first-page>
                              <sb:last-page>1103</sb:last-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib19">
                     <ce:label>[19]</ce:label>
                     <sb:reference id="sref19">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>A.</ce:given-name>
                                 <ce:surname>Reichstein</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>S.</ce:given-name>
                                 <ce:surname>Vortherms</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>S.</ce:given-name>
                                 <ce:surname>Bannwitz</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.</ce:given-name>
                                 <ce:surname>Tentrop</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>H.</ce:given-name>
                                 <ce:surname>Prinz</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>K.</ce:given-name>
                                 <ce:surname>Muller</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Synthesis and structure-activity relationships of lapacho analogues. 1. Suppression of human keratinocyte hyperproliferation by 2-substituted naphtho[2,3-b]furan-4,9-diones, activation by enzymatic one- and two-electron reduction, and intracellular generation of superoxide</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>J. Med. Chem.</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>55</sb:volume-nr>
                              </sb:series>
                              <sb:date>2012</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>7273</sb:first-page>
                              <sb:last-page>7284</sb:last-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib20">
                     <ce:label>[20]</ce:label>
                     <sb:reference id="sref20">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>Q.</ce:given-name>
                                 <ce:surname>Zhou</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>C.</ce:given-name>
                                 <ce:surname>Peng</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>F.</ce:given-name>
                                 <ce:surname>Du</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>L.</ce:given-name>
                                 <ce:surname>Zhou</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>Y.</ce:given-name>
                                 <ce:surname>Shi</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>Y.</ce:given-name>
                                 <ce:surname>Du</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>D.</ce:given-name>
                                 <ce:surname>Liu</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>W.</ce:given-name>
                                 <ce:surname>Sun</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.</ce:given-name>
                                 <ce:surname>Zhang</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>G.</ce:given-name>
                                 <ce:surname>Chen</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Design, synthesis and activity of BBI608 derivatives targeting on stem cells</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Eur. J. Med. Chem.</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>151</sb:volume-nr>
                              </sb:series>
                              <sb:date>2018</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>39</sb:first-page>
                              <sb:last-page>50</sb:last-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib21">
                     <ce:label>[21]</ce:label>
                     <sb:reference id="sref21">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>A.W.</ce:given-name>
                                 <ce:surname>Zhiwei Jiang</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>Hongwei</ce:given-name>
                                 <ce:surname>Hu</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>Jiali</ce:given-name>
                                 <ce:surname>Xu</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>Yuesong</ce:given-name>
                                 <ce:surname>Hu</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Novel Esters of 4, 9-dihydroxy-naphtho [2, 3-B] Furans for Disease Therapies</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:book>
                              <sb:date>2013</sb:date>
                              <sb:publisher>
                                 <sb:name>US20130345176A1</sb:name>
                              </sb:publisher>
                           </sb:book>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib22">
                     <ce:label>[22]</ce:label>
                     <sb:reference id="sref22">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>M.</ce:given-name>
                                 <ce:surname>Kortylewski</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.</ce:given-name>
                                 <ce:surname>Kujawski</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>T.</ce:given-name>
                                 <ce:surname>Wang</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>S.</ce:given-name>
                                 <ce:surname>Wei</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>S.</ce:given-name>
                                 <ce:surname>Zhang</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>S.</ce:given-name>
                                 <ce:surname>Pilon-Thomas</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>G.</ce:given-name>
                                 <ce:surname>Niu</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>H.</ce:given-name>
                                 <ce:surname>Kay</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.</ce:given-name>
                                 <ce:surname>Mule</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>W.G.</ce:given-name>
                                 <ce:surname>Kerr</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>R.</ce:given-name>
                                 <ce:surname>Jove</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>D.</ce:given-name>
                                 <ce:surname>Pardoll</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>H.</ce:given-name>
                                 <ce:surname>Yu</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Inhibiting Stat3 signaling in the hematopoietic system elicits multicomponent antitumor immunity</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Nat. Med.</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>11</sb:volume-nr>
                              </sb:series>
                              <sb:date>2005</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>1314</sb:first-page>
                              <sb:last-page>1321</sb:last-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib23">
                     <ce:label>[23]</ce:label>
                     <sb:reference id="sref23">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>R.K.J.</ce:given-name>
                                 <ce:surname>Chongming Wu</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>Michael R.</ce:given-name>
                                 <ce:surname>Mattern</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>Jackson C.</ce:given-name>
                                 <ce:surname>Wong</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>David G.I.</ce:given-name>
                                 <ce:surname>Kingston</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Synthesis of furanonaphthoquinones with hydroxyamino side chains</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>J. Nat. Prod.</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>62</sb:volume-nr>
                              </sb:series>
                              <sb:date>1999</sb:date>
                           </sb:issue>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
               </ce:bibliography-sec>
            </ce:bibliography>
         </tail>
      </article>
   </xocs:serial-item></xocs:doc></originaltext></full-text-retrieval-response>